Author: "Van, Dam" / Topic: business - Searchworks@Jio Institute Digital Library Search Results

Your search keyword '"Van, Dam"' showing total 3,239 results

Start Over Author "Van, Dam" Topic business

3,239 results on '"Van, Dam"'

1. RCE Rhine-Meuse: Towards Learning for Sustainable Development

Author: van Dam-Mieras, M. C. E. and Rikers, J. H. A. N.
Abstract: In the context of the UN Decade of Education for Sustainable Development (DESD), United Nations University (UNU) initiated the creation of a network of Regional Centres of Expertise (RCEs) for Education for Sustainable Development. This paper describes the philosophy behind the activities performed by one of those RCEs, RCE Rhine-Meuse, an RCE initiative in the triangle formed by the cities of Eindhoven (the Netherlands), Cologne (Germany) and Leuven (Belgium). A small and flexible structure was created that allows the organisation to operate at the lowest possible level of costs. Safeguards in relation to both academic quality and stakeholder participation were instituted to guarantee a lasting commitment on the part of regional actors; and a strategic advisory board made up of regional stakeholders and academic professionals was formed. Some examples of RCE Rhine-Meuse projects are given. (Contains 1 figure and 2 notes.)
Published: 2007
Full Text: View/download PDF

2. Theories and practices for reconciling transport, public space, and people – a review

Author: Liu Yang, Arnab Majumdar, Lufeng Zhang, and Koen H. van Dam
Subjects: Sustainable development, Public space, Transportation planning, Sustainability, Urban regeneration, Business, Infrastructure planning, Environmental planning, Civil and Structural Engineering, Transport infrastructure
Abstract: Prioritising people and public spaces in urban transport infrastructure planning is crucial to achieving sustainable development. This paper examines the theories, principles and real-world practices in pursuing a human-centred and sustainable design of an integrated transport infrastructure–public space system. The paper chronologically reviews the origins of the concept for building such a holistic system within urban and transportation planning discourse and revisits a set of typical practices of applying the design theories to various urban contexts. The findings of this paper are presented in a timeline of multi-disciplinary theories, and in a table of development patterns of context-based solutions for reconciling transport, spaces and people. These results expand theoretical and practical knowledge of strategies for integrating transport, spaces and people in urban regeneration programmes. Furthermore, they could support practitioners and scholars to revisit existing urban projects and to develop sustainable transport plans prioritising the roles of people and public space.
Published: 2022
Full Text: View/download PDF

3. Pan-European survey on the implementation of robotic and laparoscopic minimally invasive liver surgery

Author: Frederik Berrevoet, Carolijn L.M.A. Nota, Luca Aldrighetti, Ronald M. van Dam, Emir Hoti, Jeroen Hagendoorn, Maurice J. W. Zwart, Rutger-Jan Swijnenburg, Burak Görgec, R. Fichtinger, Marcel J. van der Poel, David Fuks, Bjørn Edwin, Mohammed Abu Hilal, Marc G. Besselink, Abdullah Arabiyat, Graduate School, Surgery, CCA - Cancer Treatment and Quality of Life, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, CCA -Cancer Center Amsterdam, Radiology and Nuclear Medicine, Zwart, M. J. W., Gorgec, B., Arabiyat, A., Nota, C. L. M., van der Poel, M. J., Fichtinger, R. S., Berrevoet, F., van Dam, R. M., Aldrighetti, L., Fuks, D., Hoti, E., Edwin, B., Besselink, M. G., Abu Hilal, M., Hagendoorn, J., Swijnenburg, R. -J., RS: NUTRIM - R2 - Liver and digestive health, MUMC+: MA Heelkunde (9), and RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy
Subjects: Liver surgery, CLINICAL-OUTCOMES, medicine.medical_specialty, RESECTION, IMPACT, HEPATECTOMY, Liver resections, Resection, Robotic Surgical Procedures, Pan european, Medicine and Health Sciences, Hepatectomy, Humans, Minimally Invasive Surgical Procedures, Medicine, Robotic surgery, Hepatology, business.industry, General surgery, Gastroenterology, Center volume, surgical procedures, operative, Liver, EXPERIENCE, Laparoscopy, business
Abstract: BACKGROUND: Laparoscopic and robotic minimally invasive liver surgery (MILS) is gaining popularity. Recent data and views on the implementation of laparoscopic and robotic MILS throughout Europe are lacking.METHODS: An anonymous survey consisting of 46 questions was sent to all members of the European-African Hepato-Pancreato-Biliary Association.RESULTS: The survey was completed by 120 surgeons from 103 centers in 24 countries. Median annual center volume of liver resection was 100 [IQR 50-140]. The median annual volume of MILS per center was 30 [IQR 16-40]. For minor resections, laparoscopic MILS was used by 80 (67%) surgeons and robotic MILS by 35 (29%) surgeons. For major resections, laparoscopic MILS was used by 74 (62%) surgeons and robotic MILS by 33 (28%) surgeons. The majority of the surgeons stated that minimum annual volume of MILS per center should be around 21-30 procedures/year. Of the surgeons performing robotic surgery, 28 (70%) felt they missed specific equipment, such as a robotic-CUSA. Seventy (66%) surgeons provided a formal MILS training to residents and fellows. In 5 years' time, 106 (88%) surgeons felt that MILS would have superior value as compared to open liver surgery.CONCLUSION: In the participating European liver centers, MILS comprised about one third of all liver resections and is expected to increase further. Laparoscopic MILS is still twice as common as robotic MILS. Development of specific instruments for robotic liver parenchymal transection might further increase its adoption.
Published: 2022
Full Text: View/download PDF

4. Underestimating harm in mindfulness-based stress reduction

Author: Nicholas T. Van Dam, Julieta Galante, Van Dam, Nicholas T [0000-0002-1131-0739], and Apollo - University of Cambridge Repository
Subjects: Mindfulness-based stress reduction, Psychiatry and Mental health, Psychotherapist, Harm, business.industry, Depression, MEDLINE, Medicine, Humans, business, Mindfulness, Applied Psychology, Stress, Psychological
Published: 2023

5. Epidermal Growth Factor Receptor-Targeted Fluorescence Molecular Imaging for Postoperative Lymph Node Assessment in Patients with Oral Cancer

Author: Gooitzen M. van Dam, Evert van den Broek, Yang Hang Tang, Bert van der Vegt, W. T. R. Hooghiemstra, Jan J. Doff, Kees-Pieter Schepman, Jasper Vonk, Sebastiaan A. H. J. de Visscher, Matthijs D. Linssen, Max J. H. Witjes, F. J. Voskuil, Jaron Gérard de Wit, Damage and Repair in Cancer Development and Cancer Treatment (DARE), Basic and Translational Research and Imaging Methodology Development in Groningen (BRIDGE), Guided Treatment in Optimal Selected Cancer Patients (GUTS), Microbes in Health and Disease (MHD), and Targeted Gynaecologic Oncology (TARGON)
Subjects: medicine.medical_specialty, PET/CT, EGFR, Cetuximab, fluorescence molecular imaging, cetuximab-800CW, Metastasis, NECK-CANCER, medicine, Humans, Radiology, Nuclear Medicine and imaging, HEAD, Stage (cooking), Lymph node, Retrospective Studies, integumentary system, lymph node metastasis, business.industry, Head and neck cancer, Cancer, medicine.disease, Primary tumor, Molecular Imaging, ErbB Receptors, medicine.anatomical_structure, VISION, Head and Neck Neoplasms, Lymphatic Metastasis, Carcinoma, Squamous Cell, Resection margin, Lymph Node Excision, Mouth Neoplasms, head and neck cancer, Lymph Nodes, Radiology, business, epidermal growth factor receptor, BURDEN, medicine.drug
Abstract: In most oral cancer patients, surgical treatment includes resection of the primary tumor combined with excision of lymph nodes (LNs), either for staging or for treatment. All LNs harvested during surgery require tissue processing and subsequent microscopic histopathologic assessment to determine the nodal stage. In this study, we investigated the use of the fluorescent tracer cetuximab-800CW to discriminate between tumor-positive and tumor-negative LNs before histopathologic examination. Here, we report a retrospective ad hoc analysis of a clinical trial designed to evaluate the resection margin in patients with oral squamous cell carcinoma (NCT02415881). Methods: Two days before surgery, patients were intravenously administered 75 mg of cetuximab followed by 15 mg of cetuximab800CW, an epidermal growth factor receptor-targeting fluorescent tracer. Fluorescence images of excised, formalin-fixed LNs were obtained and correlated with histopathologic assessment. Results: Fluorescence molecular imaging of 514 LNs (61 pathologically positive nodes) could detect tumor-positive LNs ex vivo with 100% sensitivity and 86.8% specificity (area under the curve, 0.98). In this cohort, the number of LNs that required microscopic assessment was decreased by 77.4%, without missing any metastases. Additionally, in 7.5% of the LNs false-positive on fluorescence imaging, we identified metastases missed by standard histopathologic analysis. Conclusion: Our findings suggest that epidermal growth factor receptor-targeted fluorescence molecular imaging can aid in the detection of LN metastases in the ex vivo setting in oral cancer patients. This image-guided concept can improve the efficacy of postoperative LN examination and identify additional metastases, thus safeguarding appropriate postoperative therapy and potentially improving prognosis.
Published: 2022
Full Text: View/download PDF

6. Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblings

Author: Velthorst E., Mollon J., Murray R. M., de Haan L., Germeys I. M., Glahn D. C., Arango C., van der Ven E., Di Forti M., Bernardo M., Guloksuz S., Delespaul P., Mezquida G., Amoretti S., Bobes J., Saiz P. A., Garcia-Portilla M. P., Santos J. L., Jimenez-Lopez E., Sanjuan J., Aguilar E. J., Arrojo M., Carracedo A., Lopez G., Gonzalez-Penas J., Parellada M., Atbasoglu C., Saka M. C., Ucok A., Alptekin K., Akdede B., Binbay T., Altinyazar V., Ulas H., Yalincetin B., Gumus-Akay G., Beyaz B. C., Soygur H., Cankurtaran E. S., Kaymak S. U., Maric N. P., Mihaljevic M. M., Petrovic S. A., Mirjanic T., Del-Ben C. M., Ferraro L., Gayer-Anderson C., Jones P. B., Jongsma H. E., Kirkbride J. B., La Cascia C., Lasalvia A., Tosato S., Llorca P. -M., Menezes P. R., Morgan C., Quattrone D., Menchetti M., Selten J. -P., Szoke A., Tarricone I., Tortelli A., McGuire P., Valmaggia L., Kempton M. J., van der Gaag M., Riecher-Rossler A., Bressan R. A., Barrantes-Vidal N., Nelson B., McGorry P., Pantelis C., Krebs M. -O., Ruhrmann S., Sachs G., Rutten B. P. F., van Os J., Alizadeh B. Z., van Amelsvoort T., Bartels-Velthuis A. A., Bruggeman R., van Beveren N. J., Luykx J. J., Cahn W., Simons C. J. P., Kahn R. S., Schirmbeck F., van Winkel R., Calem M., Tognin S., Modinos G., Pisani S., Kraan T. C., van Dam D. S., Burger N., Amminger G. P., Politis A., Goodall J., Borgwardt S., Studerus E., Gadelha A., Brietzke E., Asevedo G., Asevedo E., Zugman A., Dominguez-Martinez T., Monsonet M., Cristobal-Narvaez P., Racioppi A., Kwapil T. R., Kazes M., Daban C., Bourgin J., Gay O., Mam-Lam-Fook C., Nordholm D., Rander L., Krakauer K., Glenthoj L. B., Glenthoj B., Gebhard D., Arnhold J., Klosterkotter J., Lasser I., Winklbaur B., Reichenberg A., Velthorst E., Mollon J., Murray R.M., de Haan L., Germeys I.M., Glahn D.C., Arango C., van der Ven E., Di Forti M., Bernardo M., Guloksuz S., Delespaul P., Mezquida G., Amoretti S., Bobes J., Saiz P.A., Garcia-Portilla M.P., Santos J.L., Jimenez-Lopez E., Sanjuan J., Aguilar E.J., Arrojo M., Carracedo A., Lopez G., Gonzalez-Penas J., Parellada M., Atbasoglu C., Saka M.C., Ucok A., Alptekin K., Akdede B., Binbay T., Altinyazar V., Ulas H., Yalincetin B., Gumus-Akay G., Beyaz B.C., Soygur H., Cankurtaran E.S., Kaymak S.U., Maric N.P., Mihaljevic M.M., Petrovic S.A., Mirjanic T., Del-Ben C.M., Ferraro L., Gayer-Anderson C., Jones P.B., Jongsma H.E., Kirkbride J.B., La Cascia C., Lasalvia A., Tosato S., Llorca P.-M., Menezes P.R., Morgan C., Quattrone D., Menchetti M., Selten J.-P., Szoke A., Tarricone I., Tortelli A., McGuire P., Valmaggia L., Kempton M.J., van der Gaag M., Riecher-Rossler A., Bressan R.A., Barrantes-Vidal N., Nelson B., McGorry P., Pantelis C., Krebs M.-O., Ruhrmann S., Sachs G., Rutten B.P.F., van Os J., Alizadeh B.Z., van Amelsvoort T., Bartels-Velthuis A.A., Bruggeman R., van Beveren N.J., Luykx J.J., Cahn W., Simons C.J.P., Kahn R.S., Schirmbeck F., van Winkel R., Calem M., Tognin S., Modinos G., Pisani S., Kraan T.C., van Dam D.S., Burger N., Amminger G.P., Politis A., Goodall J., Borgwardt S., Studerus E., Gadelha A., Brietzke E., Asevedo G., Asevedo E., Zugman A., Dominguez-Martinez T., Monsonet M., Cristobal-Narvaez P., Racioppi A., Kwapil T.R., Kazes M., Daban C., Bourgin J., Gay O., Mam-Lam-Fook C., Nordholm D., Rander L., Krakauer K., Glenthoj L.B., Glenthoj B., Gebhard D., Arnhold J., Klosterkotter J., Lasser I., Winklbaur B., Reichenberg A., RS: MHeNs - R2 - Mental Health, Psychiatrie & Neuropsychologie, RS: MHeNs - R1 - Cognitive Neuropsychiatry and Clinical Neuroscience, Neurosciences, Psychiatry, Clinical Developmental Psychology, World Health Organization (WHO) Collaborating Center, Life Course Epidemiology (LCE), Groningen Institute for Gastro Intestinal Genetics and Immunology (3GI), Clinical Cognitive Neuropsychiatry Research Program (CCNP), Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET), Adult Psychiatry, APH - Mental Health, Amsterdam Neuroscience - Complex Trait Genetics, and Amsterdam Neuroscience - Mood, Anxiety, Psychosis, Stress & Sleep
Subjects: 0301 basic medicine, validity, medicine.medical_treatment, CHILDHOOD, Neuropsychological Tests, FAMÍLIA, episode, Cognition, 0302 clinical medicine, DEFICITS, Settore MED/48 -Scienze Infermierist. e Tecn. Neuro-Psichiatriche e Riabilitat, Medicine, Cognitive impairment, Psychiatry, Symptom severity, Cannabis use, IMPAIRMENT, ABILITY, Psychiatry and Mental health, Schizophrenia, RELIABILITY, Neuropsychological Test, Life Sciences & Biomedicine, Human, Clinical psychology, Adult, Biochemistry & Molecular Biology, impairment, schizophrenia-patients, ability, GENETIC RISK, Psychotic Disorder, SCHIZOPHRENIA-PATIENTS, 03 medical and health sciences, Cellular and Molecular Neuroscience, SDG 3 - Good Health and Well-being, Settore M-PSI/08 - Psicologia Clinica, Humans, In patient, Cognitive skill, VALIDITY, Antipsychotic, Molecular Biology, Settore MED/25 - Psichiatria, Aged, Cross-Sectional Studie, DECLINE, Science & Technology, reliability, business.industry, Working memory, Siblings, Neurosciences, Diagnostic markers, medicine.disease, Cross-Sectional Studies, 030104 developmental biology, deficits, Psychotic Disorders, PSYCHOSIS, COGNITION, MULTICENTRIC STUDY, Neurosciences & Neurology, business, EPISODE, 030217 neurology & neurosurgery
Abstract: The European Community’s Seventh Framework Programme under grant agreement No. HEALTH-F2-2010-241909 (EUGEI); The Spanish sample was supported by the Spanish Ministry of Science and Innovation, Instituto de Salud Carlos III (SAM16PE07CP1, PI16/02012, PI19/024) (...), Velthorst, E., Mollon, J., Murray, R.M., de Haan, L., Germeys, I.M., Glahn, D.C., Arango, C., van der Ven, E., Di Forti, M., Bernardo, M., Guloksuz, S., Delespaul, P., Mezquida, G., Amoretti, S., Bobes, J., Saiz, P.A., García-Portilla, M.P., Santos, J.L., Jiménez-López, E., Sanjuan, J., Aguilar, E.J., Arrojo, M., Carracedo, A., López, G., González-Peñas, J., Parellada, M., Atbaşoğlu, C., Saka, M.C., Üçok, A., Alptekin, K., Akdede, B., Binbay, T., Altınyazar, V., Ulaş, H., Yalınçetin, B., Gümüş-Akay, G., Beyaz, B.C., Soygür, H., Cankurtaran, E.Ş., Kaymak, S.U., Maric, N.P., Mihaljevic, M.M., Petrovic, S.A., Mirjanic, T., Del-Ben, C.M., Ferraro, L., Gayer-Anderson, C., Jones, P.B., Jongsma, H.E., Kirkbride, J.B., La Cascia, C., Lasalvia, A., Tosato, S., Llorca, P.-M., Menezes, P.R., Morgan, C., Quattrone, D., Menchetti, M., Selten, J.-P., Szöke, A., Tarricone, I., Tortelli, A., McGuire, P., Valmaggia, L., Kempton, M.J., van der Gaag, M., Riecher-Rössler, A., Bressan, R.A., Barrantes-Vidal, N., Nelson, B., McGorry, P., Pantelis, C., Krebs, M.-O., Ruhrmann, S., Sachs, G., Rutten, B.P.F., van Os, J., Alizadeh, B.Z., van Amelsvoort, T., Bartels-Velthuis, A.A., Bruggeman, R., van Beveren, N.J., Luykx, J.J., Cahn, W., Simons, C.J.P., Kahn, R.S., Schirmbeck, F., van Winkel, R., Calem, M., Tognin, S., Modinos, G., Pisani, S., Kraan, T.C., van Dam, D.S., Burger, N., Amminger, G.P., Politis, A., Goodall, J., Borgwardt, S., Studerus, E., Gadelha, A., Brietzke, E., Asevedo, G., Asevedo, E., Zugman, A., Domínguez-Martínez, T., Monsonet, M., Cristóbal-Narváez, P., Racioppi, A., Kwapil, T.R., Kazes, M., Daban, C., Bourgin, J., Gay, O., Mam-Lam-Fook, C., Nordholm, D., Rander, L., Krakauer, K., Glenthøj, L.B., Glenthøj, B., Gebhard, D., Arnhold, J., Klosterkötter, J., Lasser, I., Winklbaur, B., Reichenberg, A., EU-GEI High Risk Study
Published: 2021
Full Text: View/download PDF

7. Obsessive-Compulsive Symptoms and Other Symptoms of the At-risk Mental State for Psychosis

Author: Ong, Hui Lin, Isvoranu, Adela-Maria, Schirmbeck, Frederike, McGuire, Philip, Valmaggia, Lucia, Kempton, Matthew J., van der Gaag, Mark, Riecher-Rössler, Anita, Bressan, Rodrigo A., Barrantes-Vidal, Neus, Nelson, Barnaby, Amminger, G. Paul, McGorry, Patrick, Pantelis, Christos, Krebs, Marie-Odile, Nordentoft, Merete, Glenthøj, Birte, Ruhrmann, Stephan, Sachs, Gabriele, Rutten, Bart P. F., van Os, Jim, de Haan, Lieuwe, Borsboom, Denny, Calem, Maria, Tognin, Stefania, Modinos, Gemma, Pisani, Sara, Hedges, Emily, Velthorst, Eva, Kraan, Tamar C., van Dam, Daniella S., Burger, Nadine, Politis, Athena, Goodall, Joanne, Borgwardt, Stefan, Studerus, Erich, Gadelha, Ary, Brietzke, Elisa, Asevedo, Graccielle, Asevedo, Elson, Zugman, Andre, Domínguez-Martínez, Tecelli, Monsonet, Manel, Hinojosa, Lidia, Racioppi, Anna, Kwapil, Thomas R., Kazes, Mathilde, Daban, Claire, Bourgin, Julie, Gay, Olivier, Mam-Lam-Fook, C. lia, Nordholm, Dorte, Randers, Lasse, Krakauer, Kristine, Glenthøj, Louise Birkedal, Gebhard, Dominika, Arnhold, Julia, Klosterkötter, Joachim, Lasser, Iris, Winklbaur, Bernadette, Delespaul, Philippe A., University of Amsterdam [Amsterdam] (UvA), Arkin Institute for Mental Health [Amsterdam, The Netherlands] (AIMH), King‘s College London, Vrije Universiteit Amsterdam [Amsterdam] (VU), Universitätsspital Basel [Switzerland], Universidade Federal de São Paulo, Universitat Autònoma de Barcelona (UAB), Centro de Investigación Biomédica en Red Salud Mental [Madrid] (CIBER-SAM), University of Melbourne, Institut de psychiatrie et neurosciences de Paris (IPNP - U1266 Inserm), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Paris (UP), University of Copenhagen = Københavns Universitet (KU), University of Cologne, Medizinische Universität Wien = Medical University of Vienna, Maastricht University Medical Centre (MUMC), Maastricht University [Maastricht], Utrecht University [Utrecht], EU-GEI High Risk Study: Maria Calem, Stefania Tognin, Gemma Modinos, Sara Pisani, Emily Hedges, Eva Velthorst, Tamar C Kraan, Daniella S van Dam, Nadine Burger, Athena Politis, Joanne Goodall, Stefan Borgwardt, Erich Studerus, Ary Gadelha, Elisa Brietzke, Graccielle Asevedo, Elson Asevedo, Andre Zugman, Tecelli Domínguez-Martínez, Manel Monsonet, Lidia Hinojosa, Anna Racioppi, Thomas R Kwapil, Mathilde Kazes, Claire Daban, Julie Bourgin, Olivier Gay, Célia Mam-Lam-Fook, Dorte Nordholm, Lasse Randers, Kristine Krakauer, Louise Birkedal Glenthøj, Dominika Gebhard, Julia Arnhold, Joachim Klosterkötter, Iris Lasser, Bernadette Winklbaur, Philippe A Delespaul, Adult Psychiatry, ANS - Mood, Anxiety, Psychosis, Stress & Sleep, APH - Mental Health, ANS - Complex Trait Genetics, Psychologische Methodenleer (Psychologie, FMG), Clinical Psychology, RS: MHeNs - R3 - Neuroscience, Psychiatrie & Neuropsychologie, MUMC+: MA Psychiatrie (3), RS: MHeNs - R2 - Mental Health, Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), University of Copenhagen = Københavns Universitet (UCPH), and Martinez Rico, Clara
Subjects: Male, DISORDER, Obsessive-Compulsive Disorder, Ultra-high risk, obsessive-compulsive, Psychological intervention, clinical high risk, Anxiety, 0302 clinical medicine, SCHIZOPHRENIA, COMPREHENSIVE ASSESSMENT, psychosis, Social isolation, network analysis, Depression (differential diagnoses), ASSOCIATIONS, Psychiatry, [SDV.MHEP] Life Sciences [q-bio]/Human health and pathology, Obsessive-compulsive, Depression, Clinical high risk, anxiety, CHILDHOOD TRAUMA, Psychiatry and Mental health, Schizophrenia, depression, Blunted Affect, Female, Network analysis, medicine.symptom, Life Sciences & Biomedicine, Clinical psychology, Adult, Psychosis, AcademicSubjects/MED00810, Risk Assessment, ultra-high risk, 03 medical and health sciences, Young Adult, medicine, Humans, METAANALYSIS, VULNERABILITY, SPECTRUM, Science & Technology, business.industry, At risk mental state, medicine.disease, 030227 psychiatry, INDIVIDUALS, Psychotic Disorders, Case-Control Studies, business, 030217 neurology & neurosurgery, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology, Regular Articles
Abstract: Background The high prevalence of obsessive-compulsive symptoms (OCS) among subjects at Ultra-High Risk (UHR) for psychosis is well documented. However, the network structure spanning the relations between OCS and symptoms of the at risk mental state for psychosis as assessed with the Comprehensive Assessment of At Risk Mental States (CAARMS) has not yet been investigated. This article aimed to use a network approach to investigate the associations between OCS and CAARMS symptoms in a large sample of individuals with different levels of risk for psychosis. Method Three hundred and forty-one UHR and 66 healthy participants were included, who participated in the EU-GEI study. Data analysis consisted of constructing a network of CAARMS symptoms, investigating central items in the network, and identifying the shortest pathways between OCS and positive symptoms. Results Strong associations between OCS and anxiety, social isolation and blunted affect were identified. Depression was the most central symptom in terms of the number of connections, and anxiety was a key item in bridging OCS to other symptoms. Shortest paths between OCS and positive symptoms revealed that unusual thought content and perceptual abnormalities were connected mainly via anxiety, while disorganized speech was connected via blunted affect and cognitive change. Conclusions Findings provide valuable insight into the central role of depression and the potential connective component of anxiety between OCS and other symptoms of the network. Interventions specifically aimed to reduce affective symptoms might be crucial for the development and prospective course of symptom co-occurrence.
Published: 2021
Full Text: View/download PDF

8. Effects of Traffic-Related Air Pollution on Exercise Endurance, Dyspnea, and Cardiorespiratory Responses in Health and COPD

Author: Nafeez Syed, Min Hyung Ryu, Satvir Dhillon, Michele R. Schaeffer, Andrew H. Ramsook, Janice M. Leung, Christopher J. Ryerson, Christopher Carlsten, Jordan A. Guenette, Shawn Aaron, James Martin, Peter Paré, James Hogg, Jonathon Leipsic, Don Sin, Wan Tan, Jordan Guenette, Mark FitzGerald, Harvey Coxson, Mohsen Sadatsafavi, Carlo Marra, John Mayo, David Proud, Richard Leigh, Anita Kozyrskyj, Jacqueline Quail, Andrew Halayko, Marni Brownell, Grace Parraga, Parameswaran Nair, Martin Stampfli, Paul O’Byrne, Samir Gupta, Noe Zamel, Felix Ratjen, Dina Brooks, Andrea Gershon, Teresa To, Wendy Ungar, Diane Lougheed, Denis O’Donnell, Bernard Thebaud, Smita Pakhale, Dean Fergusson, Ian Graham, Jeremy Grimshaw, Katherine Vandemheen, Anne Van Dam, Andrea Benedetti, Jean Bourbeau, Larry Lands, Dennis Jensen, Jennifer Landry, Lucie Blais, Francine Ducharme, Catherine Lemière, Anne-Monique Nuyt, Yohan Bossé, Louis-Philippe Boulet, Francois Maltais, Marieve Doucet, and Paul Hernandez
Subjects: Pulmonary and Respiratory Medicine, Vital capacity, COPD, medicine.medical_specialty, business.industry, Cardiorespiratory fitness, 010501 environmental sciences, Critical Care and Intensive Care Medicine, medicine.disease, Placebo, 01 natural sciences, Crossover study, respiratory tract diseases, 03 medical and health sciences, FEV1/FVC ratio, 0302 clinical medicine, 030228 respiratory system, Internal medicine, medicine, Cardiology, Lung volumes, Cardiology and Cardiovascular Medicine, Adverse effect, business, 0105 earth and related environmental sciences
Abstract: Background Individuals with COPD have increased sensitivity to traffic-related air pollution (TRAP) such as diesel exhaust (DE), but little is known about the acute effects of TRAP on exercise responses in COPD. Research question Does pre-exercise exposure to TRAP (DE300, PM2.5=300 μg/m3) have greater adverse effects on exercise endurance, exertional dyspnea, and cardiorespiratory responses to exercise in participants with mild-to-moderate COPD compared to former smokers with normal spirometry and healthy controls? Study design and Methods In this double-blind, randomized, placebo-controlled, crossover study, 11 healthy never-smokers, 9 ex-smokers without COPD and 9 ex-smokers with COPD were separately exposed to filtered air (FA) and DE300 for 2 hours separated by a minimum of 4 weeks. Participants performed symptom limited constant load cycling tests within 2.5 hours of exposure with detailed cardiorespiratory and exertional symptom measurements. Results There was a significant negative effect of TRAP on exercise endurance time in healthy controls (DE300 vs. FA: 10.2±8.2 vs. 12.9±9.5 min, respectively; p=0.03), but not in ex-smokers without COPD (10.1±6.9 vs. 12.2±8.0 min; respectively, p=0.57) or ex-smokers with COPD (9.8±6.4 vs. 8.4±6.6 min, respectively, p=0.31). Furthermore, significant increases in inspiratory duty cycle and absolute end-expiratory and end-inspiratory lung volumes were observed, and dyspnea ratings were elevated at select submaximal measurement times only in healthy controls. Interpretation Contrary to our hypothesis, it was the healthy controls rather than the ex-smokers with and without COPD that were negatively impacted by TRAP during exercise.
Published: 2022
Full Text: View/download PDF

9. No justice Without Charity: Humanitarianism After Empire

Author: Peter van Dam, ASH (FGw), and Cultural Transformations & Globalization
Subjects: Cultural Studies, History, Sociology and Political Science, Human rights, business.industry, media_common.quotation_subject, Empire, Economic Justice, Fair trade, Work (electrical), Political science, Law, Religious differences, business, media_common
Abstract: Humanitarian actors have firmly stated that they have moved on from charity since the 1960s. Instead, they have anchored their work in a notion of justice, rejecting religious differences and colonial ties. Their new focus was on the structural reforms to which the disadvantaged had a right. The analysis of the activities of the agencies which imported fair trade products from the 1960s until the 1980s demonstrates how the purported transition from charity to justice impacted humanitarian action. Despite being important to contemporaries, it does not provide a plausible historical account. Earlier ‘charitable’ initiatives did present a transformative impetus. Presuming a transition from charity to justice also fails to acknowledge the continued importance of charitable impulses among activists and their supporters. The changing interplay between charity and justice is crucial to understanding how social justice was defined within a transnational network of activists coming to terms with a postcolonial world.
Published: 2022
Full Text: View/download PDF

10. Impact of Complications After Pancreatoduodenectomy on Mortality, Organ Failure, Hospital Stay, and Readmission: Analysis of a Nationwide Audit

Author: Bert A. Bonsing, Marc G. Besselink, Geert Kazemier, Olivier R. Busch, F. Jasmijn Smits, Ignace H J T de Hingh, Sebastiaan Festen, Mark Meerdink, Erwin van der Harst, Misha Luyer, Martijn W J Stommel, Mike Liem, Marion van der Kolk, I. Quintus Molenaar, Casper H.J. van Eijck, Lois A Daamen, Ronald M. van Dam, Maaike E Verweij, C. Henri van Werkhoven, Jennifer M.J. Schreinemakers, Babs M Zonderhuis, Daphne Roos, F. Wit, Hjalmar C. van Santvoort, Bas Groot Koerkamp, Lucas Goense, Vincent E de Meijer, Vincent B. Nieuwenhuijs, Joost M. Klaase, J. Sven D. Mieog, Surgery, CCA - Cancer Treatment and Quality of Life, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, MUMC+: MA Heelkunde (9), RS: NUTRIM - R2 - Liver and digestive health, CCA - Cancer Treatment and quality of life, and AGEM - Re-generation and cancer of the digestive system
Subjects: Male, Complications, INTERNATIONAL STUDY-GROUP, Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14], 0302 clinical medicine, Postoperative Complications, ADJUVANT CHEMOTHERAPY, Risk Factors, Hospital Mortality, Netherlands, education.field_of_study, OUTCOMES, Incidence, Confounding, Middle Aged, CANCER, Survival Rate, Pancreatic fistula, 030220 oncology & carcinogenesis, 030211 gastroenterology & hepatology, Female, medicine.medical_specialty, POSTPANCREATECTOMY HEMORRHAGE PPH, Population, Patient Readmission, Pancreaticoduodenectomy, 03 medical and health sciences, SDG 3 - Good Health and Well-being, Pancreatic cancer, POSTOPERATIVE PANCREATIC FISTULA, medicine, Humans, Quality improvement, education, Adverse effect, Pancreas, Aged, Retrospective Studies, Gastric emptying, business.industry, Length of Stay, medicine.disease, Surgery, Pancreatic Neoplasms, Pneumonia, DEFINITION, GEMCITABINE, Complication, business, GRADE C, Follow-Up Studies
Abstract: Contains fulltext : 251531.pdf (Publisher’s version ) (Closed access) OBJECTIVE: To quantify the impact of individual complications on mortality, organ failure, hospital stay, and readmission after pancreatoduodenectomy. SUMMARY OF BACKGROUND DATA: An initial complication may provoke a sequence of adverse events potentially leading to mortality after pancreatoduodenectomy. This study was conducted to aid prioritization of quality improvement initiatives. METHODS: Data from consecutive patients undergoing pancreatoduodenectomy (2014-2017) were extracted from the Dutch Pancreatic Cancer Audit. Population attributable fractions (PAF) were calculated for the association of each complication (ie, postoperative pancreatic fistula, postpancreatectomy hemorrhage, bile leakage, delayed gastric emptying, wound infection, and pneumonia) with each unfavorable outcome [ie, in-hospital mortality, organ failure, prolonged hospital stay (>75th percentile), and unplanned readmission), whereas adjusting for confounders and other complications. The PAF represents the proportion of an outcome that could be prevented if a complication would be eliminated completely. RESULTS: Overall, 2620 patients were analyzed. In-hospital mortality occurred in 95 patients (3.6%), organ failure in 198 patients (7.6%), and readmission in 427 patients (16.2%). Postoperative pancreatic fistula and postpancreatectomy hemorrhage had the greatest independent impact on mortality [PAF 25.7% (95% CI 13.4-37.9) and 32.8% (21.9-43.8), respectively] and organ failure [PAF 21.8% (95% CI 12.9-30.6) and 22.1% (15.0-29.1), respectively]. Delayed gastric emptying had the greatest independent impact on prolonged hospital stay [PAF 27.6% (95% CI 23.5-31.8)]. The impact of individual complications on unplanned readmission was smaller than 11%. CONCLUSION: Interventions focusing on postoperative pancreatic fistula and postpancreatectomy hemorrhage may have the greatest impact on in-hospital mortality and organ failure. To prevent prolonged hospital stay, initiatives should in addition focus on delayed gastric emptying.
Published: 2022
Full Text: View/download PDF

11. Neoadjuvant therapy or upfront surgery for resectable and borderline resectable pancreatic cancer

Author: Marjolein Y.V. Homs, Roeland F. de Wilde, Casper H.J. van Eijck, Quisette P. Janssen, Geertjan van Tienhoven, Marc G. Besselink, Johanna W. Wilmink, Jacob L van Dam, Bas Groot Koerkamp, Hjalmar C. van Santvoort, Surgery, Medical Oncology, CCA - Cancer Treatment and Quality of Life, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, Radiotherapy, Oncology, Radiation Oncology, Internal medicine, and VU University medical center
Subjects: Cancer Research, medicine.medical_specialty, FOLFIRINOX, medicine.medical_treatment, Adjuvant therapy, SDG 3 - Good Health and Well-being, Pancreatic cancer, medicine, Chemotherapy, Humans, Neoadjuvant therapy, Randomized Controlled Trials as Topic, business.industry, Hazard ratio, Chemoradiotherapy, medicine.disease, Survival Analysis, Gemcitabine, Neoadjuvant Therapy, Surgery, Pancreatic Neoplasms, Oncology, business, medicine.drug
Abstract: INTRODUCTION: Neoadjuvant therapy may improve survival compared with upfront surgery in patients with resectable and borderline resectable pancreatic cancer, but high-quality evidence is lacking.METHODS: We systematically searched for randomised trials comparing neoadjuvant therapy with upfront surgery for resectable and borderline resectable pancreatic cancer published since database inception until December 2020. The primary outcome was overall survival (OS) by intention-to-treat with subgroup analyses for resectability status. Meta-analyses using a random-effects model were performed. Certainty of evidence was assessed using the GRADE approach.RESULTS: Seven trials with 938 patients were included. All trials included a neoadjuvant gemcitabine-based chemo(radio)therapy arm. None of the studies used adjuvant FOLFIRINOX. Neoadjuvant therapy improved OS (hazard ratio [HR] 0.66, 95% confidence interval [CI] 0.52-0.85; P = 0.001; I 2 = 46%) compared with upfront surgery. This represents an increase in median OS from 19 to 29 months. In the subgroup of resectable pancreatic cancer (i.e., venous contact ≤180°, no arterial contact), no statistically significant difference in OS was observed (HR 0.77, 95% CI 0.53-1.12; P = 0.18; I 2 = 20%). In the subgroup of borderline resectable pancreatic cancer (i.e. venous contact >180°, any arterial contact), neoadjuvant therapy improved OS (HR 0.61, 95% CI 0.44-0.85; P = 0.004; I 2 = 59%). The GRADE certainty of evidence was high for the outcome of OS. CONCLUSIONS: Neoadjuvant therapy improves OS compared with upfront surgery in patients with borderline resectable pancreatic cancer. More evidence is required on whether neoadjuvant therapy improves survival for patients with resectable pancreatic cancer.
Published: 2022
Full Text: View/download PDF

12. Clinical Relevance of Closed-Incision Negative Pressure Therapy (ciNPT) for SSI-Risk Reduction in Vascular Surgery Through a Groin Incision

Author: Randolph G. Statius van Eps, Jan J. Wever, Martijn A. van Dam, Merel Strietman, and Hugo T.C. Veger
Subjects: Male, medicine.medical_specialty, medicine.medical_treatment, Surgical Wound, Population, Groin, Patient Readmission, Body Mass Index, Cohort Studies, Negative-pressure wound therapy, medicine, Humans, Surgical Wound Infection, Prospective Studies, education, Aged, Postoperative Care, education.field_of_study, Revascularization surgery, business.industry, Wound dehiscence, Surgical wound, General Medicine, Plastic Surgery Procedures, Vascular surgery, medicine.disease, Bandages, Surgery, medicine.anatomical_structure, Lower Extremity, Seroma, Female, Cardiology and Cardiovascular Medicine, business, Vascular Surgical Procedures, Negative-Pressure Wound Therapy, Aortic Aneurysm, Abdominal
Abstract: Background Vascular surgery, especially lower limb revascularization surgery, has one of the highest rates of surgical complications, predominantly surgical site infections (SSI). Resulting in a significant burden of additional costs due to longer hospital stays, re-admissions and re-interventions, mainly attributable to deep incisional SSIs. Closed incisional negative pressure therapy (ciNPT) is a relatively new strategy in the postoperative management surgical wounds, aiming to reduce surgical wound complications. When discussing the clinical relevance of ciNPT, it is crucial to take into account the outcome of therapy as well as the additional costs related to ciNPT. Since, the additional costs must be justified by an associated decrease in the morbidity and costs associated with groin wound complications, which are particularly attributable to deep incisional SSIs. The current literature evaluating the beneficial effect of ciNPT in groin incisional vascular surgery, predominantly focusses on the decrease in superficial SSIs. Whereas this study aims to address and discuss the clinical relevance of ciNPT over conventional wound dressings, by separately evaluating and comparing the incidence of superficial and deep SSIs and their related re-admissions and re-interventions. Methods In this single center prospective cohort study performed in a non-academic hospital in The Netherlands, 59 consecutive patients (67 incisions) were included between January and October 2019. All underwent elective vascular surgery with groin (access) incisions for either lower limb revascularization surgery or abdominal aortic aneurysm surgery. The study group was treated with six days ciNPT (PREVENA Incision Management System; KCI/3M, San Antonio, TX, USA) and matched for equal comparison to a historical retrospectively analysed cohort of 54 consecutive patients (60 incisions), all of whom have undergone elective vascular surgery for equal indications with groin (access) incisions in our center between January and October 2018. The standard-care group was treated following standard surgical wound care protocol with conventional surgical self-adhesive plaster (10 × 15cm, Mepore, Molnlycke Health Care AB, Gothenburg, Sweden). Results Study groups were comparable at baseline, except for Body Mass Index (BMI), which was significantly higher in the ciNPT-group (P =.021). No significant differences for formation of seroma, hematoma, as well as wound dehiscence and SSIs were found between both groups. Groin SSIs were seen in 12.1% of the patients in the ciNPT-group and in 13.0% in the Standard-care group (OR 0.80, CI ((0.26, 2.48)), deep SSI contributed for 4 out of 7 patients of total SSIs in the ciNPT-group and for 2 out of 7 patients in the standard of care group (P-value >0.05). Analysis for incidence of hospital re-admission and re-intervention in both study groups showed no significant difference. Subset analysis in both study groups for SSIs differentiated in superficial and deep SSIs showed that only deep SSIs resulted in re-interventions. Conclusions Based on the findings in the population of our single center study, we conclude that routine use of ciNPT was not effective in reducing groin wound complications, and therefore could not replicate the promising findings from some previous studies. Furthermore, we did not find a reduction in the incidence of deep SSIs, which comprise the highest morbidity and costs. Considering our findings as well as the associated additional expenses related to ciNPT, it might be superfluous at this stage to use ciNPT as the new standard of post-operative groin incision care for all lower limb revascularization and abdominal aortic aneurysm surgeries. In our opinion further research is warranted for establishing a risk-factor based model for determination of the indication of ciNPT. To be able to achieve a more substantiated decision for utilizing ciNPT compared to standard surgical wound care in groin incisional vascular surgical interventions.
Published: 2022
Full Text: View/download PDF

13. Kidney failure prediction models

Author: Ramspek, Chava L, Evans, Marie, Wanner, Christoph, Drechsler, Christiane, Chesnaye, Nicholas C, Szymczak, Maciej, Krajewska, Magdalena, Torino, Claudia, Porto, Gaetana, Hayward, Samantha, Caskey, Fergus, Dekker, Friedo W, Jager, Kitty J, van Diepen, Merel, EQUAL Study Investigators: Adamasco Cupisti, Adelia Sagliocca, Alberto Ferraro, Aleksandra Musiała, Alessandra Mele, Alessandro Naticchia, Alex Còsaro, Alistair Woodman, Andrea Ranghino, Andrea Stucchi, Andreas Jonsson, Andreas Schneider, Angelo Pignataro, Anita Schrander, Anke Torp, Anna McKeever, Anna Szymczak, Anna-Lena Blom, Antonella De Blasio, Antonello Pani, Aris Tsalouichos, Asad Ullah, Barbara McLaren, Bastiaan van Dam, Beate Iwig, Bellasi Antonio, Biagio Raffaele Di Iorio, Björn Rogland, Boris Perras, Butti Alessandra, Camille Harron, Carin Wallquist, Carl Siegert, Carla Barrett, Carlo Gaillard, Carlo Garofalo, Cataldo Abaterusso, Charles Beerenhout, Charlotte O'Toole, Chiara Somma, Christian Marx, Christina Summersgill, Christof Blaser, Claudia D'alessandro, Claudia Emde, Claudia Zullo, Claudio Pozzi, Colin Geddes, Cornelis Verburgh, Daniela Bergamo, Daniele Ciurlino, Daria Motta, Deborah Glowski, Deborah McGlynn, Denes Vargas, Detlef Krieter, Domenico Russo, Dunja Fuchs, Dympna Sands, Ellen Hoogeveen, Ellen Irmler, Emöke Dimény, Enrico Favaro, Eva Platen, Ewelina Olczyk, Ewout Hoorn, Federica Vigotti, Ferruccio Ansali, Ferruccio Conte, Francesca Cianciotta, Francesca Giacchino, Francesco Cappellaio, Francesco Pizzarelli, Fredrik Sundelin, Fredrik Uhlin, Gaetano Greco, Geena Roy, Gaetana Porto, Giada Bigatti, Giancarlo Marinangeli, Gianfranca Cabiddu, Gillian Hirst, Giordano Fumagalli, Giorgia Caloro, Giorgina Piccoli, Giovanbattista Capasso, Giovanni Gambaro, Giuliana Tognarelli, Giuseppe Bonforte, Giuseppe Conte, Giuseppe Toscano, Goffredo Del Rosso, Gunilla Welander, Hanna Augustyniak-Bartosik, Hans Boots, Hans Schmidt-Gürtler, Hayley King, Helen McNally, Hendrik Schlee, Henk Boom, Holger Naujoks, Houda Masri-Senghor, Hugh Murtagh, Hugh Rayner, Ilona Miśkowiec-Wiśniewska, Ines Schlee, Irene Capizzi, Isabel Bascaran Hernandez, Ivano Baragetti, Jacek Manitius, Jane Turner, Jan-Willem Eijgenraam, Jeroen Kooman, Joachim Beige, Joanna Pondel, Joanne Wilcox, Jocelyn Berdeprado, Jochen Röthele, Jonathan Wong, Joris Rotmans, Joyce Banda, Justyna Mazur, Kai Hahn, Kamila Jędrzejak, Katarzyna Nowańska, Katja Blouin, Katrin Neumeier, Kirsteen Jones, Kirsten Anding-Rost, Knut-Christian Gröntoft, Lamberto Oldrizzi, Lesley Haydock, Liffert Vogt, Lily Wilkinson, Loreto Gesualdo, Lothar Schramm, Luigi Biancone, Łukasz Nowak, Maarten Raasveld, Magdalena Durlik, Manuela Magnano, Marc Vervloet, Marco Ricardi, Margaret Carmody, Maria Di Bari, Maria Laudato, Maria Luisa Sirico, Maria Stendahl, Maria Svensson, Maria Weetman, Marjolijn van Buren, Martin Joinson, Martina Ferraresi, Mary Dutton, Merel van Diepen, Michael Matthews, Michele Provenzano, Monika Hopf, Moreno Malaguti, Nadja Wuttke, Neal Morgan, Nicola Palmieri, Nikolaus Frischmuth, Nina Bleakley, Paola Murrone, Paul Cockwell, Paul Leurs, Paul Roderick, Pauline Voskamp, Pavlos Kashioulis, Pawlos Ichtiaris, Peter Blankestijn, Petra Kirste, Petra Schulz, Phil Mason, Philip Kalra, Pietro Cirillo, Pietro Dattolo, Pina Acampora, Rincy Sajith, Rita Nigro, Roberto Boero, Roberto Scarpioni, Rosa Sicoli, Rosella Malandra, Sabine Aign, Sabine Cäsar, Sadie van Esch, Sally Chapman, Sandra Biribauer, Santee Navjee, Sarah Crosbie, Sharon Brown, Sheila Tickle, Sherin Manan, Silke Röser, Silvana Savoldi, Silvio Bertoli, Silvio Borrelli, Siska Boorsma, Stefan Heidenreich, Stefan Melander, Stefania Maxia, Stefano Maffei, Stefano Mangano, Stephanie Palm, Stijn Konings, Suresh Mathavakkannan, Susanne Schwedler, Sylke Delrieux, Sylvia Renker, Sylvia Schättel, Szyszkowska Dorota, Teresa Cicchetti, Teresa Nieszporek, Theresa Stephan, Thomas Schmiedeke, Thomas Weinreich, Til Leimbach, Tiziana Rappa, Tora Almquist, Torsten Stövesand, Udo Bahner, Ulrika Jensen, Valentina Palazzo, Walter De Simone, Wolfgang Seeger, Ying Kuan, Zbigniew Heleniak, Zeynep Aydin, Internal Medicine, Chava L, Ramspek, Marie, Evan, Christoph, Wanner, Christiane, Drechsler, Nicholas C, Chesnaye, Maciej, Szymczak, Magdalena, Krajewska, Claudia, Torino, Gaetana, Porto, Samantha, Hayward, Fergus, Caskey, Friedo W, Dekker, Kitty J, Jager, Merel, van Diepen, Study Investigators: Adamasco Cupisti, Equal, Sagliocca, Adelia, Ferraro, Alberto, Musiała, Aleksandra, Mele, Alessandra, Naticchia, Alessandro, Còsaro, Alex, Woodman, Alistair, Ranghino, Andrea, Stucchi, Andrea, Jonsson, Andrea, Schneider, Andrea, Pignataro, Angelo, Schrander, Anita, Torp, Anke, Mckeever, Anna, Szymczak, Anna, Blom, Anna-Lena, De Blasio, Antonella, Pani, Antonello, Tsalouichos, Ari, Ullah, Asad, Mclaren, Barbara, van Dam, Bastiaan, Iwig, Beate, Antonio, Bellasi, Raffaele Di Iorio, Biagio, Rogland, Björn, Perras, Bori, Alessandra, Butti, Harron, Camille, Wallquist, Carin, Siegert, Carl, Barrett, Carla, Gaillard, Carlo, Garofalo, Carlo, Abaterusso, Cataldo, Beerenhout, Charle, O'Toole, Charlotte, Somma, Chiara, Marx, Christian, Summersgill, Christina, Blaser, Christof, D'Alessandro, Claudia, Emde, Claudia, Zullo, Claudia, Pozzi, Claudio, Geddes, Colin, Verburgh, Corneli, Bergamo, Daniela, Ciurlino, Daniele, Motta, Daria, Glowski, Deborah, Mcglynn, Deborah, Vargas, Dene, Krieter, Detlef, Russo, Domenico, Fuchs, Dunja, Sands, Dympna, Hoogeveen, Ellen, Irmler, Ellen, Dimény, Emöke, Favaro, Enrico, Platen, Eva, Olczyk, Ewelina, Hoorn, Ewout, Vigotti, Federica, Ansali, Ferruccio, Conte, Ferruccio, Cianciotta, Francesca, Giacchino, Francesca, Cappellaio, Francesco, Pizzarelli, Francesco, Sundelin, Fredrik, Uhlin, Fredrik, Greco, Gaetano, Roy, Geena, Porto, Gaetana, Bigatti, Giada, Marinangeli, Giancarlo, Cabiddu, Gianfranca, Hirst, Gillian, Fumagalli, Giordano, Caloro, Giorgia, Piccoli, Giorgina, Capasso, Giovanbattista, Gambaro, Giovanni, Tognarelli, Giuliana, Bonforte, Giuseppe, Conte, Giuseppe, Toscano, Giuseppe, Del Rosso, Goffredo, Welander, Gunilla, Augustyniak-Bartosik, Hanna, Boots, Han, Schmidt-Gürtler, Han, King, Hayley, Mcnally, Helen, Schlee, Hendrik, Boom, Henk, Naujoks, Holger, Masri-Senghor, Houda, Murtagh, Hugh, Rayner, Hugh, Miśkowiec-Wiśniewska, Ilona, Schlee, Ine, Capizzi, Irene, Bascaran Hernandez, Isabel, Baragetti, Ivano, Manitius, Jacek, Turner, Jane, Eijgenraam, Jan-Willem, Kooman, Jeroen, Beige, Joachim, Pondel, Joanna, Wilcox, Joanne, Berdeprado, Jocelyn, Röthele, Jochen, Wong, Jonathan, Rotmans, Jori, Banda, Joyce, Mazur, Justyna, Hahn, Kai, Jędrzejak, Kamila, Nowańska, Katarzyna, Blouin, Katja, Neumeier, Katrin, Jones, Kirsteen, Anding-Rost, Kirsten, Gröntoft, Knut-Christian, Oldrizzi, Lamberto, Haydock, Lesley, Vogt, Liffert, Wilkinson, Lily, Gesualdo, Loreto, Schramm, Lothar, Biancone, Luigi, Nowak, Łukasz, Raasveld, Maarten, Durlik, Magdalena, Magnano, Manuela, Vervloet, Marc, Ricardi, Marco, Carmody, Margaret, Di Bari, Maria, Laudato, Maria, Luisa Sirico, Maria, Stendahl, Maria, Svensson, Maria, Weetman, Maria, van Buren, Marjolijn, Joinson, Martin, Ferraresi, Martina, Dutton, Mary, van Diepen, Merel, Matthews, Michael, Provenzano, Michele, Hopf, Monika, Malaguti, Moreno, Wuttke, Nadja, Morgan, Neal, Palmieri, Nicola, Frischmuth, Nikolau, Bleakley, Nina, Murrone, Paola, Cockwell, Paul, Leurs, Paul, Roderick, Paul, Voskamp, Pauline, Kashioulis, Pavlo, Ichtiaris, Pawlo, Blankestijn, Peter, Kirste, Petra, Schulz, Petra, Mason, Phil, Kalra, Philip, Cirillo, Pietro, Dattolo, Pietro, Acampora, Pina, Sajith, Rincy, Nigro, Rita, Boero, Roberto, Scarpioni, Roberto, Sicoli, Rosa, Malandra, Rosella, Aign, Sabine, Cäsar, Sabine, van Esch, Sadie, Chapman, Sally, Biribauer, Sandra, Navjee, Santee, Crosbie, Sarah, Brown, Sharon, Tickle, Sheila, Manan, Sherin, Röser, Silke, Savoldi, Silvana, Bertoli, Silvio, Borrelli, Silvio, Boorsma, Siska, Heidenreich, Stefan, Melander, Stefan, Maxia, Stefania, Maffei, Stefano, Mangano, Stefano, Palm, Stephanie, Konings, Stijn, Mathavakkannan, Suresh, Schwedler, Susanne, Delrieux, Sylke, Renker, Sylvia, Schättel, Sylvia, Dorota, Szyszkowska, Cicchetti, Teresa, Nieszporek, Teresa, Stephan, Theresa, Schmiedeke, Thoma, Weinreich, Thoma, Leimbach, Til, Rappa, Tiziana, Almquist, Tora, Stövesand, Torsten, Bahner, Udo, Jensen, Ulrika, Palazzo, Valentina, De Simone, Walter, Seeger, Wolfgang, Kuan, Ying, Heleniak, Zbigniew, Aydin, Zeynep, Medical Informatics, ACS - Pulmonary hypertension & thrombosis, APH - Aging & Later Life, APH - Health Behaviors & Chronic Diseases, APH - Methodology, APH - Quality of Care, and APH - Global Health
Subjects: Male, progression of chronic renal failure, medicine.medical_specialty, Time Factors, epidemiology and outcome, 030232 urology & nephrology, Risk Assessment, Cohort Studies, 03 medical and health sciences, 0302 clinical medicine, Older patients, external validation, Predictive Value of Tests, medicine, Humans, Failure risk, Clinical Epidemiology, In patient, comprehensive external validation, 030212 general & internal medicine, Statistic, Aged, Aged, 80 and over, Kidney, Models, Statistical, business.industry, External validation, General Medicine, prediction, kidney failure, Europe, prediction model, medicine.anatomical_structure, chronic kidney disease, epidemiology and outcomes, prognosis, Nephrology, Emergency medicine, Disease Progression, Kidney Failure, Chronic, Female, business, prognostic, Predictive modelling, prognosi, Cohort study
Abstract: Background Various prediction models have been developed to predict the risk of kidney failure in patients with CKD. However, guideline-recommended models have yet to be compared head to head, their validation in patients with advanced CKD is lacking, and most do not account for competing risks. Methods To externally validate 11 existing models of kidney failure, taking the competing risk of death into account, we included patients with advanced CKD from two large cohorts: the European Quality Study (EQUAL), an ongoing European prospective, multicenter cohort study of older patients with advanced CKD, and the Swedish Renal Registry (SRR), an ongoing registry of nephrology-referred patients with CKD in Sweden. The outcome of the models was kidney failure (defined as RRT-treated ESKD). We assessed model performance with discrimination and calibration. Results The study included 1580 patients from EQUAL and 13,489 patients from SRR. The average c statistic over the 11 validated models was 0.74 in EQUAL and 0.80 in SRR, compared with 0.89 in previous validations. Most models with longer prediction horizons overestimated the risk of kidney failure considerably. The 5-year Kidney Failure Risk Equation (KFRE) overpredicted risk by 10%-\18%. The four- and eight-variable 2-year KFRE and the 4-year Grams model showed excellent calibration and good discrimination in both cohorts. Conclusions Some existing models can accurately predict kidney failure in patients with advanced CKD. KFRE performed well for a shorter time frame (2 years), despite not accounting for competing events. Models predicting over a longer time frame (5 years) overestimated risk because of the competing risk of death. The Grams model, which accounts for the latter, is suitable for longer-term predictions (4 years).
Published: 2021
Full Text: View/download PDF

14. Let’s embrace optical imaging

Author: Riemer H. J. A. Slart, Gooitzen M. van Dam, Schelto Kruijff, Wouter B. Nagengast, Rudi Dierckx, Milou E Noltes, Pieter J van der Zaag, Wiktor Szymanski, Basic and Translational Research and Imaging Methodology Development in Groningen (BRIDGE), Microbes in Health and Disease (MHD), Guided Treatment in Optimal Selected Cancer Patients (GUTS), Molecular Biophysics, Cardiovascular Centre (CVC), Translational Immunology Groningen (TRIGR), Synthetic Organic Chemistry, and Molecular Neuroscience and Ageing Research (MOLAR)
Subjects: THERANOSTICS, medicine.medical_specialty, business.industry, General Medicine, Molecular Imaging, Tree (data structure), Optical imaging, PET, ATHEROSCLEROSIS, TOMOGRAPHY, SPECT, HISTORY, medicine, 1ST-IN-HUMAN, Humans, VISUALIZATION, Radiology, Nuclear Medicine and imaging, Tomography, Radiology, Molecular imaging, business, 11 CANCERS, IN-VIVO
Published: 2021
Full Text: View/download PDF

15. A Novel and Generic Workflow of Indocyanine Green Perfusion Assessment Integrating Standardization and Quantification Toward Clinical Implementation

Author: Tessa M van Ginhoven, Schelto Kruijff, Gooitzen M. van Dam, Adrienne H. Brouwers, Christiaan E Boerma, Anton F. Engelsman, Jesse D. Pasternak, Milou E Noltes, Menno R. Vriens, Lorne Rotstein, Wido Heeman, Madelon J H Metman, Surgery, Health & Food, Basic and Translational Research and Imaging Methodology Development in Groningen (BRIDGE), Guided Treatment in Optimal Selected Cancer Patients (GUTS), and Microbes in Health and Disease (MHD)
Subjects: Indocyanine Green, Male, medicine.medical_specialty, genetic structures, Standardization, medicine.medical_treatment, Population, Proof of Concept Study, Workflow, Parathyroid Glands, chemistry.chemical_compound, Postoperative Complications, medicine, Humans, Prospective Studies, education, education.field_of_study, business.industry, Organ dysfunction, Angiography, Thyroidectomy, Reproducibility of Results, medicine.disease, eye diseases, medicine.anatomical_structure, chemistry, Hypoparathyroidism, Feasibility Studies, Female, Surgery, Parathyroid gland, Radiology, medicine.symptom, business, Indocyanine green, Perfusion
Abstract: OBJECTIVE: This study aims to generate a reproducible and generalizable Workflow model of ICG-angiography integrating Standardization and Quantification (WISQ) that can be applied uniformly within the surgical innovation realm independent of the user.SUMMARY BACKGROUND DATA: Tissue perfusion based on indocyanine green (ICG)-angiography is a rapidly growing application in surgical innovation. Interpretation of have been subjective and error-prone due to the lack of a standardized and quantitative ICG-workflow and analytical methodology. There is a clinical need for a more generic, reproducible, and quantitative ICG perfusion model for objective assessment of tissue perfusion.METHODS: In this multicenter, proof-of-concept study, we present a generic and reproducible ICG-workflow integrating standardization and quantification for perfusion assessment. To evaluate our model's clinical feasibility and reproducibility, we assessed the viability of parathyroid glands after performing thyroidectomy. Biochemical hypoparathyroidism was used as the postoperative endpoint and its correlation with ICG quantification intraoperatively. Parathyroid gland are an ideal model as parathyroid function post-surgery is only affected by perfusion.RESULTS: We show that visual -subjective- interpretation of ICG-angiography by experienced surgeons on parathyroid perfusion cannot reliably predict organ function impairment postoperatively, emphasizing the importance of an ICG quantification model. WISQ was able to standardize and quantify ICG-angiography and provided a robust and reproducible perfusion curve analysis. A low ingress slope of the perfusion curve combined with a compromised egress slope was indicative for parathyroid organ dysfunction in 100% of the cases.CONCLUSION: WISQ needs prospective validation in larger series and may eventually support clinical decision-making to predict and prevent postoperative organ function impairment in a large and varied surgical population.
Published: 2021
Full Text: View/download PDF

16. The impact of the COVID-19 pandemic on perceived access to health care and preferences for health care provision in individuals (being) treated for breast cancer

Author: Claudia A. Bargon, W Maarse, Rhode Bijlsma, Dieuwke R Mink van der Molen, A. Doeksen, Miranda F. Ernst, M. Sier, Helena M. Verkooijen, Marilot C T Batenburg, Iris E van Dam, Danny A. Young-Afat, Thijs van Dalen, Ernst J. P. Schoenmaeckers, Femke van der Leij, Lilianne E van Stam, and Inge O Baas
Subjects: Corona virus, Cancer Research, medicine.medical_specialty, Longitudinal study, Coronavirus disease 2019 (COVID-19), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Breast Neoplasms, Telehealth, Health Services Accessibility, Breast cancer, Pandemic, Health care, medicine, Humans, Longitudinal Studies, Prospective Studies, Pandemics, SARS-CoV-2, business.industry, COVID-19, medicine.disease, Clinical Trial, Oncology, Family medicine, Cohort, Female, business
Abstract: Purpose To evaluate perceived access to health care and preferences for health care provision among patients (being) treated for breast cancer during the COVID-19 pandemic. Methods Longitudinal study within the prospective, multicenter UMBRELLA cohort of patients (being) treated for breast cancer. All cohort participants enrolled in UMBRELLA between October 2013 and November 2020 were sent a COVID-19-specific survey during the first and second wave of the COVID-19 pandemic, i.e., April 2020 and November 2020, respectively. Results In total, 1106 (69.3%) and 822 (50.9%) cohort participants completed the survey in the first and second wave, respectively. The proportion of patients experiencing that their treatment or follow-up care was affected due to COVID-19 decreased from 28.4% (n = 198) in April 2020 to 14.8% (n = 103) in November 2020. Throughout the pandemic, one or more hospital consultations were postponed in 10.0% (n = 82) of all patients and changed into a teleconsultation in 23.1% (n = 190). The proportion of patients who experienced a higher threshold to contact their general practitioner due to COVID-19 decreased from 29.9% (n = 204) in the first wave to 20.8% (n = 145) in the second wave. In-person consultations remained most preferred in 35.2% (n = 289) of all patients. Nearly half of all patients (48.3%, n = 396) indicated that telehealth would be a useful alternative for in-person consultations in future. Conclusion Perceived access to health care has improved substantially throughout the pandemic. Digital care is well received by patients (being) treated for breast cancer. Supplementary Information The online version contains supplementary material available at 10.1007/s10549-021-06458-3.
Published: 2021
Full Text: View/download PDF

17. Nurses’ perceptions of preparedness for acting as Nurse Unit Managers: A cross-sectional study

Author: P Griffin, Pieter J Van Dam, and Angela Manion
Subjects: 030504 nursing, Leadership development, business.industry, media_common.quotation_subject, Professional development, Affect (psychology), Unit (housing), 03 medical and health sciences, 0302 clinical medicine, Mentorship, Nursing, Feeling, Preparedness, Health care, 030212 general & internal medicine, 0305 other medical science, business, Psychology, General Nursing, media_common
Abstract: Background The Nurse Unit Manager role is vital to achieving outcomes in health care. Although research shows that Nurse Unit Managers feel underprepared for the role, little is known about the experiences of senior clinical nurses as they move into the role. The perspectives of these nurses are important because their perceptions of preparedness will likely affect their experiences, impacting patient and organisational outcomes. Aim The aim of this study was to explore the development opportunities available to potential nurse unit managers in an Australian health service, the effectiveness of these and nurses’ perceptions of preparedness for acting in the role. Methods A largely quantitative approach was used to collect cross-sectional data via a survey-based study design. The study examined the experiences of senior nurses who had acted in the Nurse Unit Manager role, across four domains aligned with the role's position description. Findings Overall, participants reported feeling unprepared for the Nurse Unit Manager role, which negatively affected their experiences. Participants reported a deficit in support and structured development opportunities provided to potential Nurse Unit Managers. Where education was received, participants reported feeling more confident and prepared. Discussion The findings suggest that education, mentorship and experience in acting in the role contributed to nurses feeling prepared and confident about transitioning into the Nurse Unit Manager role. Further research should be directed to the development, implementation and evaluation of structured development programs that encompass these aspects. Conclusion This study indicates that strategies should be implemented to improve the preparation of potential Nurse Unit Managers.
Published: 2021
Full Text: View/download PDF

18. Management of post-acute COVID-19 patients in geriatric rehabilitation: EuGMS guidance

Author: Marije S. Holstege, Francesco Landi, Else P. Poot, Esther Roquer, Wilco P. Achterberg, Mirko Petrovic, Desmond O'Neill, Martin Smalbrugge, Frances Dockery, Stefan Grund, Jos M. G. A. Schols, Romke van Balen, Irma H. J. Everink, Stefan Bachmann, Laura M. Pérez, Jolanda C. M. van Haastregt, Finbarr C. Martin, Adam L. Gordon, Leonoor van Dam van Isselt, RS: CAPHRI - R1 - Ageing and Long-Term Care, Health Services Research, Family Medicine, Elderly care medicine, APH - Aging & Later Life, and APH - Quality of Care
Subjects: medicine.medical_specialty, Care process, SYMPTOMS, Geriatric rehabilitation, Coronavirus disease 2019 (COVID-19), medicine.medical_treatment, Older patients, Medicine and Health Sciences, medicine, SURVIVORS, RISK, Geriatrics, Rehabilitation, business.industry, COVID-19, Special Interest Group, medicine.disease, Quality assurance, Guidance, CRITICAL ILLNESS, Medical emergency, business, Post-acute care
Abstract: Purpose To describe a guidance on the management of post-acute COVID 19 patients in geriatric rehabilitation. Methods The guidance is based on guidelines for post-acute COVID-19 geriatric rehabilitation developed in the Netherlands, updated with recent insights from literature, related guidance from other countries and disciplines, and combined with experiences from experts in countries participating in the Geriatric Rehabilitation Special Interest Group of the European Geriatric Medicine Society. Results This guidance for post-acute COVID-19 rehabilitation is divided into a section addressing general recommendations for geriatric rehabilitation and a section addressing specific processes and procedures. The Sect. "General recommendations for geriatric rehabilitation" addresses: (1) general requirements for post-acute COVID-19 rehabilitation and (2) critical aspects for quality assurance during COVID-19 pandemic. The Sect. "Specific processes and procedures", addresses the following topics: (1) patient selection; (2) admission; (3) treatment; (4) discharge; and (5) follow-up and monitoring. Conclusion Providing tailored geriatric rehabilitation treatment to post-acute COVID-19 patients is a challenge for which the guidance is designed to provide support. There is a strong need for additional evidence on COVID-19 geriatric rehabilitation including developing an understanding of risk profiles of older patients living with frailty to develop individualised treatment regimes. The present guidance will be regularly updated based on additional evidence from practice and research. Key summary pointsAim To describe a guidance on the management of post-acute COVID 19 patients in geriatric rehabilitation. Findings This guidance addresses general requirements for post-acute COVID-19 geriatric rehabilitation and critical aspects for quality assurance during the COVID-19 pandemic. Furthermore, the guidance describes relevant care processes and procedures divided in five topics: patient selection; admission; treatment; discharge; and follow-up and monitoring. Message This guidance is designed to provide support to care professionals involved in the geriatric rehabilitation treatment of post-acute COVID-19 patients.
Published: 2021
Full Text: View/download PDF

19. Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands

Author: Laura Y Kummer, Sofie Keijzer, Erik H Vogelzang, Gertjan Wolbink, Laura Boekel, Luuk Wieske, Filip Eftimov, Maurice Steenhuis, Michael T Nurmohamed, Ronald van Vollenhoven, Gestur Vidarsson, T. Rispens, Koos P J van Dam, Joep Killestein, Olvi Cristianawati, S. Marieke van Ham, Zoé L.E. van Kempen, Yaëlle R Besten, Eileen W Stalman, Sander W. Tas, Alexandre E Voskuyl, Taco W. Kuijpers, Femke Hooijberg, Maarten Boers, SILS Other Research (FNWI), Rheumatology, AII - Inflammatory diseases, APH - Societal Participation & Health, Neurology, Amsterdam Neuroscience - Neuroinfection & -inflammation, Medical Microbiology and Infection Prevention, AII - Infectious diseases, Epidemiology and Data Science, APH - Methodology, ACS - Atherosclerosis & ischemic syndromes, Graduate School, Landsteiner Laboratory, ANS - Neuroinfection & -inflammation, Clinical Immunology and Rheumatology, AMS - Musculoskeletal Health, Paediatric Infectious Diseases / Rheumatology / Immunology, ARD - Amsterdam Reproduction and Development, Experimental Immunology, and EURO-NMD
Subjects: medicine.medical_specialty, biology, business.industry, Multiple sclerosis, Immunogenicity, Immunology, Odds ratio, Articles, medicine.disease, Vaccination, Rheumatology, Internal medicine, medicine, biology.protein, Immunology and Allergy, Dosing, Antibody, Seroconversion, Prospective cohort study, business
Abstract: Background: Data are scarce on immunogenicity of COVID-19 vaccines in patients with autoimmune diseases, who are often treated with immunosuppressive drugs. We aimed to investigate the effect of different immunosuppressive drugs on antibody development after COVID-19 vaccination in patients with autoimmune diseases. Methods: In this study, we used serum samples collected from patients with autoimmune diseases and healthy controls who were included in two ongoing prospective cohort studies in the Netherlands. Participants were eligible for inclusion in this substudy if they had been vaccinated with any COVID-19 vaccine via the Dutch national vaccine programme, which at the time was prioritising vaccination of older individuals. Samples were collected after the first or second COVID-19 vaccination. No serial samples were collected. Seroconversion rates and IgG antibody titres against the receptor-binding domain of the SARS-CoV-2 spike protein were measured. Logistic and linear regression analyses were used to investigate the association between medication use at the time of vaccination and at least until sampling, seroconversion rates, and IgG antibody titres. The studies from which data were collected are registered on the Netherlands Trial Register, Trial ID NL8513, and ClinicalTrials.org, NCT04498286.Findings: Between April 26, 2020, and March 1, 2021, 3682 patients with rheumatic diseases, 546 patients with multiple sclerosis, and 1147 healthy controls were recruited to participate in the two prospective cohort studies. Samples were collected from patients with autoimmune diseases (n=632) and healthy controls (n=289) after their first (507 patients and 239 controls) or second (125 patients and 50 controls) COVID-19 vaccination. The mean age of both patients and controls was 63 years (SD 11), and 423 (67%) of 632 patients with autoimmune diseases and 195 (67%) of 289 controls were female. Among participants without previous SARS-CoV-2 infection, seroconversion after first vaccination were significantly lower in patients than in controls (210 [49%] of 432 patients vs 154 [73%] of 210 controls; adjusted odds ratio 0·33 [95% CI 0·23-0·48]; pInterpretation: Our data suggest that seroconversion after a first COVID-19 vaccination is delayed in older patients on specific immunosuppressive drugs, but that second or repeated exposure to SARS-CoV-2, either via infection or vaccination, improves humoral immunity in patients treated with immunosuppressive drugs. Therefore, delayed second dosing of COVID-19 vaccines should be avoided in patients receiving immunosuppressive drugs. Future studies that include younger patients need to be done to confirm the generalisability of our results.FUNDING: ZonMw, Reade Foundation, and MS Center Amsterdam.
Published: 2021
Full Text: View/download PDF

20. Immunomics-guided discovery of serum and urine antibodies for diagnosing urogenital schistosomiasis: a biomarker identification study

Author: Cornelis H. Hokke, Donald P. McManus, Alex Loukas, Govert J. van Dam, Takafira Mduluza, Said M. Ali, Thewarach Laha, Al Jasinskas, Maria Elena Bottazzi, Mark S. Pearson, Beatrice Greco, Sujittra Chaiyadet, A.A. Adegnika, Paul L. A. M. Corstjens, Matthew A. Field, Abena S. Amoah, Denise L. Doolan, Gebeyaw G Mekonnen, Javier Sotillo, Fatma Kabole, Claude Oeuvray, Bemnet Amare Tedla, Carla Proietti, Philip L. Felgner, Stefanie Knopp, Rie Nakajima, Luke Becker, David Rollinson, Pengfei Cai, Francisca Mutapi, Australian Trade and Investment Commission, Fundación Merck Salud, Bill & Melinda Gates Foundation, Australian Institute of Tropical Health and Medicine, University of Georgia (Estados Unidos), National Health and Medical Research Council (Australia), James Cook University (Australia), Wellcome Trust, Thrasher Research Fund, and European and Developing Countries Clinical Trials
Subjects: Microbiology (medical), Male, Medicine (General), Proteome, Schistosomiasis, Urine, Microbiology, Immunomics, Schistosomiasis haematobia, R5-920, Antigen, Virology, parasitic diseases, Medicine, Animals, Humans, Schistosoma haematobium, biology, business.industry, Area under the curve, Australia, Extracellular vesicle, Articles, biology.organism_classification, medicine.disease, QR1-502, Infectious Diseases, Immunoglobulin G, Immunology, biology.protein, Female, Antibody, business, Biomarkers
Abstract: Background: Sensitive diagnostics are needed for effective management and surveillance of schistosomiasis so that current transmission interruption goals set by WHO can be achieved. We aimed to screen the Schistosoma haematobium secretome to find antibody biomarkers of schistosome infection, validate their diagnostic performance in samples from endemic populations, and evaluate their utility as point of care immunochromatographic tests (POC-ICTs) to diagnose urogenital schistosomiasis in the field. Methods: We did a biomarker identification study, in which we constructed a proteome array containing 992 validated and predicted proteins from S haematobium and screened it with serum and urine antibodies from endemic populations in Gabon, Tanzania, and Zimbabwe. Arrayed antigens that were IgG-reactive and a select group of antigens from the worm extracellular vesicle proteome, predicted to be diagnostically informative, were then evaluated by ELISA using the same samples used to probe arrays, and samples from individuals residing in a low-endemicity setting (ie, Pemba and Unguja islands, Zanzibar, Tanzania). The two most sensitive and specific antigens were incorporated into POC-ICTs to assess their ability to diagnose S haematobium infection from serum in a field-deployable format. Findings: From array probing, in individuals who were infected, 208 antigens were the targets of significantly elevated IgG responses in serum and 45 antigens were the targets of significantly elevated IgG responses in urine. Of the five proteins that were validated by ELISA, Sh-TSP-2 (area under the curve [AUC]serum=0·98 [95% CI 0·95-1·00]; AUCurine=0·96 [0·93-0·99]), and MS3_01370 (AUCserum=0·93 [0·89-0·97]; AUCurine=0·81 [0·72-0·89]) displayed the highest overall diagnostic performance in each biofluid and exceeded that of S haematobium-soluble egg antigen in urine (AUC=0·79 [0·69-0·90]). When incorporated into separate POC-ICTs, Sh-TSP-2 showed absolute specificity and a sensitivity of 75% and MS3_01370 showed absolute specificity and a sensitivity of 89%. Interpretation: We identified numerous biomarkers of urogenital schistosomiasis that could form the basis of novel antibody diagnostics for this disease. Two of these antigens, Sh-TSP-2 and MS3_01370, could be used as sensitive, specific, and field-deployable diagnostics to support schistosomiasis control and elimination initiatives, with particular focus on post-elimination surveillance. This study received financial support from Merck Global Health Institute and the Australian Trade and Investment Commission (Australian Tropical Medicine Commercialisation grants programme ATMC50322). Research for the Zanzibar Elimination of Schistosomiasis Transmission project was funded by the University of Georgia Research Foundation, which is funded by the Bill & Melinda Gates Foundation for the Schistosomiasis Consortium for Operational Research and Evaluation projects (prime award number 50816, sub-award number RR374-053/4893206). SK received financial support by sub-award number RR374-053/4893196 and via direct grants from the Gates Foundation (investment identification numbers OPP1191423 and OPP1198086). AL was funded by a National Health and Medical Research Council Senior Principal Research Fellowship (number APP1117504). BAT was funded by a James Cook University Postgraduate Scholarship. GGM was funded by an Australian Institute of Tropical Health and Medicine postgraduate scholarship. Funding was granted to AAA by a European and Developing Countries Clinical Trials Partnership senior fellowship training award (number TA_11_40200). FM was funded by the Thrasher Research Fund (number 12440) and the Wellcome Trust (number 108061/Z/15/Z). Sí
Published: 2021
Full Text: View/download PDF

21. The Relationship Between Dry Eye in Adults with Indications for Kidney Transplantation and Influence Factors

Author: Le Viet Thang, Nguyen Dinh Ngan, Do Nhu Binh, Pham Quoc Toan, Vu Anh Tuan, Nguyen Le Trung, Hoang Tuan Anh, Nguyen Kien Trung, Nguyen Van Dam, Nguyen Van Cuong, Vo Thi Hang, and Nguyen Chien Thang
Subjects: renal failure, Univariate analysis, Kidney, medicine.medical_specialty, Visual acuity, genetic structures, business.industry, Clinical Ophthalmology, Disease, Odds ratio, medicine.disease, Logistic regression, eye diseases, dry eye, Ophthalmology, medicine.anatomical_structure, renal transplant, medicine, Hanoi Vietnam, medicine.symptom, business, Kidney transplantation, Original Research, Calcification
Abstract: Nguyen Le Trung,1,2 Pham Quoc Toan,1,3 Le Viet Thang,1,3 Nguyen Dinh Ngan,1,2 Nguyen Chien Thang,1,2 Nguyen Van Cuong,1,2 Nguyen Van Dam,1,2 Hoang Tuan Anh,1,2 Vo Thi Hang,1,2 Nguyen Kien Trung,4 Do Nhu Binh,1,5 Vu Anh Tuan6 1Vietnam Military Medical University, Hanoi, 12108, Vietnam; 2Vietnam Department of Opthalmology, Military Hospital 103, Hanoi, 12108, Vietnam; 3Vietnam Department of Nephrology, Military Hospital 103, Hanoi, 12108, Vietnam; 4Vietnam National Eye Hospital, Hanoi, 11613, Vietnam; 5Vietnam Department of Infectious Diseases, Military Hospital 103, Hanoi, 12108, Vietnam; 6Vietnam Hanoi Medical University, Hanoi, 11601, VietnamCorrespondence: Vu Anh Tuan Email vuanhtuan64@gmail.comPurpose: Patients with end-stage renal failure are susceptible to dry eye disease. This study explores the relationship between dry eye disease and influence factors.Patients and Methods: The control group consisted of 57 healthy subjects who were kidney donors. They were of the same age and sex as the kidney transplant recipients. The outcome variable was the dry eye condition of the participants. The Schirmer test confirmed dry eye disease, TBUT (breakup time test), and the Eye Surface Disease Index (OSDI) questionnaire, using linear regression to evaluate the association.Results: The total number of subjects was 146 (89 kidney recipients and 57 kidney donors). When univariate analysis found the level of visual acuity, the age group involved was statistically significant, while the other factors were not statistically significant. In multivariable logistic regression analysis, age (odds ratio: 2.8, p< 0.05), smoking history (odd ratio: 0.1, p< 0.05), corneal conjunctival calcification (odd ratio: 0.2, p< 0.05); central corneal thickness (odd ratio: 1.02, p< 0.05) is considered to be an influence factor for disease progression.Conclusion: Age group, smoking history, corneal central thickness, and conjunctival calcification are factors for dry eye disease in patients preparing to receive a kidney. These results reinforce the evidence for multifactorial dry eye disease in patients with renal impairment.Keywords: dry eye, renal failure, renal transplant, Hanoi Vietnam
Published: 2021
Full Text: View/download PDF

22. Thyroid function and IVF outcome for different indications of subfertility

Author: K. Aissa, Y. Feenstra, E W C M van Dam, M. Ter Haar, A. De Roos, C C Repelaer van Driel-Delprat, Roel Schats, C.B. Lambalk, G. Beelen, P. M. van de Ven, Obstetrics and gynaecology, and Amsterdam Reproduction & Development (AR&D)
Subjects: Male, endocrine system, medicine.medical_specialty, QH471-489, endocrine system diseases, thyroid-stimulating hormone, Thyroid Gland, Thyrotropin, Fertilization in Vitro, primary subfertility, Pregnancy, unexplained subfertility, Humans, Medicine, conventional in vitro fertilization, Ivf outcome, Retrospective Studies, business.industry, Obstetrics, Reproduction, Research, Gynecology and obstetrics, General Medicine, live birth rate, Infertility, RG1-991, Female, Thyroid function, business, hormones, hormone substitutes, and hormone antagonists
Abstract: Graphical Abstract Abstract Studies evaluating pregnancy outcomes after assisted reproductive treatment (ART) in women with high-normal (2.5–4.5 mIU/L) thyroid-stimulating hormone (TSH) levels are conflicting, possibly due to different patient charactistics and subfertility indications. The aim of this study was to examine the hypothesis that high-normal compared to low-normal TSH levels are associated with adverse implications for pregnancy outcomes in conventional in vitro fertilization (IVF)-treated women. Therefore, we analyzed retrospectively the characteristics and pregnancy outcomes of 949 subfertile women with TSH 0.3–4.5 mIU/L, treated with conventional IVF between January 2008 and March 2012. Demographic and baseline characteristics were compared between groups of patients based on TSH quartiles, using one-way Anova, Kruskal–Wallis ANOVA and chi-square test. Women with high-normal quartile TSH were significantly more likely to be primary subfertile (P = 0.01), with a higher prevalence of unexplained subfertility and with 15% fewer live births after IVF compared to lower TSH quartiles (P = 0.02). In secondary subfertile women with high-normal TSH, male factor subfertility prevailed (P = 0.01), with more live births (P = 0.01). When analyzing primary and secondary subfertile women as one group, these differences failed to be observed, showing no differences in cumulative pregnancy outcomes of IVF between TSH quartiles (I: 0.3–1.21 mIU/L; II: 1.22–1.68 mIU/L; III: 1.69–2.31 mIU/L; IV: 2.32–4.5 mIU/L). In conclusion, primary subfertile women predominate in the high-normal TSH quartile, associated with significantly fewer live births in a subgroup of primary unexplained subfertile women (9%; n = 87/949), while in secondary subfertile women, dominated by male factor subfertility, high-normal TSH is associated with more live births. Lay summary Thyroid hormones are required for all cell processes in the body. An underactive thyroid gland, in which insufficient thyroid hormones are produced and thyroid-stimulating hormone (TSH) rises, is associated with a lower chance of pregnancy. It is not yet clear above which TSH level, 4.5 or also 2.5 mIU/L, this lower probability occurs. Therefore, in 949 couples treated with conventional IVF, we examined whether high-normal TSH levels (TSH: 2.5–4.5 mIU/L) compared to low normal TSH levels (0.3–2.5 mIU/L) affect the live birth rate. We found that women who were trying to become pregnant for the first time, especially without any other cause, that is unexplained subfertility, were more likely to have higher TSH levels. These women had a much lower chance of having a baby compared to women with low-normal TSH levels.
Published: 2021
Full Text: View/download PDF

23. Targeted optical fluorescence imaging: a meta-narrative review and future perspectives

Author: L. A. Huisman, G. M. van Dam, J.M. van Dijl, Schelto Kruijff, Rudi Dierckx, H. M. Schouw, Ronald Borra, Adrienne H. Brouwers, Antoon T. M. Willemsen, Wiktor Szymanski, Riemer H. J. A. Slart, Y. F. Janssen, and Hendrikus H. Boersma
Subjects: medicine.medical_specialty, INDOCYANINE GREEN, Cardiology, Optical fluorescence imaging, Review Article, Medical Oncology, Fluorescence, Optical imaging, RENAL-CELL CARCINOMA, GUIDED SURGERY, medicine, Humans, Radiology, Nuclear Medicine and imaging, Medical physics, HEAD, Head and neck, Reimbursement, COLORECTAL ORIGIN, Inflammation, Developmental stage, Infectious disease, Infectious Disease Medicine, business.industry, Gynaecological oncology, Optical Imaging, General Medicine, OPEN-LABEL, Cardiovascular disease, CANCER, Optical fluorescence, PERITONEAL CARCINOMATOSIS, Oncology, Infectious disease (medical specialty), Narrative review, business, SENTINEL LYMPH-NODE, SINGLE-CENTER, Forecasting
Abstract: Purpose The aim of this review is to give an overview of the current status of targeted optical fluorescence imaging in the field of oncology, cardiovascular, infectious and inflammatory diseases to further promote clinical translation. Methods A meta-narrative approach was taken to systematically describe the relevant literature. Consecutively, each field was assigned a developmental stage regarding the clinical implementation of optical fluorescence imaging. Results Optical fluorescence imaging is leaning towards clinical implementation in gastrointestinal and head and neck cancers, closely followed by pulmonary, neuro, breast and gynaecological oncology. In cardiovascular and infectious disease, optical imaging is in a less advanced/proof of concept stage. Conclusion Targeted optical fluorescence imaging is rapidly evolving and expanding into the clinic, especially in the field of oncology. However, the imaging modality still has to overcome some major challenges before it can be part of the standard of care in the clinic, such as the provision of pivotal trial data. Intensive multidisciplinary (pre-)clinical joined forces are essential to overcome the delivery of such compelling phase III registration trial data and subsequent regulatory approval and reimbursement hurdles to advance clinical implementation of targeted optical fluorescence imaging as part of standard practice.
Published: 2021

24. Anthracyclines Strike Back: Rediscovering Non-Pegylated Liposomal Doxorubicin in Current Therapeutic Scenarios of Breast Cancer

Author: Javier Cortes, Mariavittoria Locci, Daniele Generali, Diana Lüftner, Sergio Venturini, Lucia Del Mastro, Nadia Harbeck, Matteo Lambertini, Guy Jerusalem, Concetta Elisa Onesti, Francesco Schettini, Alessandra Gennari, Miguel Martin, Vivianne C. G. Tjan-Heijnen, Mario Giuliano, Rupert Bartsch, Giorgio Mustacchi, David J. Pinato, Khalil Zaman, Ahmad Awada, Sylvie Rottey, Mario Campone, Sabino De Placido, Ida Paris, Peter van Dam, Joseph Gligorov, Hans Wildiers, Giuseppe Curigliano, Institut Català de la Salut, [Schettini F] Translational Genomics and Targeted Therapies in Solid Tumors Research Group, Barcelona, Spain. Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain. [Giuliano M] Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy. [Lambertini M] Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy. Department of Medical Oncology, U.O.C Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy. [Bartsch R] Division of Oncology, Department of Medicine 1, Medical University of Vienna, Vienna, Austria. [Pinato DJ] Division of Cancer, Department of Surgery and Cancer, Imperial College London, London SW7 2AZ, UK. Department of Translational Medicine, Università del Piemonte Orientale 'A. Avogadro', Novara, Italy. [Onesti CE] Clinical and Oncological Research Department, IRCCS Regina Elena National Cancer Institute, Rome, Italy. [Cortes J] Oncology Department, IOB Institute of Oncology, Quiron Group, 08023 Madrid, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus, Schettini, Francesco, Giuliano, Mario, Lambertini, Matteo, Bartsch, Rupert, Pinato, David Jame, Onesti, Concetta Elisa, Harbeck, Nadia, Lüftner, Diana, Rottey, Sylvie, van Dam, Peter A, Zaman, Khalil, Mustacchi, Giorgio, Gligorov, Joseph, Awada, Ahmad, Campone, Mario, Wildiers, Han, Gennari, Alessandra, Tjan-Heijnen, Vivianne C G, Cortes, Javier, Locci, Mariavittoria, Paris, Ida, Del Mastro, Lucia, De Placido, Sabino, Martín, Miguel, Jerusalem, Guy, Venturini, Sergio, Curigliano, Giuseppe, Generali, Daniele, Schettini, F., Giuliano, M., Lambertini, M., Bartsch, R., Pinato, D. J., Onesti, C. E., Harbeck, N., Luftner, D., Rottey, S., van Dam, P. A., Zaman, K., Mustacchi, G., Gligorov, J., Awada, A., Campone, M., Wildiers, H., Gennari, A., Tjan-heijnen, V. C. G., Cortes, J., Locci, M., Paris, I., Mastro, L. D., De Placido, S., Martin, M., Jerusalem, G., Venturini, S., Curigliano, G., and Generali, D.
Subjects: Oncology, Cancer Research, medicine.medical_treatment, Non‐pegylated liposomal doxorubicin, Neoplasms::Neoplasms by Site::Breast Neoplasms [DISEASES], EPIRUBICIN, Review, Anthracycline, Other subheadings::Other subheadings::/drug therapy [Other subheadings], Oncología, Breast cancer, CYCLOPHOSPHAMIDE, Medicine and Health Sciences, Endocrinología, Other subheadings::/therapeutic use [Other subheadings], NAB-PACLITAXEL, RC254-282, MULTICENTER TRIAL, anthracyclines, neoplasias::neoplasias por localización::neoplasias de la mama [ENFERMEDADES], PRIMARY, TRASTUZUMAB PLUS DOCETAXEL, terapéutica::terapéutica::farmacoterapia::protocolos antineoplásicos::terapéutica::farmacoterapia::protocolos de quimioterapia antineoplásica combinada [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Neoplasms. Tumors. Oncology. Including cancer and carcinogens, PHASE-III TRIAL, Sciences bio-médicales et agricoles, CHEMOTHERAPY, metastatic, Settore SECS-S/01 - STATISTICA, Metastatic, Epirubicin, medicine.drug, medicine.medical_specialty, Cyclophosphamide, Side effect, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], anthracycline, Hormone receptor, Quimioteràpia combinada, triple negative, Therapeutic index, breast cancer, Internal medicine, Therapeutics::Therapeutics::Drug Therapy::Antineoplastic Protocols::Therapeutics::Drug Therapy::Antineoplastic Combined Chemotherapy Protocols [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], CONVENTIONAL DOXORUBICIN, medicine, Doxorubicin, Chemotherapy, Cardiotoxicity, business.industry, PRIMARY CHEMOTHERAPY, Otros calificadores::/uso terapéutico [Otros calificadores], ENCAPSULATED DOXORUBICIN, hormone receptor, medicine.disease, Anthracyclines, Triple negative, Cancérologie, Mama - Càncer - Tractament, Human medicine, 1ST-LINE THERAPY, business, non-pegylated liposomal doxorubicin
Abstract: Anthracyclines are among the most active chemotherapies (CT) in breast cancer (BC). However, cardiotoxicity is a risk and peculiar side effect that has been limiting their use in clinical practice, especially after the introduction of taxanes. Non‐pegylated liposomal doxorubicin (NPLD) has been developed to optimize the toxicity profile induced by anthracyclines, while maintaining its unquestionable therapeutic index, thanks to its delivering characteristics that increase its diffusion in tumor tissues and reduce it in normal tissues. This feature allows NPLD to be safely administered beyond the standard doxorubicin maximum cumulative dose of 450–480 mg/m2. Following three pivotal first‐line phase III trials in HER2‐negative metastatic BC (MBC), this drug was finally approved in combination with cyclophosphamide in this specific setting. Given the increasing complexity of the therapeutic scenario of HER2‐negative MBC, we have carefully revised the most updated literature on the topic and dissected the potential role of NPLD in the evolving therapeutic algorithms., SCOPUS: re.j, info:eu-repo/semantics/published
Published: 2021

25. The significance of tree-tree interactions for forest ecosystem functioning

Author: Ulrich Brose, Nico Eisenhauer, Lingli Liu, Andreas Schuldt, Matthias Kunz, Wensheng Bu, Ming-Qiang Wang, Christian Wirth, Steffen Neumann, Xiaoyong Cui, Zeqing Ma, Sylvia Haider, Bo Yang, Tesfaye Wubet, Zhiyao Tang, Kai Xue, Gemma Rutten, Naili Zhang, Yanfen Wang, Jürgen Bauhus, John Connolly, Douglas Chesters, Goddert von Oheimb, Xingliang Xu, Nicole M. van Dam, Liang-Dong Guo, Werner Härdtle, Simone Cesarz, Chao-Dong Zhu, Alexander Weinhold, Keping Ma, Shaopeng Wang, Weiguo Sang, Xiaojuan Liu, Stefan Trogisch, and Helge Bruelheide
Subjects: 0106 biological sciences, Biotic feedbacks, Biodiversity, TreeDì, BEF-China, 010603 evolutionary biology, 01 natural sciences, Ecosystem services, Forest structure, Forest ecology, Ecosystem, Resource partitioning, Neighbourhood (mathematics), Ecology, Evolution, Behavior and Systematics, Tree neighbourhood, business.industry, Environmental resource management, 15. Life on land, Tree diversity experiment, Tree (data structure), Climate change mitigation, Geography, Ecosystems Research, 13. Climate action, Facilitation, Species richness, business, 010606 plant biology & botany
Abstract: Global change exposes forest ecosystems to many risks including novel climatic conditions, increased frequency of climatic extremes and sudden emergence and spread of pests and pathogens. At the same time, forest landscape restoration has regained global attention as an integral strategy for climate change mitigation. Owing to unpredictable future risks and the need for new forests that provide multiple ecosystem services, mixed-species forests have been advocated for this purpose. However, the successful establishment of mixed forests requires intrinsic knowledge of biodiversity's role for forest ecosystem functioning. In this respect, a better understanding of tree-tree interactions and how they contribute to observed positive tree species richness effects on key ecosystem functions is critical. Here, we review the current knowledge of the underlying mechanisms of tree-tree interactions and argue that positive net biodiversity effects at the community scale may emerge from the dominance of positive over negative interactions at the local neighbourhood scale. In a second step, we demonstrate how tree-tree interactions and the immediate tree neighbourhood's role can be systematically assessed in a tree diversity experiment. The expected results will improve predictions about the effects of tree interactions on ecosystem functioning based on general principles. We argue that this knowledge is urgently required to guide the design of tree species mixtures for the successful establishment of newly planted forests.
Published: 2021
Full Text: View/download PDF

26. Changes in Diet Quality from Mid- to Late Life Are Associated with Cognitive Impairment in the Singapore Chinese Health Study

Author: Cynthia Chen, Nithya Neelakantan, Clare Whitton, Rob M. van Dam, Woon-Puay Koh, An Pan, Lei Feng, Jun Shi Lai, Eunice Huiying Tong, Yan-Feng Zhou, and Mary Foong-Fong Chong
Subjects: Adult, Male, 0301 basic medicine, China, Medicine (miscellaneous), Logistic regression, Lower risk, Odds, 03 medical and health sciences, 0302 clinical medicine, Dash, Humans, Medicine, Cognitive Dysfunction, Prospective Studies, 030212 general & internal medicine, Cognitive impairment, Aged, Aged, 80 and over, Singapore, 030109 nutrition & dietetics, Nutrition and Dietetics, business.industry, Cognition, Middle Aged, Diet, Diet quality, Cohort, Female, business, Demography
Abstract: BACKGROUND Although higher diet quality at mid-life has been associated with better cognitive function in late adulthood, it is unclear whether dietary improvement after mid-life may reduce the risk of cognitive impairment. OBJECTIVES We examined associations between changes in diet quality and risk of cognitive impairment in the Singapore Chinese Health Study cohort. METHODS We used data from 14,683 Chinese men and women who were recruited at ages 45 to 74 y from 1993 to 1998 and re-interviewed after 20 y at ages 61 to 96 y during follow-up 3 (2014-2016). Diet quality was measured using the Dietary Approaches to Stop Hypertension (DASH) scores at baseline and follow-up 3 interviews. Cognitive impairment was defined using scores from the Singapore-modified Mini-Mental State Examination at the follow-up 3 interview. Multivariable logistic regression models were used to estimate ORs and 95% CIs for the associations between change in DASH scores and cognitive impairment. RESULTS Higher quintiles in DASH scores at baseline and follow-up 3 interviews were associated with lower odds of cognitive impairment in a dose-dependent manner (both: P-trend
Published: 2021
Full Text: View/download PDF

27. Quality Diet Index and Risk of Pancreatic Cancer: Findings from the Singapore Chinese Health Study

Author: Randall E. Brand, Hung N. Luu, Woon-Puay Koh, Nithya Neelakantan, Rob M. van Dam, Jian-Min Yuan, Aizhen Jin, Renwei Wang, and Pedram Paragomi
Subjects: Male, medicine.medical_specialty, Mediterranean diet, Epidemiology, Diet Surveys, Risk Assessment, Article, Asian People, Singapore chinese, Pancreatic cancer, Internal medicine, Dash, medicine, Humans, Prospective Studies, Prospective cohort study, Aged, Aged, 80 and over, Singapore, business.industry, Middle Aged, medicine.disease, Healthy diet, Confidence interval, Pancreatic Neoplasms, Oncology, Cohort, Female, Diet, Healthy, business
Abstract: Background: Limited research has been conducted on the effect of quality diet index (QDI), which represents a comprehensive assessment of healthy diet quality and quantity, on pancreatic cancer risk in Asian populations. Methods: Using data from the Singapore Chinese Health Study, a prospective cohort of 63,257 middle-aged or older Chinese men and women, four QDI scores: the Alternative Health Eating Index-2010 (AHEI-2010), the alternate Mediterranean Diet (aMED), the Dietary Approaches to Stop Hypertension (DASH), and the Heathy Diet Indicator (HDI), at baseline were calculated. After 25 years of follow-up, 311 cohort participants developed pancreatic cancer. Cox proportional hazard regression method was used to estimate HR and 95% confidence interval (CI) for pancreatic cancer associated with higher QDI scores. Results: Higher scores of AHEI-2010, aMED, and DASH were significantly associated with lower pancreatic cancer risk (all Ptrend < 0.05). Compared with the lowest quartile, HRs (95% CIs) of pancreatic cancer for the highest quartiles of AHEI-2010, aMED, and DASH scores were 0.65 (0.46–0.90), 0.57 (0.38–0.85), and 0.66 (0.46–0.95), respectively. These associations were more apparent among men. Overall, there was no statistically significant difference in the QDI–pancreatic cancer risk association between subgroups stratified by levels of body mass index, history of diabetes, and smoking status. Conclusions: Higher QDI scores were significantly associated with reduced risk of pancreatic cancer. Impact: The consistent results across multiple QDIs shows that adherence to a healthy diet may lower pancreatic cancer risk, suggesting that dietary modification may be a promising approach for primary prevention of pancreatic cancer.
Published: 2021
Full Text: View/download PDF

28. Evaluation of a new online cognitive assessment tool in breast cancer survivors with cognitive impairment: a prospective cohort study

Author: Peter van Dam, Anne Bellens, Bernard Sabbe, Ella Roelant, and Marc Peeters
Subjects: Adult, Adolescent, Breast Neoplasms, Hospital Anxiety and Depression Scale, Young Adult, Cognition, Cancer Survivors, Surveys and Questionnaires, Humans, Medicine, Outpatient clinic, Cognitive Dysfunction, Prospective Studies, Cognitive rehabilitation therapy, Aged, CFQ, Depression, business.industry, Middle Aged, Cognitive training, Cognitive test, Oncology, Anxiety, Female, Human medicine, medicine.symptom, business, Clinical psychology
Abstract: Introduction Currently cancer-related cognitive impairment (CRCI) is mainly assessed by means of questionnaires, which is very laborious for the patients and the supervising physician. We evaluated a new online cognitive assessment tool, the MyCognition Quotient (MyCQ, Cambridge) in breast cancer survivors with CRCI, and compared the results with a psychometric test measuring cognitive complaints, depression, and anxiety. Materials and methods In this prospective study, 46 adult patients between 18 and 70 years old with a diagnosis of BC were studied, all complaining of disturbing cognitive impairment. They participated in a physical cognitive rehabilitation program. The patients had an online cognitive assessment (MyCQ Med by MyCognition) every 4 weeks on their home computer. In addition patients were assessed in the outpatient clinic by the principal investigator at baseline, after 3 and 6 months using the following validated neuro-psychological surveys: the Hospital Anxiety and Depression Scale (HADS), Beck Cognitive Insight Scale (BCIS), and Cognitive Failure Questionnaire (CFQ). MyCQ scores were correlated with the results of these surveys. Results Only weak correlations could be found between overall MyCQ or the MyCQ subtests with the psychometric tests (between - 0.43 and 0.458) at baseline and when combining data at time point 0, 3, and 6 months. Linear mixed models showed there was a significant association between Latency Choice Reaction Time and CFQ (continuous; p = 0.026). An AUC of 0.640 and a cut-off of 481.5 ms in Latency Choice Reaction Time were found to distinguish patients with CFQ below 44 to patients with CFQ above 44 (sensitivity 0.63 and specificity 0.73). In Latency Coding an AUC of 0.788 and a cut-off of 1316 ms were found to distinguish non-depressive patients from patients likely to present with depressive symptoms (sensitivity 0.75 and specificity 0.76). Conclusion MyCQ cannot replace the various psychometric tests. However, abnormal Latency in cognitive tests, Choice Reaction Time and Coding, seems promising to be used as a screening tool to detect specific aspects of abnormal cognitive functioning in patients with cognitive complaints and depressive symptoms.
Published: 2021
Full Text: View/download PDF

29. Diet Quality and Lower Refined Grain Consumption are Associated With Less Weight Gain in a Multi-Ethnic Asian Adult Population

Author: Salome A. Rebello, Charlie G.Y. Lim, Rob M. van Dam, and Clare Whitton
Subjects: Adult, Nutrition and Dietetics, Waist, business.industry, Weight change, Medicine (miscellaneous), Weight Gain, medicine.disease, Obesity, Diet, Animal science, Cohort, Dash, Red meat, Humans, Medicine, Prospective Studies, Waist Circumference, medicine.symptom, business, Prospective cohort study, Weight gain
Abstract: Background The prevalence of obesity is increasing in many Asian countries. However, longitudinal data on the impacts of dietary factors on weight gain in Asian populations are sparse. Objectives We evaluated the relationship between changes in intakes of nutrients, foods, and beverages and diet quality and long-term changes in body weight. Methods We used data (n = 3064) from the Singapore Multi-Ethnic Cohort, a prospective cohort including Chinese, Indian, and Malay residents aged 21-65 years. Dietary intakes were assessed using an FFQ, and body weight and waist circumference were measured during health examinations. Diet quality was evaluated using the Dietary Approaches to Stop Hypertension (DASH) and Alternative Healthy Eating Index (AHEI-2010) scores. Data were collected at baseline (2004-2010) and follow-up (2011-2016), with a mean follow-up of 6.0 years. Linear regression was used to assess the associations between dietary changes and weight change, adjusted for socio-demographic and lifestyle variables. Results Improvements in dietary quality scores (DASH, -0.34 kg per 5 points; AHEI-2010, -0.35 kg per 10 points) and replacement of carbohydrates with protein (-0.44 kg per 5% of energy) were significantly associated with less weight gain. Increased intakes of white rice (+0.25 kg per serving/d), soft drinks (+0.69 kg), red meat (+0.58 kg), and poultry with skin (+0.74 kg) were directly associated with weight gain. The replacement of 1 serving per day of white rice with whole grains (-0.68 kg), vegetables (-0.33 kg), poultry without skin (-0.79 kg), and eggs (-0.87 kg) was associated with less weight gain. Similar associations were observed between changes in dietary factors and changes in waist circumference. Conclusions Among Asian adults, increasing dietary quality, reducing soft drink consumption, and replacing white rice with whole grains, vegetables, and selected high-protein foods was associated with less weight gain.
Published: 2021
Full Text: View/download PDF

30. Safety of rapid injection of undiluted ferric carboxymaltose to patients with iron‐deficiency anaemia: a <scp>Phase II</scp> single‐arm study

Author: Elizabeth Coughlin, Stephen Opat, Anouk Dev, Sanjeev Chunilal, Matthew van Dam, Sant-Rayn Pasricha, Michael Gilbertson, Ashwini Bennett, and Tishya Indran
Subjects: Anemia, Iron-Deficiency, business.industry, Anemia, Iron, medicine.medical_treatment, Phases of clinical research, Iron deficiency, medicine.disease, Ferric Compounds, law.invention, Randomized controlled trial, law, Anesthesia, Ambulatory, Internal Medicine, Humans, Medicine, Maltose, business, Adverse effect, Saline, Hypophosphatemia
Abstract: Background Ferric carboxymaltose is increasingly utilised to treat iron deficiency and is usually diluted in saline and administered as an intravenous infusion over 15 minutes. Whilst this is highly convenient compared with older formulations, we hypothesised the drug could be administered safely given as a rapid bolus injection. Aims To define the risk of serious adverse events following administration of an undiluted, rapid, high dose ferric carboxymaltose injection. Secondary aims included all other adverse events, as well as longitudinal effects on haemoglobin, iron stores, phosphate, and hepcidin. Methods In a single arm, Phase II study in 121 patients with iron deficiency anaemia, we administered up to 1000mg of ferric carboxymaltose as a rapid undiluted bolus injection, and recorded adverse events and collected blood samples over the first hour, and again at two and four weeks post-treatment. Results No patient experienced a serious adverse event. Flushing during the injection was common, as was a transient headache in the subsequent weeks. A single patient experienced Grade 3 chest tightness necessitating emergency department assessment but not admission or treatment. Treatment produced an average 12.3g/L improvement in haemoglobin within two weeks, but commonly caused reductions in serum phosphate (although none of these were clinically symptomatic). Parenteral iron caused elevations in hepcidin sustained to four weeks post injection. Patients stated they would be prepared to receive the treatment again. Conclusion Rapid injection of undiluted ferric carboxymaltose is well tolerated and could provide an approach to treat patients in the ambulatory setting. This article is protected by copyright. All rights reserved.
Published: 2021
Full Text: View/download PDF

31. The Pre-Diabetes Interventions and Continued Tracking to Ease-out Diabetes (Pre-DICTED) program: study protocol for a randomized controlled trial

Author: Tazeen H. Jafar, Eric A. Finkelstein, Kar-Fu Yeung, Gavin Tan, Yong Mong Bee, Clare Whitton, Su-Yen Goh, Gilbert Choon Seng Tan, Alvin Yeow Meng Chia, Julian Thumboo, Rob M. van Dam, Emily Tse Lin Ho, Selly Julianty, Mihir Gandhi, Yee Leong Teoh, Eugene Jin Wen Shum, Angela Fang Yung Koh, Amanda Yun Rui Lam, Tampere University, and Clinical Medicine
Subjects: Adult, medicine.medical_specialty, Medicine (General), Psychological intervention, Medicine (miscellaneous), Type 2 diabetes, Overweight, 3121 Internal medicine, law.invention, Impaired glucose tolerance, Prediabetic State, Study Protocol, R5-920, Randomized controlled trial, law, Weight loss, 3123 Gynaecology and paediatrics, medicine, Clinical endpoint, Humans, Pharmacology (medical), Obesity, Life Style, Randomized Controlled Trials as Topic, business.industry, Prevention, Diabetes, Impaired fasting glucose, medicine.disease, 3142 Public health care science, environmental and occupational health, Diabetes Mellitus, Type 2, Physical therapy, medicine.symptom, Pre-diabetes, business
Abstract: Background Community-based diabetes prevention programs varied widely in effectiveness, and the intervention strategy consisting of lifestyle interventions, stepwise addition of metformin, and financial incentives has not been studied in real-world clinical practice settings. The Pre-Diabetes Interventions and Continued Tracking to Ease-out Diabetes (Pre-DICTED) trial is a pragmatic trial that aims to compare the effectiveness of a community-based stepwise diabetes prevention program with added financial incentives (intervention) versus the standard of care (control) in reducing the risk of type 2 diabetes over 3 years among overweight or obese individuals with pre-diabetes. Methods This is an open-label, 1:1 randomized controlled trial which aims to recruit 846 adult individuals with isolated impaired fasting glucose (IFG), isolated impaired glucose tolerance (IGT), or both IFG and IGT from Singapore. Intervention arm participants attend 12 group-based sessions (2 nutrition workshops, 9 exercise sessions, and a goal-setting workshop) delivered at community sites (weeks 1 to 6), receive weekly physical activity and nutrition recommendations delivered by printed worksheets (weeks 7 to 12), and receive monthly health tips delivered by text messages (months 4 to 36). From month 6 onwards, intervention arm participants who remain at the highest risk of conversion to diabetes are prescribed metformin. Intervention arm participants are also eligible for a payment/rewards program with incentives tied to attendance at the group sessions and achievement of the weight loss target (5% of baseline weight). All participants are assessed at baseline, month 3, month 6, and every 6 months subsequently till month 36. The primary endpoint is the proportion of participants with diabetes at 3 years. Secondary endpoints include the mean change from baseline at 3 years in fasting plasma glucose, 2-hour plasma glucose, HbA1c, body weight, body mass index, physical activity, and dietary intake. Discussion The Pre-DICTED trial will provide evidence of the effectiveness and feasibility of a community-based stepwise diabetes prevention program with added financial incentives for individuals with pre-diabetes in Singapore. The study will provide data for a future cost-effectiveness analysis, which will be used to inform policymakers of the value of a nationwide implementation of the diabetes prevention program. Trial registration ClinicalTrials.govNCT03503942. Retrospectively registered on April 20, 2018. Protocol version: 5.0 Date: 1 March 2019
Published: 2021

32. Adaptive Cardiac Resynchronization Therapy Effect on Electrical Dyssynchrony (aCRT-ELSYNC): A randomized controlled trial

Author: Jason Thomas, Ashley Wirth, Merritt H. Raitt, Khidir Dalouk, Maros Ferencik, Cristina Fuss, Ryle Przybylowicz, Katherine J. Lutz, Peter M. Jessel, Ignatius Gerardo E. Zarraga, Thomas A. Dewland, Larisa G. Tereshchenko, Charles A. Henrikson, Bassel Beitinjaneh, Nichole M. Rogovoy, Christopher Hamilton, Karen S. MacMurdy, Aron Bender, David M. German, Kazi T. Haq, Babak Nazer, Peter M. van Dam, and Eric C. Stecker
Subjects: medicine.medical_specialty, medicine.medical_treatment, Cardiac resynchronization therapy, Heart failure, Noninvasive mapping, AV optimization, QRS complex, Clinical, Interquartile range, Internal medicine, medicine, Diseases of the circulatory (Cardiovascular) system, cardiovascular diseases, Implantable Devices, Ischemic cardiomyopathy, Ejection fraction, Bundle branch block, Left bundle branch block, business.industry, Electrocardiographic imaging, medicine.disease, Ventricular conduction abnormalities, Dyssynchrony, Randomized controlled trial, RC666-701, Cardiology, cardiovascular system, CRT, ECGI, business
Abstract: Background Adaptive cardiac resynchronization therapy (aCRT) is known to have clinical benefits over conventional CRT, but the mechanisms are unclear. Objective Compare effects of aCRT and conventional CRT on electrical dyssynchrony. Methods A prospective, double-blind, 1:1 parallel-group assignment randomized controlled trial in patients receiving CRT for routine clinical indications. Participants underwent cardiac computed tomography and 128-electrode body surface mapping. The primary outcome was change in electrical dyssynchrony measured on the epicardial surface using noninvasive electrocardiographic imaging before and 6 months post-CRT. Ventricular electrical uncoupling (VEU) was calculated as the difference between the mean left ventricular (LV) and right ventricular (RV) activation times. An electrical dyssynchrony index (EDI) was computed as the standard deviation of local epicardial activation times. Results We randomized 27 participants (aged 64 ± 12 years; 34% female; 53% ischemic cardiomyopathy; LV ejection fraction 28% ± 8%; QRS duration 155 ± 21 ms; typical left bundle branch block [LBBB] in 13%) to conventional CRT (n = 15) vs aCRT (n = 12). In atypical LBBB (n = 11; 41%) with S waves in V5-V6, conduction block occurred in the anterior RV, as opposed to the interventricular groove in strict LBBB. As compared to baseline, VEU reduced post-CRT in the aCRT (median reduction 18.9 [interquartile range 4.3–29.2 ms; P = .034]), but not in the conventional CRT (21.4 [-30.0 to 49.9 ms; P = .525]) group. There were no differences in the degree of change in VEU and EDI indices between treatment groups. Conclusion The effect of aCRT and conventional CRT on electrical dyssynchrony is largely similar, but only aCRT harmoniously reduced interventricular dyssynchrony by reducing RV uncoupling., Graphical abstract
Published: 2021

33. Pancreatic resection in the pediatric, adolescent and young adult population

Author: Vincent E de Meijer, Marielle M.E. Coolsen, Michael F. Gerhards, Casper H.J. van Eijck, J. Sven D. Mieog, Hjalmar C. van Santvoort, Bobby K Pranger, Jacob L van Dam, Bert A. Bonsing, Geert Kazemier, Jesse V. Groen, Olivier R. Busch, Koert P. de Jong, Ruben H J de Kleine, Joost M. Klaase, Erwin van der Harst, Bas Groot Koerkamp, I. Quintus Molenaar, Marc G. Besselink, Martijn W J Stommel, MUMC+: MA Heelkunde (9), RS: FHML non-thematic output, Groningen Institute for Organ Transplantation (GIOT), Guided Treatment in Optimal Selected Cancer Patients (GUTS), Value, Affordability and Sustainability (VALUE), Center for Liver, Digestive and Metabolic Diseases (CLDM), Surgery, and AGEM - Amsterdam Gastroenterology Endocrinology Metabolism
Subjects: medicine.medical_specialty, NUTRITIONAL-STATUS, Adolescent, SURGERY, Population, INTERNATIONAL STUDY-GROUP, CHILDREN, 030230 surgery, Gastroenterology, Young Adult, 03 medical and health sciences, Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14], Pancreatectomy, Postoperative Complications, 0302 clinical medicine, All institutes and research themes of the Radboud University Medical Center, TUMOR, SDG 3 - Good Health and Well-being, Internal medicine, Diabetes mellitus, medicine, Humans, Young adult, Child, Pancreatic resection, education, Exocrine pancreatic insufficiency, Pancreas, TERM-FOLLOW-UP, Retrospective Studies, education.field_of_study, OUTCOMES, Hepatology, business.industry, Retrospective cohort study, medicine.disease, CANCER, Pancreatic Neoplasms, Treatment Outcome, 030220 oncology & carcinogenesis, Cohort, PANCREATICODUODENECTOMY, Severe morbidity, Exocrine Pancreatic Insufficiency, business
Abstract: BACKGROUND: The aim of this study was to determine pancreatic surgery specific short- and long-term complications of pediatric, adolescent and young adult (PAYA) patients who underwent pancreatic resection, as compared to a comparator cohort of adults.METHODS: A nationwide retrospective cohort study was performed in PAYA patients who underwent pancreatic resection between 2007 and 2016. PAYA was defined as all patients RESULTS: A total of 230 patients were included in the PAYA cohort (112 distal pancreatectomies, 99 pancreatoduodenectomies), and 2526 patients in the comparator cohort. For pancreatoduodenectomy, severe morbidity (29.3% vs. 28.6%; P = 0.881), in-hospital mortality (1% vs. 4%; P = 0.179) and textbook outcome (62% vs. 58%; P = 0.572) were comparable between the PAYA and the comparator cohort. These outcomes were also similar for distal pancreatectomy. After pancreatoduodenectomy, new-onset diabetes mellitus (8% vs. 16%) and exocrine pancreatic insufficiency (27% vs. 73%) were lower in the PAYA cohort when compared to adult literature.CONCLUSION: Pancreatic surgery-specific complications were comparable with patients ≥40 years. Development of endocrine and exocrine insufficiency in PAYA patients who underwent pancreatoduodenectomy, however, was substantially lower compared to adult literature.
Published: 2021

34. Microjet Configuration Sensitivities for Active Flow Control on Multi-Element High-Lift Systems

Author: Shishir A. Pandya, Aubryn Cooperman, Seyedeh Sheida Hosseini, and C. P. van Dam
Subjects: Physics, 020301 aerospace & aeronautics, business.industry, Aerospace Engineering, 02 engineering and technology, Mechanics, Active flow control, Computational fluid dynamics, 01 natural sciences, Multi element, 010305 fluids & plasmas, Flow separation, 0203 mechanical engineering, Incompressible flow, 0103 physical sciences, Mass flow rate, Trailing edge, Reynolds-averaged Navier–Stokes equations, business
Abstract: Various characteristics of small surface-normal jets (microjets) located on a flap’s pressure-side near the trailing edge are investigated as an active aerodynamic load control technology for multi...
Published: 2021
Full Text: View/download PDF

35. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants

Author: Zhou, B, Carrillo-Larco, Rm, Danaei, G, Riley, Lm, Paciorek, Cj, Stevens, Ga, Gregg, Ew, Bennett, Je, Solomon, B, Singleton, Rk, Sophiea, Mk, Iurilli, Mlc, Lhoste, Vpf, Cowan, Mj, Savin, S, Woodward, M, Balanova, Y, Cifkova, R, Damasceno, A, Elliott, P, Farzadfar, F, He, J, Ikeda, N, Kengne, Ap, Khang, Yh, Kim, Hc, Laxmaiah, A, Lin, Hh, Maira, Pm, Miranda, Jj, Neuhauser, H, Sundstrom, J, Varghese, C, Widyahening, Is, Zdrojewski, T, Ezzati, M, Abarca-Gomez, L, Abdeen, Za, Rahim, Hfa, Abu-Rmeileh, Nm, Acosta-Cazares, B, Adams, Rj, Aekplakorn, W, Afsana, K, Afzal, S, Agdeppa, Ia, Aghazadeh-Attari, J, Aguilar-Salinas, Ca, Agyemang, C, Ahmad, Na, Ahmadi, A, Ahmadi, N, Ahmadizar, F, Ahmed, Sh, Ahrens, W, Ajlouni, K, Al-Raddadi, R, Alarouj, M, Albuhairan, F, Aldhukair, S, Ali, Mm, Alkandari, A, Alkerwi, A, Allin, K, Aly, E, Amarapurkar, Dn, Amougou, N, Amouyel, P, Andersen, Lb, Anderssen, Sa, Anjana, Rm, Ansari-Moghaddam, A, Ansong, D, Aounallah-Skhiri, H, Araujo, J, Ariansen, I, Aris, T, Arku, Re, Arlappa, N, Aryal, Kk, Aspelund, T, Assah, Fk, Assuncao, Mcf, Auvinen, J, Avdicova, M, Azevedo, A, Azimi-Nezhad, M, Azizi, F, Azmin, M, Babu, Bv, Bahijri, S, Balakrishna, N, Bamoshmoosh, M, Banach, M, Banadinovic, M, Bandosz, P, Banegas, Jr, Baran, J, Barbagallo, Cm, Barcelo, A, Barkat, A, Barreto, M, Barros, Ajd, Barros, Mvg, Bartosiewicz, A, Basit, A, Bastos, Jld, Bata, I, Batieha, Am, Batyrbek, A, Baur, La, Beaglehole, R, Belavendra, A, Ben Romdhane, H, Benet, M, Benson, Ls, Berkinbayev, S, Bernabe-Ortiz, A, Bettiol, H, Bezerra, J, Bhagyalaxmi, A, Bhargava, Sk, Bia, D, Biasch, K, Lele, Ecb, Bikbov, Mm, Bista, B, Bjerregaard, P, Bjertness, E, Bjertness, Mb, Bjorkelund, C, Bloch, Kv, Blokstra, A, Bo, S, Bobak, M, Boeing, H, Boggia, Jg, Boissonnet, Cp, Bojesen, Se, Bongard, V, Bonilla-Vargas, A, Bopp, M, Borghs, H, Bovet, P, Boyer, Cb, Braeckman, L, Brajkovich, I, Branca, F, Breckenkamp, J, Brenner, H, Brewster, Lm, Briceno, Y, Brito, M, Bruno, G, Bueno-de-Mesquita, Hb, Bueno, G, Bugge, A, Burns, C, Bursztyn, M, de Leon, Ac, Cacciottolo, J, Cameron, C, Can, G, Candido, Apc, Capanzana, Mv, Capkova, N, Capuano, E, Capuano, V, Cardoso, Vc, Carlsson, Ac, Carvalho, J, Casanueva, Ff, Censi, L, Cervantes-Loaiza, M, Chadjigeorgiou, Ca, Chamukuttan, S, Chan, Aw, Chan, Q, Chaturvedi, Hk, Chaturvedi, N, Chee, Ml, Chen, Cj, Chen, Ff, Chen, Hs, Chen, Sh, Chen, Zm, Cheng, Cy, Cheraghian, B, Dekkaki, Ic, Chetrit, A, Chien, Kl, Chiolero, A, Chiou, St, Chirita-Emandi, A, Chirlaque, Md, Cho, B, Christensen, K, Christofaro, Dg, Chudek, J, Cinteza, E, Claessens, F, Clarke, J, Clays, E, Cohen, E, Concin, H, Cooper, C, Coppinger, Tc, Costanzo, S, Cottel, D, Cowell, C, Craig, Cl, Crampin, Ac, Crujeiras, Ab, Cruz, Jj, Csilla, S, Cui, Lf, Cureau, Fv, Cuschieri, S, D'Arrigo, G, D'Orsi, E, Dallongeville, J, Dankner, R, Dantoft, Tm, Dauchet, L, Davletov, K, De Backer, G, De Bacquer, D, De Curtis, A, de Gaetano, G, De Henauw, S, de Oliveira, Pd, De Ridder, D, De Smedt, D, Deepa, M, Deev, Ad, Degennaro, V, Delisle, H, Demarest, S, Dennison, E, Deschamps, V, Dhimal, M, Di Castelnuovo, Af, Dias-da-Costa, Js, Diaz, A, Dickerson, Tt, Dika, Z, Djalalinia, S, Htp, Do, Dobson, Aj, Donfrancesco, C, Donoso, Sp, Doring, A, Dorobantu, M, Dorr, M, Doua, K, Dragano, N, Drygas, W, Duante, Ca, Duboz, P, Duda, Rb, Dulskiene, V, Dushpanova, A, Dzakula, A, Dzerve, V, Dziankowska-Zaborszczyk, E, Eddie, R, Eftekhar, E, Eggertsen, R, Eghtesad, S, Eiben, G, Ekelund, U, El-Khateeb, M, El Ati, J, Eldemire-Shearer, D, Eliasen, M, Elosua, R, Erasmus, Rt, Erbel, R, Erem, C, Eriksen, L, Eriksson, Jg, Escobedo-de la Pena, J, Eslami, S, Esmaeili, A, Evans, A, Faeh, D, Fakhretdinova, Aa, Fall, Ch, Faramarzi, E, Farjam, M, Fattahi, Mr, Fawwad, A, Felix-Redondo, Fj, Felix, Sb, Ferguson, Ts, Fernandes, Ra, Fernandez-Berges, D, Ferrante, D, Ferrao, T, Ferrari, M, Ferrario, Mm, Ferreccio, C, Ferreira, Hs, Ferrer, E, Ferrieres, J, Figueiro, Th, Fink, G, Fischer, K, Foo, Lh, Forsner, M, Fouad, Hm, Francis, Dk, Grego, Franco, Frikke-Schmidt, R, Frontera, G, Fuchs, Fd, Fuchs, Sc, Fujita, Y, Fumihiko, M, Furdela, V, Furer, A, Furusawa, T, Gaciong, Z, Galbarczyk, A, Galenkamp, H, Galvano, F, Gao, Jl, Gao, P, Garcia-de-la-Hera, M, Garcia, P, Gareta, D, Garnett, Sp, Gaspoz, Jm, Gasull, M, Gazzinelli, A, Gehring, U, Geleijnse, Jm, George, R, Ghanbari, A, Ghasemi, E, Gheorghe-Fronea, Of, Ghimire, A, Gialluisi, A, Giampaoli, S, Gieger, C, Gill, Tk, Giovannelli, J, Gironella, G, Giwercman, A, Gkiouras, K, Goldberg, M, Goldsmith, Ra, Gomez, Lf, Gomula, A, da Silva, Bgc, Goncalves, H, Goncalves, M, Gonzalez-Chica, Da, Gonzalez-Gross, M, Gonzalez-Rivas, Jp, Gonzalez-Villalpando, C, Gonzalez-Villalpando, Me, Gonzalez, Ar, Gorbea, Mb, Gottrand, F, Graff-Iversen, S, Grafnetter, D, Grajda, A, Grammatikopoulou, Mg, Gregor, Rd, Grodzicki, T, Grosso, G, Gruden, G, Df, Gu, Guan, Op, Gudmundsson, Ef, Gudnason, V, Guerrero, R, Guessous, I, Guimaraes, Al, Gulliford, Mc, Gunnlaugsdottir, J, Gunter, Mj, Gupta, Pc, Gupta, R, Gureje, O, Gurzkowska, B, Gutierrez, L, Gutzwiller, F, Ha, S, Hadaegh, F, Haghshenas, R, Hakimi, H, Halkjaer, J, Hambleton, Ir, Hamzeh, B, Hange, D, Hanif, Aam, Hantunen, S, Hao, J, Hardman, Cm, Kumar, Rh, Hashemi-Shahri, Sm, Hata, J, Haugsgjerd, T, Hayes, Aj, Yn, He, Heier, M, Hendriks, Me, Henrique, Rd, Henriques, A, Cadena, Lh, Herrala, S, Heshmat, R, Hill, Ag, Sy, Ho, Sc, Ho, Hobbs, M, Holdsworth, M, Homayounfar, R, Dinc, Gh, Horimoto, Arvr, Hormiga, Cm, Horta, Bl, Houti, L, Howitt, C, Htay, Tt, Htet, As, Htike, Mmt, Yh, Hu, Huerta, Jm, Huhtaniemi, It, Huiart, L, Huisman, M, Husseini, As, Huybrechts, I, Hwalla, N, Iacoviello, L, Iannone, Ag, Ibrahim, Mm, Wong, Ni, Ikram, Ma, Iotova, V, Irazola, Ve, Ishida, T, Isiguzo, Gc, Islam, M, Islam, Sms, Iwasaki, M, Jackson, Rt, Jacobs, Jm, Jaddou, Hy, Jafar, T, James, K, Jamrozik, K, Janszky, I, Janus, E, Jarvelin, Mr, Jasienska, G, Jelakovic, A, Jelakovic, B, Jennings, G, Jha, Ak, Jiang, Cq, Jimenez, Ro, Jockel, Kh, Joffres, M, Johansson, M, Jokelainen, Jj, Jonas, Jb, Jorgensen, T, Joshi, P, Joukar, F, Jozwiak, J, Juolevi, A, Jurak, G, Juresa, V, Kaaks, R, Kafatos, A, Kajantie, Eo, Kalmatayeva, Z, Kalpourtzi, N, Kalter-Leibovici, O, Kampmann, Fb, Kannan, S, Karaglani, E, Karhus, Ll, Karki, Kb, Katibeh, M, Katz, J, Kauhanen, J, Kaur, P, Kavousi, M, Kazakbaeva, Gm, Keil, U, Boker, Lk, Keinanen-Kiukaanniemi, S, Kelishadi, R, Kemper, Hcg, Keramati, M, Kerimkulova, A, Kersting, M, Key, T, Khader, Ys, Khalili, D, Khaw, Kt, Kheiri, B, Kheradmand, M, Khosravi, A, Kiechl-Kohlendorfer, U, Kiechl, S, Killewo, J, Kim, Dw, Kim, J, Klakk, H, Klimek, M, Klumbiene, J, Knoflach, M, Kolle, E, Kolsteren, P, Kontto, Jp, Korpelainen, R, Korrovits, P, Kos, J, Koskinen, S, Kouda, K, Kowlessur, S, Koziel, S, Kratenova, J, Kriaucioniene, V, Kristensen, Pl, Krokstad, S, Kromhout, D, Kruger, Hs, Kubinova, R, Kuciene, R, Kujala, Um, Kulaga, Z, Kumar, Rk, Kurjata, P, Kusuma, Ys, Kutsenko, V, Kuulasmaa, K, Kyobutungi, C, Laatikainen, T, Lachat, C, Laid, Y, Lam, Th, Landrove, O, Lanska, V, Lappas, G, Larijani, B, Latt, Ts, Le Coroller, G, Bao, Kln, Le, THUY DUNG, Lee, J, Lehmann, N, Lehtimaki, T, Lemogoum, D, Levitt, Ns, Yp, Li, Lilly, Cl, Lim, Wy, Lima-Costa, Mf, Lin, X, Lin, Yt, Lind, L, Lingam, V, Linneberg, A, Lissner, L, Litwin, M, Wc, Lo, Loit, Hm, Lopez-Garcia, E, Lopez, T, Lotufo, Pa, Lozano, Je, Lovrencic, Il, Lukrafka, Jl, Luksiene, D, Lundqvist, A, Lundqvist, R, Lunet, N, Lustigova, M, Luszczki, E, Gs, Ma, Ma, J, Machado-Coelho, Gll, Machado-Rodrigues, Am, Macia, E, Macieira, Lm, Madar, Aa, Maggi, S, Magliano, Dj, Magriplis, E, Mahasampath, G, Maire, B, Majer, M, Makdisse, M, Malekzadeh, F, Malekzadeh, R, Malhotra, R, Mallikharjuna, K, Malyutina, Sk, Maniego, Lv, Manios, Y, Mann, Ji, Mansour-Ghanaei, F, Manzato, E, Marcil, A, Margozzini, P, Marild, Sb, Glavic, Mm, Marques-Vidal, P, Marques, Lp, Marrugat, J, Martorell, R, Mascarenhas, Lp, Matasin, M, Mathiesen, Eb, Mathur, P, Matijasevich, A, Matlosz, P, Matsha, Te, Mavrogianni, C, Mbanya, Jcn, Posso, Ajm, Mcfarlane, Sr, Mcgarvey, St, Mclachlan, S, Mclean, Rm, Mclean, Sb, Mcnulty, Ba, Benchekor, Sm, Medzioniene, J, Mehdipour, P, Mehlig, K, Mehrparvar, Ah, Meirhaeghe, A, Meisinger, C, Montano, Cm, Menezes, Amb, Menon, Gr, Mereke, A, Meshram, Ii, Metspalu, A, Meyer, He, Mi, J, Michels, N, Mikkel, K, Milkowska, K, Miller, Jc, Minderico, Cs, Mini, Gk, Mirjalili, Mr, Mirrakhimov, E, Misigoj-Durakovic, M, Modesti, Pa, Moghaddam, Ss, Mohajer, B, Mohamed, Mk, Mohamed, Sf, Mohammad, K, Mohammadi, Mr, Mohammadi, Z, Mohammadifard, N, Mohammadpourhodki, R, Mohan, V, Mohanna, S, Yusoff, Mfm, Mohebbi, I, Mohebi, F, Moitry, M, Mollehave, Lt, Molnar, D, Momenan, A, Mondo, Ck, Monterrubio-Flores, E, Monyeki, Kdk, Moon, Js, Moosazadeh, M, Moreira, Lb, Morejon, A, Moreno, La, Morgan, K, Moschonis, G, Mossakowska, M, Mostafa, A, Mostafavi, Sa, Mota, J, Motlagh, Me, Motta, J, Moura-dos-Santos, Ma, Mridha, Mk, Msyamboza, Kp, Tt, Mu, Muhihi, Aj, Muiesan, Ml, Muller-Nurasyid, M, Murphy, N, Mursu, J, Musa, Ki, Milanovic, Sm, Musil, V, Mustafa, N, Nabipour, I, Naderimagham, S, Nagel, G, Naidu, Bm, Najafi, F, Nakamura, H, Namesna, J, Nang, Eek, Nangia, Vb, Narake, S, Ndiaye, Nc, Neal, Wa, Nejatizadeh, A, Nenko, I, Neovius, M, Neuhauser, Hk, Nguyen, Ct, Nguyen, Nd, Nguyen, Qv, Nguyen, Qn, Nieto-Martinez, Re, Niiranen, Tj, Nikitin, Yp, Ninomiya, T, Nishtar, S, Njelekela, Ma, Noale, M, Noboa, Oa, Noorbala, Aa, Norat, T, Nordendahl, M, Nordestgaard, Bg, Noto, D, Nowak-Szczepanska, N, Al Nsour, M, Nunes, B, O'Neill, Tw, O'Reilly, D, Ochimana, C, Oda, E, Odili, An, Oh, K, Ohara, K, Ohtsuka, R, Olie, V, Olinto, Mta, Oliveira, Io, Omar, Ma, Onat, A, Ong, Sk, Ono, Lm, Ordunez, P, Ornelas, R, Ortiz, Pj, Osmond, C, Ostojic, Sm, Ostovar, A, Otero, Ja, Overvad, K, Owusu-Dabo, E, Paccaud, Fm, Padez, C, Pahomova, E, de Paiva, Km, Pajak, A, Palli, D, Palmieri, L, Pan, Wh, Panda-Jonas, S, Panza, F, Paoli, M, Papandreou, D, Park, Sw, Park, S, Parnell, Wr, Parsaeian, M, Pasquet, P, Patel, Nd, Pavlyshyn, H, Pecin, I, Pednekar, Ms, Pedro, Jm, Peer, N, Peixoto, Sv, Peltonen, M, Pereira, Ac, Peres, Kgda, Peres, Ma, Peters, A, Petkeviciene, J, Peykari, N, Pham, St, Pichardo, Rn, Pigeot, I, Pikhart, H, Pilav, A, Pilotto, L, Pitakaka, F, Piwonska, A, Pizarro, An, Plans-Rubio, P, Polasek, O, Porta, M, Poudyal, A, Pourfarzi, F, Pourshams, A, Poustchi, H, Pradeepa, R, Price, Aj, Price, Jf, Providencia, R, Puhakka, Se, Puiu, M, Punab, M, Qasrawi, Rf, Qorbani, M, Queiroz, D, Bao, Tq, Radic, I, Radisauskas, R, Rahimikazerooni, S, Rahman, M, Raitakari, O, Raj, M, Rakhimova, Em, Rao, Sr, Ramachandran, A, Ramos, E, Rampal, L, Rampal, S, Reina, Dar, Rarra, V, Rech, Cr, Redon, J, Reganit, Pfm, Regecova, V, Revilla, L, Rezaianzadeh, A, Ribeiro, R, Riboli, E, Richter, A, Rigo, F, de Wit, Tfr, Ritti-Dias, Rm, Robitaille, C, Rodriguez-Artalejo, F, Rodriguez-Perez, Md, Rodriguez-Villamizar, La, Roggenbuck, U, Rojas-Martinez, R, Romaguera, D, Romeo, El, Rosengren, A, Roy, Jgr, Rubinstein, A, Ruidavets, Jb, Ruiz-Betancourt, Bs, Ruiz-Castell, M, Rusakova, Ia, Russo, P, Rutkowski, M, Sabanayagam, C, Sabbaghi, H, Sachdev, Hs, Sadjadi, A, Safarpour, Ar, Safi, S, Safiri, S, Saidi, O, Sakarya, S, Saki, N, Salanave, B, Martinez, Es, Salmeron, D, Salomaa, V, Salonen, Jt, Salvetti, M, Sanchez-Abanto, J, Sans, S, Santos, Da, Santos, Is, Santos, Lc, Santos, Mp, Santos, R, Saramies, Jl, Sardinha, Lb, Sarganas, G, Sarrafzadegan, N, Sathish, T, Saum, Ku, Savva, S, Sawada, N, Sbaraini, M, Scazufca, M, Schaan, Bd, Schargrodsky, H, Schipf, S, Schmidt, Co, Schnohr, P, Schottker, B, Schramm, S, Schultsz, C, Schutte, Ae, Sebert, S, Sein, Aa, Sen, A, Senbanjo, Io, Sepanlou, Sg, Servais, J, Shalnova, Sa, Shamah-Levy, T, Shamshirgaran, M, Shanthirani, Cs, Sharafkhah, M, Sharma, Sk, Shaw, Je, Shayanrad, A, Shayesteh, Aa, Shi, Zm, Shibuya, K, Shimizu-Furusawa, H, Shin, Dw, Shirani, M, Shiri, R, Shrestha, N, Si-Ramlee, K, Siani, A, Siantar, R, Sibai, Am, Silva, Crd, Silva, Das, Simon, M, Simons, J, Simons, La, Sjostrom, M, Slowikowska-Hilczer, J, Slusarczyk, P, Smeeth, L, Hk, So, Soares, Fc, Sobngwi, E, Soderberg, S, Soemantri, A, Sofat, R, Solfrizzi, V, Somi, Mh, Sonestedt, E, Song, Y, Sorensen, Tia, Sorgjerd, Ep, Soric, M, Jerome, Cs, Soumare, A, Sparboe-Nilsen, B, Sparrenberger, K, Staessen, Ja, Starc, G, Stavreski, B, Steene-Johannessen, J, Stehle, P, Stein, Ad, Stergiou, Gs, Stessman, J, Stieber, J, Stockl, D, Stocks, T, Stokwiszewski, J, Stronks, K, Strufaldi, Mw, Suka, M, Sun, Ca, Sung, Yt, Suriyawongpaisal, P, Rg, Sy, Syddall, He, Sylva, Rc, Szklo, M, Tai, Es, Tammesoo, Ml, Tamosiunas, A, Tan, Ej, Tang, X, Tanser, F, Tao, Y, Tarawneh, Mr, Tarqui-Mamani, Cb, Taylor, A, Taylor, J, Tebar, Wr, Tell, Gs, Tello, T, Tham, Yc, Thankappan, Kr, Theobald, H, Theodoridis, X, Thijs, L, Thinggaard, M, Thomas, N, Thorand, B, Thuesen, Bh, Timmermans, Ej, Tjandrarini, Dh, Tjonneland, A, Toft, U, Tolonen, Hk, Tolstrup, Js, Topbas, M, Topor-Madry, R, Tormo, Mj, Tornaritis, Mj, Torrent, M, Torres-Collado, L, Touloumi, G, Traissac, P, Triantafyllou, A, Trichopoulos, D, Trichopoulou, A, Trinh, Oth, Trivedi, A, Tshepo, L, Tsugane, S, Tuliakova, Am, Tulloch-Reid, Mk, Tullu, F, Tuomainen, Tp, Tuomilehto, J, Turley, Ml, Twig, G, Tynelius, P, Tzourio, C, Ueda, P, Ugel, E, Ulmer, H, Uusitalo, Hmt, Valdivia, G, Valvi, D, van Dam, Rm, van den Born, Bj, Van der Heyden, J, van der Schouw, Yt, Van Herck, K, Minh, Hv, Van Schoor, Nm, van Valkengoed, Igm, van Zutphen, Em, Vanderschueren, D, Vanuzzo, D, Varbo, A, Vasan, Sk, Vega, T, Veidebaum, T, Velasquez-Melendez, G, Veronesi, G, Verschuren, Wmm, Verstraeten, R, Victora, Cg, Viet, L, Villalpando, S, Vineis, P, Vioque, J, Virtanen, Jk, Visvikis-Siest, S, Viswanathan, B, Vlasoff, T, Vollenweider, P, Voutilainen, A, Wade, An, Walton, J, Wambiya, Eoa, Bebakar, Wmw, Mohamud, Wnw, Wanderley, Rd, Wang, Md, Wang, Nl, Wang, Q, Wang, Xj, Wang, Yx, Wang, Yw, Wannamethee, Sg, Wareham, N, Wei, Wb, Weres, A, Werner, B, Whincup, Ph, Widhalm, K, Wiecek, A, Wilks, Rj, Willeit, J, Willeit, P, Williams, Ea, Wilsgaard, T, Wojtyniak, B, Wong-McClure, Ra, Wong, A, Wong, Ty, Woo, J, Fc, Wu, Sl, Wu, Wyszynska, J, Hq, Xu, Xu, L, Yaacob, Na, Yan, Wl, Yang, L, Yang, Xg, Yang, Y, Yasuharu, T, Xw, Ye, Yiallouros, Pk, Yoosefi, M, Yoshihara, A, You, Sl, Younger-Coleman, No, Yusoff, Af, Zainuddin, Aa, Zakavi, Sr, Zamani, F, Zambon, S, Zampelas, A, Zapata, Me, Zaw, Kk, Zejglicova, K, Vrkic, Tz, Zeng, Y, Zhang, Lx, Zhang, Zy, Zhao, D, Zhao, Mh, Zhen, Sq, Zheng, Yf, Zholdin, B, Zhu, D, Zins, M, Zitt, E, Zocalo, Y, Zoghlami, N, Cisneros, Jz, Borghs, Herman, Claessens, Frank, Staessen, Jan, Thijs, Lutgarde, Vanderschueren, Dirk, Zhang, Zhen-Yu, Imperial Coll London, Harvard TH Chan Sch Publ Hlth, WHO, Univ Calif Berkeley, Univ New South Wales, Natl Med Res Ctr Therapy & Prevent Med, Charles Univ Prague, Thomayer Hosp, Eduardo Mondlane Univ, Noncommunicable Dis Res Ctr, Tulane Univ, Natl Inst Biomed Innovat Hlth & Nutr, South African Med Res Council, Seoul Natl Univ, Yonsei Univ, ICMR Natl Inst Nutr, Natl Taiwan Univ, Pontificia Univ Catolica Chile, Univ Peruana Cayetano Heredia, Robert Koch Inst, Uppsala Univ, Univ Indonesia, Med Univ Gdansk, Univ Ghana, Caja Costarricense Seguro Social, Al Quds Univ, Qatar Univ, Birzeit Univ, Inst Mexicano Seguro Social, Flinders Univ S Australia, Mahidol Univ, BRAC Univ, Univ Copenhagen, Copenhagen Univ Hosp, Food & Nutr Res Inst, Urmia Univ Med Sci, Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Univ Amsterdam, Minist Hlth, Modeling Hlth Res Ctr, Shahid Sadoughi Univ Med Sci, Erasmus MC, Univ Oslo, Leibniz Inst Prevent Res & Epidemiol BIPS, Natl Ctr Diabet Endocrinol & Genet, King Abdulaziz Univ, Dasman Diabet Inst, Aldara Hosp & Med Ctr, King Abdullah Int Med Res Ctr, Luxembourg Inst Hlth, Bispebjerg, Frederiksberg Univ Hosp, WHO Reg Off Eastern Mediterranean, Bombay Hosp & Med Res Ctr, CNRS, Univ Lille, Lille Univ Hosp, Western Norway Univ Appl Sci, Norwegian Sch Sport Sci, Madras Diabet Res Fdn, Zahedan Univ Med Sci, Kwame Nkrumah Univ Sci & Technol, Natl Inst Publ Hlth, Univ Porto, Norwegian Inst Publ Hlth, Univ Massachusetts, Abt Associates Inc, Univ Iceland, Univ Yaounde I, Univ Fed Pelotas, Univ Oulu, Oulu Univ Hosp, Banska Bystr Reg Author Publ Hlth, Neyshabur Univ Med Sci, Res Inst Endocrine Sci, Indian Council Med Res, Univ Sci & Technol, Med Univ Lodz, Univ Zagreb, Univ Autonoma Madrid CIBERESP, Univ Rzeszow, Univ Palermo, Pan Amer Hlth Org, Mohammed V Univ Rabat, Natl Inst Hlth Doutor Ricardo Jorge, NOVA Univ Lisbon, Univ Pernambuco, Baqai Inst Diabetol & Endocrinol, Universidade Federal de Santa Catarina (UFSC), Dalhousie Univ, Jordan Univ Sci & Technol, Al Farabi Kazakh Natl Univ, Univ Sydney, Univ Auckland, Christian Med Coll Vellore, Univ Tunis El Manar, Cafam Univ Fdn, Univ Utah, Kazakh Natl Med Univ, Lithuanian Univ Hlth Sci, Universidade de São Paulo (USP), BJ Med Coll, Sunder Lal Jain Hosp, Univ Republica, Univ Strasbourg, Inst Med Res & Med Plant Studies, Ufa Eye Res Inst, Nepal Hlth Res Council, Univ Southern Denmark, Univ Gothenburg, Universidade Federal do Rio de Janeiro (UFRJ), Natl Inst Publ Hlth & Environm, Univ Turin, UCL, German Inst Human Nutr, Ctr Educ Med & Invest Clin, Toulouse Univ, Univ Zurich, Univ Hosp KU Leuven, Unisante, Univ Ghent, Univ Cent Venezuela, Bielefeld Univ, German Canc Res Ctr, Univ Andres, Inst Politecn Lisboa, Univ Zaragoza, Univ Coll Copenhagen, Munster Technol Univ, Hadassah Univ, Univ La Laguna, Univ Malta, Canadian Fitness & Lifestyle Res Inst, Istanbul Univ Cerrahpasa, Univ Fed Juiz de Fora, Gaetano Fucito Hosp, Karolinska Inst, Santiago Compostela Univ, Council Agr Res & Econ, Res & Educ Inst Child Hlth, India Diabet Res Fdn, Duke NUS Med Sch, ICMR Natl Inst Med Stat, Singapore Eye Res Inst, Acad Sinica, Capital Inst Pediat, Duke Univ, Kailuan Gen Hosp, Univ Oxford, Ahvaz Jundishapur Univ Med Sci, Gertner Inst Epidemiol & Hlth Policy Res, Univ Bern, Minist Hlth & Welf, Victor Babes Univ Med & Pharm Timisoara, CIBER Epidemiol & Salud Publ, Universidade Estadual Paulista (UNESP), Med Univ Silesia, Carol Davila Univ Med & Pharm, Katholieke Univ Leuven, STAT Canada, Agcy Prevent & Social Med, Univ Southampton, IRCCS Neuromed, Inst Pasteur, Malawi Epidemiol & Intervent Res Unit, CIBEROBN, Univ Autonoma Madrid, Univ Debrecen, Univ Fed Rio Grande do Sul, CNR, Geneva Univ Hosp, Innovating Hlth Int, Univ Montreal, Sciensano, French Publ Hlth Agcy, Mediterranea Cardioctr, Univ Vale Rio dos Sinos, Natl Council Sci & Tech Res, Minist Hlth & Med Educ, Natl Inst Nutr, Univ Queensland, Ist Super Sanita, Univ Cuenca, Helmholtz Zentrum Munchen, Univ Med Greifswald, Minist Sante & Hyg Publ, Univ Hosp Dusseldorf, Natl Inst Cardiol, IRL 3189 ESS, Beth Israel Deaconess Med Ctr, Harvard Med Sch, Scuola Super Sant Anna, Univ Latvia, Minist Hlth & Med Serv, Hormozgan Univ Med Sci, Univ Tehran Med Sci, Univ Skovde, Natl Inst Nutr & Food Technol, Univ West Indies, Inst Hosp Mar Invest Med, CIBERCV, Univ Stellenbosch, Univ Duisburg Essen, Karadeniz Tech Univ, Univ Helsinki, Mashhad Univ Med Sci, Rafsanjan Univ Med Sci, Queens Univ Belfast, Tabriz Univ Med Sci, Fasa Univ Med Sci, Shiraz Univ Med Sci, Baqai Med Univ, Ctr Salud Villanueva Norte, Hosp Don Benito Villanueva de la Serena, Univ Insubria, Univ Fed Alagoas, Swiss Trop & Publ Hlth Inst, Univ Basel, Univ Tartu, Univ Sains Malaysia, Umea Univ, Universidade Federal de São Paulo (UNIFESP), Hosp Univ Son Espases, Hosp Clin Porto Alegre, Kindai Univ, Kyoto Univ, I Horbachevsky Ternopil Natl Med Univ, Tel Aviv Univ, Hebrew Univ Jerusalem, Med Univ Warsaw, Jagiellonian Univ Med Coll, Univ Catania, Peking Univ, Wuqu Kawoq, Africa Hlth Res Inst, Univ Geneva, Universidade Federal de Minas Gerais (UFMG), Univ Utrecht, Wageningen Univ, Med Res Fdn, BP Koirala Inst Hlth Sci, Univ Adelaide, Lund Univ, Aristotle Univ Thessaloniki, Inst Natl Sante & Rech Med, Paris Univ, Pontificia Univ Javeriana, PASs Hirszfeld Inst Immunol & Expt Therapy, Univ Agostinho Neto, Univ Politecn Madrid, Int Clin Res Ctr, Ctr Estudios Diabet AC, Univ Autonoma Santo Domingo, Natl Inst Hyg Epidemiol & Microbiol, Inst Clin & Expt Med, Childrens Mem Hlth Inst, Int Hellen Univ, Natl Ctr Cardiovasc Dis, Iceland Heart Assoc, Univ ICESI, Univ Estadual Montes Claros, Kings Coll London, Int Agcy Res Canc, Healis Sekhsaria Inst Publ Hlth, Eternal Heart Care Ctr & Res Inst, Univ Ibadan, Inst Clin Effectiveness & Hlth Policy, Natl Hlth Insurance Serv, Prevent Metab Disorders Res Ctr, Danish Canc Soc Res Ctr, Kermanshah Univ Med Sci, BRAC James P Grant Sch Publ Hlth, Univ Eastern Finland, Beijing Inst Ophthalmol, Universidade Federal de Pernambuco (UFPE), Kyushu Univ, Univ Bergen, Chinese Ctr Dis Control & Prevent, Joep Lange Inst, Chron Dis Res Ctr, Univ Hong Kong, Chinese Univ Hong Kong, Univ Western Australia, French Natl Res Inst Sustainable Dev, Celal Bayar Univ, Fdn Oftalmol Santander, Univ Oran 1, Minist Hlth & Sports, Sante Publ France, Vrije Univ Amsterdam Med Ctr, Amer Univ Beirut, Cairo Univ, Med Univ Varna, Univ Tokyo, Universidade Estadual de Maringá (UEM), Hosp Sick Children, Deakin Univ, Tokyo Metropolitan Inst Gerontol, Hadassah Univ Med Ctr, Norwegian Univ Sci & Technol, Univ Melbourne, Univ Hosp Ctr Zagreb, Heart Fdn, Guangzhou 12th Hosp, Univ Eugenio Maria Hostos, Simon Fraser Univ, Inst Mol & Clin Ophthalmol Basel, WHO Country Off, Guilan Univ Med Sci, Univ Opole, Finnish Inst Hlth & Welf, Univ Ljubljana, Univ Crete, Natl & Kapodistrian Univ Athens, Sree Chitra Tirunal Inst Med Sci & Technol, Harokopio Univ, Maharajgunj Med Campus, Aarhus Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Natl Inst Epidemiol, Univ Munster, Israel Ctr Dis Control, Res Inst Primordial Prevent Noncommunicable Dis, Amsterdam UMC Publ Hlth Res Inst, Kyrgyz State Med Acad, Res Inst Child Nutr, Shahid Beheshti Univ Med Sci, Univ Cambridge, Mazandaran Univ Med Sci, Hypertens Res Ctr, Med Univ Innsbruck, VASCage, Muhimbili Univ Hlth & Allied Sci, Natl Canc Ctr, Univ Coll South Denmark, Oulu Deaconess Inst Fdn, Tartu Univ Clin, Kansai Med Univ, Minist Hlth & Wellness, Univ Groningen, North West Univ, Amrita Inst Med Sci, All India Inst Med Sci, African Populat & Hlth Res Ctr, Minist Salud Publ, Sahlgrens Acad, Endocrinol & Metab Res Ctr, Univ Publ Hlth, Natl Univ Singapore, Tampere Univ Hosp, Tampere Univ, Univ Douala, Univ Cape Town, West Virginia Univ, Oswaldo Cruz Fdn Rene Rachou Res Inst, Shanghai Inst Nutr & Hlth, Taipei Med Univ, Natl Inst Hlth Dev, Univ San Martin de Porres, Consejeria Sanidad Junta Castilla & Leon, Univ Fed Ciencias Saude Porto Alegre, Norrbotten Cty Council, Univ Fed Ouro Preto, Univ Coimbra, Coimbra Univ Hosp Ctr, Inst Neurosci Natl Res Council, Baker Heart & Diabet Inst, Agr Univ Athens, Hosp Israelita Albert Einstein, SB RAS Fed Res Ctr Inst Cytol & Genet, Univ Otago, Univ Padua, Gothenburg Univ, Univ Rijeka, Lausanne Univ Hosp, Univ Lausanne, Escola Nacl Saude Publ Sergio Arouca, Emory Univ, Univ Estadual Centro Oeste, UiT Arctic Univ Norway, ICMR Natl Ctr Dis Informat & Res, Cape Peninsula Univ Technol, Inst Conmemorat Gorgas Estudios Salud, Brown Univ, Univ Edinburgh, Univ Coll Dublin, Inst Nutr Ctr Amer & Panama, Univ Lisbon, Womens Social & Hlth Studies Fdn, Univ Firenze, Ain Shams Univ, Psychiat & Psychol Res Canter, Isfahan Cardiovasc Res Ctr, Strasbourg Univ Hosp, Univ Pecs, Mulago Hosp, Univ Limpopo, Univ Med Sci Cienfuegos, Royal Coll Surgeons Ireland, La Trobe Univ, Int Inst Mol & Cell Biol, Dept Publ Hlth, Univ Brescia, Ludwig Maximilians Univ Munchen, Croatian Inst Publ Hlth, Univ Kebangsaan Malaysia, Bushehr Univ Med Sci, Ulm Univ, Dept Stat, Kobe Univ, Suraj Eye Inst, Natl Inst Hyg & Epidemiol, Univ Med & Pharm Ho Chi Minh City, Natl Hosp Endocrinol, Hanoi Med Univ, LifeDoc Hlth, Univ Turku, Heartfile, Eastern Mediterranean Publ Hlth Network, Univ Manchester, Tachikawa Gen Hosp, Univ Abuja, Korea Ctr Dis Control & Prevent, Japan Wildlife Res Ctr, Istanbul Univ, Univ Fed Parana, Univ Madeira, Univ Novi Sad, Osteoporosis Res Ctr, UniSante, Inst Canc Res Prevent & Clin Network, Inst Clin & Sci Ophthalmol & Acupuncture Jonas, IRCCS Ente Osped Specializzato Gastroenterol S de, Zayed Univ, Catholic Univ Daegu, Jivandeep Hosp, Ctr Invest Saude Angola, Griffith Univ, Natl Dent Care Ctr Singapore, Vietnam Natl Heart Inst, Clin Med Avanzada Dr Abel Gonzalez, Univ Sarajevo, Cardiovasc Prevent Ctr Udine, Publ Hlth Agcy Catalonia, Univ Split, Ardabil Univ Med Sci, London Sch Hyg & Trop Med, Alborz Univ Med Sci, Pure Earth, Univ Putra Malaysia, Univ Malaya, Sotiria Hosp, Univ Valencia, Univ Philippines, Slovak Acad Sci, Univ San Martin Porres, Minas Gerais State Secretariat Hlth, CS S Agustin Ibsalut, Amsterdam Inst Global Hlth & Dev, Univ Nove de Julho, Publ Hlth Agcy Canada, Canarian Hlth Serv, Univ Ind Santander, Assoc Calabrese Epatol, Sahlgrens Univ Hosp, Sitaram Bhartia Inst Sci & Res, Koc Univ, Natl Inst Hlth, Catalan Dept Hlth, South Karelia Social & Hlth Care Dist, German Ctr Cardiovasc Res, McMaster Univ, Hosp Italiano Buenos Aires, Acad Med Ctr Univ Amsterdam, George Inst Global Hlth, Ctr Oral Hlth Serv & Res Mid Norway, Lagos State Univ, Nippon Med Sch, Sungkyunkwan Univ, Shahrekord Univ Med Sci, Finnish Inst Occupat Hlth, Publ Hlth Promot & Dev Org, St Vincents Hosp, Diponegoro Univ, Univ Bari, Inst Reg Sante Publ, Univ Bordeaux, Oslo Metropolitan Univ, Univ Leuven, Univ Bonn, Natl Inst Hyg, Jikei Univ, Fu Jen Catholic Univ, Natl Stat Off, Univ Lincoln, Cent Univ Kerala, Amsterdam Publ Hlth Res Inst, Natl Inst Hlth Res & Dev, Hlth Serv Murcia, Inst Invest Sanitaria Illes Balears, CIBER Epidemiol Salud Publ, Hellen Hlth Fdn, Govt Med Coll, Sefako Makgatho Hlth Sci Univ, Addis Ababa Univ, Israel Def Forces Med Corps, Univ Ctr Occidental Lisandro Alvarado, Univ Tampere, Icahn Sch Med Mt Sinai, Hanoi Univ Publ Hlth, Inst Trop Med, Univ Miguel Hernandez, Univ Lorraine, North Karelia Ctr Publ Hlth, Univ Witwatersrand, Inst Med Res, Capital Med Univ, Xinjiang Med Univ, Shanghai Educ Dev Co Ltd, Orebro Univ, St Georges Univ London, Med Univ Vienna, Komfo Anokye Teaching Hosp, Minist Agr & Rural Affairs, Fudan Univ, Shanghai Educ Dev, Univ Cyprus, Niigata Univ, Iran Univ Med Sci, Ctr Estudios Nutr Infantil, Jiangsu Prov Ctr Dis Control & Prevent, Sun Yat Sen Univ, West Kazakhstan Med Univ, Inner Mongolia Med Univ, Éco-Anthropologie (EAE), Muséum national d'Histoire naturelle (MNHN)-Centre National de la Recherche Scientifique (CNRS), Universitas Indonesia (UI ), Montpellier Interdisciplinary center on Sustainable Agri-food systems (Social and nutritional sciences) (UMR MoISA), Centre de Coopération Internationale en Recherche Agronomique pour le Développement (Cirad)-Institut de Recherche pour le Développement (IRD)-Centre International de Hautes Etudes Agronomiques Méditerranéennes - Institut Agronomique Méditerranéen de Montpellier (CIHEAM-IAMM), Centre International de Hautes Études Agronomiques Méditerranéennes (CIHEAM)-Centre International de Hautes Études Agronomiques Méditerranéennes (CIHEAM)-Institut national d’études supérieures agronomiques de Montpellier (Montpellier SupAgro), Institut national d'enseignement supérieur pour l'agriculture, l'alimentation et l'environnement (Institut Agro)-Institut national d'enseignement supérieur pour l'agriculture, l'alimentation et l'environnement (Institut Agro)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Interactions Gène-Environnement en Physiopathologie Cardio-Vasculaire (IGE-PCV), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Clinicum, Research Programs Unit, Johan Eriksson / Principal Investigator, Department of General Practice and Primary Health Care, University of Helsinki, HUS Helsinki and Uusimaa Hospital District, Department of Public Health, Tampere University, Clinical Medicine, Department of Clinical Chemistry, Eye Centre, Wellcome Trust, Epidemiology, Radiology & Nuclear Medicine, Éco-Anthropologie (EA), Cohortes épidémiologiques en population (CONSTANCES), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay-Université Paris Cité (UPCité), Université Paris Cité (UPCité), Centre International de Hautes Études Agronomiques Méditerranéennes (CIHEAM)-Centre International de Hautes Études Agronomiques Méditerranéennes (CIHEAM)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE)-Institut Agro - Montpellier SupAgro, Institut national d'enseignement supérieur pour l'agriculture, l'alimentation et l'environnement (Institut Agro)-Institut national d'enseignement supérieur pour l'agriculture, l'alimentation et l'environnement (Institut Agro), Epidemiology and Data Science, APH - Aging & Later Life, APH - Societal Participation & Health, Public and occupational health, APH - Health Behaviors & Chronic Diseases, VU University medical center, APH - Personalized Medicine, Psychiatry, APH - Mental Health, Bin Zhou, Rodrigo M Carrillo-Larco, Goodarz Danaei, Leanne M Riley, Christopher J Paciorek, Gretchen A Stevens, Edward W Gregg, James E Bennett, Bethlehem Solomon, Rosie K Singleton, Marisa K Sophiea, Maria Lc Iurilli, Victor Pf Lhoste, Melanie J Cowan, Stefan Savin, Mark Woodward, Yulia Balanova, Renata Cifkova, Albertino Damasceno, Paul Elliott, Farshad Farzadfar, Jiang He, Nayu Ikeda, Andre P Kengne, Young-Ho Khang, Hyeon Chang Kim, Avula Laxmaiah, Hsien-Ho Lin, Paula Margozzini Maira, J Jaime Miranda, Hannelore Neuhauser, Johan Sundström, Cherian Varghese, Indah S Widyahening, Tomasz Zdrojewski, Leandra Abarca-Gómez, Ziad A Abdeen, Hanan F Abdul Rahim, Niveen M Abu-Rmeileh, Benjamin Acosta-Cazares, Robert J Adams, Wichai Aekplakorn, Kaosar Afsana, Shoaib Afzal, Imelda A Agdeppa, Javad Aghazadeh-Attari, Carlos A Aguilar-Salinas, Charles Agyemang, Noor Ani Ahmad, Ali Ahmadi, Naser Ahmadi, Nastaran Ahmadi, Fariba Ahmadizar, Soheir H Ahmed, Wolfgang Ahrens, Kamel Ajlouni, Rajaa Al-Raddadi, Monira Alarouj, Fadia AlBuhairan, Shahla AlDhukair, Mohamed M Ali, Abdullah Alkandari, Ala'a Alkerwi, Kristine Allin, Eman Aly, Deepak N Amarapurkar, Norbert Amougou, Philippe Amouyel, Lars Bo Andersen, Sigmund A Anderssen, Ranjit Mohan Anjana, Alireza Ansari-Moghaddam, Daniel Ansong, Hajer Aounallah-Skhiri, Joana Araújo, Inger Ariansen, Tahir Aris, Raphael E Arku, Nimmathota Arlappa, Krishna K Aryal, Thor Aspelund, Felix K Assah, Maria Cecília F Assunção, Juha Auvinen, Mária Avdićová, Ana Azevedo, Mohsen Azimi-Nezhad, Fereidoun Azizi, Mehrdad Azmin, Bontha V Babu, Suhad Bahijri, Nagalla Balakrishna, Mohamed Bamoshmoosh, Maciej Banach, Maja Banadinović, Piotr Bandosz, José R Banegas, Joanna Baran, Barbagallo Carlo Maria, Alberto Barceló, Amina Barkat, Marta Barreto, Aluisio Jd Barros, Mauro Virgílio Gomes Barros, Anna Bartosiewicz, Abdul Basit, Joao Luiz D Bastos, Iqbal Bata, Anwar M Batieha, Assembekov Batyrbek, Louise A Baur, Robert Beaglehole, Antonisamy Belavendra, Habiba Ben Romdhane, Mikhail Benet, Lowell S Benson, Salim Berkinbayev, Antonio Bernabe-Ortiz, Gailute Bernotiene, Heloísa Bettiol, Jorge Bezerra, Aroor Bhagyalaxmi, Santosh K Bhargava, Daniel Bia, Katia Biasch, Elysée Claude Bika Lele, Mukharram M Bikbov, Bihungum Bista, Peter Bjerregaard, Espen Bjertness, Marius B Bjertness, Cecilia Björkelund, Katia V Bloch, Anneke Blokstra, Simona Bo, Martin Bobak, Heiner Boeing, Jose G Boggia, Carlos P Boissonnet, Stig E Bojesen, Vanina Bongard, Alice Bonilla-Vargas, Matthias Bopp, Herman Borghs, Pascal Bovet, Christopher B Boyer, Lutgart Braeckman, Imperia Brajkovich, Francesco Branca, Juergen Breckenkamp, Hermann Brenner, Lizzy M Brewster, Yajaira Briceño, Miguel Brito, Graziella Bruno, H Bas Bueno-de-Mesquita, Gloria Bueno, Anna Bugge, Con Burns, Michael Bursztyn, Antonio Cabrera de León, Joseph Cacciottolo, Christine Cameron, Günay Can, Ana Paula C Cândido, Mario V Capanzana, Naděžda Čapková, Eduardo Capuano, Vincenzo Capuano, Viviane C Cardoso, Axel C Carlsson, Joana Carvalho, Felipe F Casanueva, Laura Censi, Marvin Cervantes-Loaiza, Charalambos A Chadjigeorgiou, Snehalatha Chamukuttan, Angelique W Chan, Queenie Chan, Himanshu K Chaturvedi, Nish Chaturvedi, Miao Li Chee, Chien-Jen Chen, Fangfang Chen, Huashuai Chen, Shuohua Chen, Zhengming Chen, Ching-Yu Cheng, Bahman Cheraghian, Imane Cherkaoui Dekkaki, Angela Chetrit, Kuo-Liong Chien, Arnaud Chiolero, Shu-Ti Chiou, Adela Chirita-Emandi, María-Dolores Chirlaque, Belong Cho, Kaare Christensen, Diego G Christofaro, Jerzy Chudek, Eliza Cinteza, Frank Claessens, Janine Clarke, Els Clays, Emmanuel Cohen, Hans Concin, Cyrus Cooper, Tara C Coppinger, Simona Costanzo, Dominique Cottel, Chris Cowell, Cora L Craig, Amelia C Crampin, Ana B Crujeiras, Juan J Cruz, Semánová Csilla, Liufu Cui, Felipe V Cureau, Sarah Cuschieri, Graziella D'Arrigo, Eleonora d'Orsi, Jean Dallongeville, Rachel Dankner, Thomas M Dantoft, Luc Dauchet, Kairat Davletov, Guy De Backer, Dirk De Bacquer, Amalia De Curtis, Giovanni de Gaetano, Stefaan De Henauw, Paula Duarte de Oliveira, David De Ridder, Delphine De Smedt, Mohan Deepa, Alexander D Deev, Vincent Jr DeGennaro, Hélène Delisle, Stefaan Demarest, Elaine Dennison, Valérie Deschamps, Meghnath Dhimal, Augusto F Di Castelnuovo, Juvenal Soares Dias-da-Costa, Alejandro Diaz, Ty T Dickerson, Zivka Dika, Shirin Djalalinia, Ha Tp Do, Annette J Dobson, Chiara Donfrancesco, Silvana P Donoso, Angela Döring, Maria Dorobantu, Marcus Dörr, Kouamelan Doua, Nico Dragano, Wojciech Drygas, Charmaine A Duante, Priscilla Duboz, Rosemary B Duda, Virginija Dulskiene, Anar Dushpanova, Aleksandar Džakula, Vilnis Dzerve, Elzbieta Dziankowska-Zaborszczyk, Ricky Eddie, Ebrahim Eftekhar, Robert Eggertsen, Sareh Eghtesad, Gabriele Eiben, Ulf Ekelund, Mohammad El-Khateeb, Jalila El Ati, Denise Eldemire-Shearer, Marie Eliasen, Roberto Elosua, Rajiv T Erasmus, Raimund Erbel, Cihangir Erem, Louise Eriksen, Johan G Eriksson, Jorge Escobedo-de la Peña, Saeid Eslami, Ali Esmaeili, Alun Evans, David Faeh, Albina A Fakhretdinova, Caroline H Fall, Elnaz Faramarzi, Mojtaba Farjam, Mohammad Reza Fattahi, Asher Fawwad, Francisco J Felix-Redondo, Stephan B Felix, Trevor S Ferguson, Romulo A Fernandes, Daniel Fernández-Bergés, Daniel Ferrante, Thomas Ferrao, Marika Ferrari, Marco M Ferrario, Catterina Ferreccio, Haroldo S Ferreira, Eldridge Ferrer, Jean Ferrieres, Thamara Hubler Figueiró, Günther Fink, Krista Fischer, Leng Huat Foo, Maria Forsner, Heba M Fouad, Damian K Francis, Maria do Carmo Franco, Ruth Frikke-Schmidt, Guillermo Frontera, Flavio D Fuchs, Sandra C Fuchs, Yuki Fujita, Matsuda Fumihiko, Viktoriya Furdela, Ariel Furer, Takuro Furusawa, Zbigniew Gaciong, Andrzej Galbarczyk, Henrike Galenkamp, Fabio Galvano, Jingli Gao, Pei Gao, Manoli Garcia-de-la-Hera, Pablo Garcia, Dickman Gareta, Sarah P Garnett, Jean-Michel Gaspoz, Magda Gasull, Andrea Gazzinelli, Ulrike Gehring, Johanna M Geleijnse, Ronnie George, Ali Ghanbari, Erfan Ghasemi, Oana-Florentina Gheorghe-Fronea, Anup Ghimire, Alessandro Gialluisi, Simona Giampaoli, Christian Gieger, Tiffany K Gill, Jonathan Giovannelli, Glen Gironella, Aleksander Giwercman, Konstantinos Gkiouras, Marcel Goldberg, Rebecca A Goldsmith, Luis F Gomez, Aleksandra Gomula, Helen Gonçalves, Mauer Gonçalves, Bruna Gonçalves Cordeiro da Silva, David A Gonzalez-Chica, Marcela Gonzalez-Gross, Juan P González-Rivas, Clicerio González-Villalpando, María-Elena González-Villalpando, Angel R Gonzalez, Mariano Bonet Gorbea, Frederic Gottrand, Sidsel Graff-Iversen, Dušan Grafnetter, Aneta Grajda, Maria G Grammatikopoulou, Ronald D Gregor, Tomasz Grodzicki, Giuseppe Grosso, Gabriella Gruden, Dongfeng Gu, Ong Peng Guan, Elias F Gudmundsson, Vilmundur Gudnason, Ramiro Guerrero, Idris Guessous, Andre L Guimaraes, Martin C Gulliford, Johanna Gunnlaugsdottir, Marc J Gunter, Prakash C Gupta, Rajeev Gupta, Oye Gureje, Beata Gurzkowska, Laura Gutierrez, Felix Gutzwiller, Seongjun Ha, Farzad Hadaegh, Rosa Haghshenas, Hamid Hakimi, Jytte Halkjær, Ian R Hambleton, Behrooz Hamzeh, Dominique Hange, Abu Am Hanif, Sari Hantunen, Jie Hao, Carla Menêses Hardman, Rachakulla Hari Kumar, Seyed Mohammad Hashemi-Shahri, Jun Hata, Teresa Haugsgjerd, Alison J Hayes, Yuna He, Margit Heier, Marleen Elisabeth Hendriks, Rafael Dos Santos Henrique, Ana Henriques, Leticia Hernandez Cadena, Herqutanto, Sauli Herrala, Ramin Heshmat, Allan G Hill, Sai Yin Ho, Suzanne C Ho, Michael Hobbs, Michelle Holdsworth, Reza Homayounfar, Gonul Horasan Dinc, Andrea Rvr Horimoto, Claudia M Hormiga, Bernardo L Horta, Leila Houti, Christina Howitt, Thein Thein Htay, Aung Soe Htet, Maung Maung Than Htike, Yonghua Hu, José María Huerta, Ilpo Tapani Huhtaniemi, Laetitia Huiart, Martijn Huisman, Abdullatif S Husseini, Inge Huybrechts, Nahla Hwalla, Licia Iacoviello, Anna G Iannone, Mohsen M Ibrahim, Norazizah Ibrahim Wong, M Arfan Ikram, Violeta Iotova, Vilma E Irazola, Takafumi Ishida, Godsent C Isiguzo, Muhammad Islam, Sheikh Mohammed Shariful Islam, Masanori Iwasaki, Rod T Jackson, Jeremy M Jacobs, Hashem Y Jaddou, Tazeen Jafar, Kenneth James, Konrad Jamrozik, Imre Janszky, Edward Janus, Marjo-Riitta Jarvelin, Grazyna Jasienska, Ana Jelaković, Bojan Jelaković, Garry Jennings, Anjani Kumar Jha, Chao Qiang Jiang, Ramon O Jimenez, Karl-Heinz Jöckel, Michel Joffres, Mattias Johansson, Jari J Jokelainen, Jost B Jonas, Torben Jørgensen, Pradeep Joshi, Farahnaz Joukar, Jacek Jóżwiak, Anne Juolevi, Gregor Jurak, Vesna Jureša, Rudolf Kaaks, Anthony Kafatos, Eero O Kajantie, Zhanna Kalmatayeva, Natasa Kalpourtzi, Ofra Kalter-Leibovici, Freja B Kampmann, Srinivasan Kannan, Eva Karaglani, Line L Kårhus, Khem B Karki, Marzieh Katibeh, Joanne Katz, Jussi Kauhanen, Prabhdeep Kaur, Maryam Kavousi, Gyulli M Kazakbaeva, Ulrich Keil, Lital Keinan Boker, Sirkka Keinänen-Kiukaanniemi, Roya Kelishadi, Han Cg Kemper, Maryam Keramati, Alina Kerimkulova, Mathilde Kersting, Timothy Key, Yousef Saleh Khader, Davood Khalili, Kay-Tee Khaw, Bahareh Kheiri, Motahareh Kheradmand, Alireza Khosravi, Ursula Kiechl-Kohlendorfer, Stefan Kiechl, Japhet Killewo, Dong Wook Kim, Jeongseon Kim, Heidi Klakk, Magdalena Klimek, Jurate Klumbiene, Michael Knoflach, Elin Kolle, Patrick Kolsteren, Jukka P Kontto, Raija Korpelainen, Paul Korrovits, Jelena Kos, Seppo Koskinen, Katsuyasu Kouda, Sudhir Kowlessur, Slawomir Koziel, Jana Kratenova, Vilma Kriaucioniene, Peter Lund Kristensen, Steiner Krokstad, Daan Kromhout, Herculina S Kruger, Ruzena Kubinova, Renata Kuciene, Urho M Kujala, Zbigniew Kulaga, R Krishna Kumar, Pawel Kurjata, Yadlapalli S Kusuma, Vladimir Kutsenko, Kari Kuulasmaa, Catherine Kyobutungi, Tiina Laatikainen, Carl Lachat, Youcef Laid, Tai Hing Lam, Orlando Landrove, Vera Lanska, Georg Lappas, Bagher Larijani, Tint Swe Latt, Gwenaëlle Le Coroller, Khanh Le Nguyen Bao, Tuyen D Le, Jeannette Lee, Jeonghee Lee, Nils Lehmann, Terho Lehtimäki, Daniel Lemogoum, Naomi S Levitt, Yanping Li, Christa L Lilly, Wei-Yen Lim, M Fernanda Lima-Costa, Xu Lin, Yi-Ting Lin, Lars Lind, Vijaya Lingam, Allan Linneberg, Lauren Lissner, Mieczyslaw Litwin, Wei-Cheng Lo, Helle-Mai Loit, Esther Lopez-Garcia, Tania Lopez, Paulo A Lotufo, José Eugenio Lozano, Iva Lukačević Lovrenčić, Janice L Lukrafka, Dalia Luksiene, Annamari Lundqvist, Robert Lundqvist, Nuno Lunet, Michala Lustigová, Edyta Luszczki, Guansheng Ma, Jun Ma, George Ll Machado-Coelho, Aristides M Machado-Rodrigues, Enguerran Macia, Luisa M Macieira, Ahmed A Madar, Stefania Maggi, Dianna J Magliano, Emmanuella Magriplis, Gowri Mahasampath, Bernard Maire, Marjeta Majer, Marcia Makdisse, Fatemeh Malekzadeh, Reza Malekzadeh, Rahul Malhotra, Kodavanti Mallikharjuna Rao, Sofia K Malyutina, Lynell V Maniego, Yannis Manios, Jim I Mann, Fariborz Mansour-Ghanaei, Enzo Manzato, Anie Marcil, Staffan B Mårild, Mihalea Marinović Glavić, Pedro Marques-Vidal, Larissa Pruner Marques, Jaume Marrugat, Reynaldo Martorell, Luis P Mascarenhas, Marija Matasin, Ellisiv B Mathiesen, Prashant Mathur, Alicia Matijasevich, Piotr Matlosz, Tandi E Matsha, Christina Mavrogianni, Jean Claude N Mbanya, Anselmo J Mc Donald Posso, Shelly R McFarlane, Stephen T McGarvey, Stela McLachlan, Rachael M McLean, Scott B McLean, Breige A McNulty, Sounnia Mediene Benchekor, Jurate Medzioniene, Parinaz Mehdipour, Kirsten Mehlig, Amir Houshang Mehrparvar, Aline Meirhaeghe, Christa Meisinger, Carlos Mendoza Montano, Ana Maria B Menezes, Geetha R Menon, Alibek Mereke, Indrapal I Meshram, Andres Metspalu, Haakon E Meyer, Jie Mi, Nathalie Michels, Kairit Mikkel, Karolina Milkowska, Jody C Miller, Cláudia S Minderico, G K Mini, Mohammad Reza Mirjalili, Erkin Mirrakhimov, Marjeta Mišigoj-Duraković, Pietro A Modesti, Sahar Saeedi Moghaddam, Bahram Mohajer, Mostafa K Mohamed, Shukri F Mohamed, Kazem Mohammad, Mohammad Reza Mohammadi, Zahra Mohammadi, Noushin Mohammadifard, Reza Mohammadpourhodki, Viswanathan Mohan, Salim Mohanna, Muhammad Fadhli Mohd Yusoff, Iraj Mohebbi, Farnam Mohebi, Marie Moitry, Line T Møllehave, Dénes Molnár, Amirabbas Momenan, Charles K Mondo, Eric Monterrubio-Flores, Kotsedi Daniel K Monyeki, Jin Soo Moon, Mahmood Moosazadeh, Leila B Moreira, Alain Morejon, Luis A Moreno, Karen Morgan, George Moschonis, Malgorzata Mossakowska, Aya Mostafa, Seyed-Ali Mostafavi, Jorge Mota, Mohammad Esmaeel Motlagh, Jorge Motta, Marcos André Moura-Dos-Santos, Malay K Mridha, Kelias P Msyamboza, Thet Thet Mu, Alfa J Muhihi, Maria L Muiesan, Martina Müller-Nurasyid, Neil Murphy, Jaakko Mursu, Kamarul Imran Musa, Sanja Musić Milanović, Vera Musil, Norlaila Mustafa, Iraj Nabipour, Shohreh Naderimagham, Gabriele Nagel, Balkish M Naidu, Farid Najafi, Harunobu Nakamura, Jana Námešná, Ei Ei K Nang, Vinay B Nangia, Sameer Narake, Ndeye Coumba Ndiaye, William A Neal, Azim Nejatizadeh, Ilona Nenko, Martin Neovius, Chung T Nguyen, Nguyen D Nguyen, Quang V Nguyen, Quang Ngoc Nguyen, Ramfis E Nieto-Martínez, Teemu J Niiranen, Yury P Nikitin, Toshiharu Ninomiya, Sania Nishtar, Marina A Njelekela, Marianna Noale, Oscar A Noboa, Ahmad Ali Noorbala, Teresa Norat, Maria Nordendahl, Børge G Nordestgaard, Noto Davide, Natalia Nowak-Szczepanska, Mohannad Al Nsour, Baltazar Nunes, Terence W O'Neill, Dermot O'Reilly, Caleb Ochimana, Eiji Oda, Augustine N Odili, Kyungwon Oh, Kumiko Ohara, Ryutaro Ohtsuka, Valérie Olié, Maria Teresa A Olinto, Isabel O Oliveira, Mohd Azahadi Omar, Altan Onat, Sok King Ong, Lariane M Ono, Pedro Ordunez, Rui Ornelas, Pedro J Ortiz, Clive Osmond, Sergej M Ostojic, Afshin Ostovar, Johanna A Otero, Kim Overvad, Ellis Owusu-Dabo, Fred Michel Paccaud, Cristina Padez, Elena Pahomova, Karina Mary de Paiva, Andrzej Pająk, Domenico Palli, Luigi Palmieri, Wen-Harn Pan, Songhomitra Panda-Jonas, Francesco Panza, Mariela Paoli, Dimitrios Papandreou, Soon-Woo Park, Suyeon Park, Winsome R Parnell, Mahboubeh Parsaeian, Patrick Pasquet, Nikhil D Patel, Halyna Pavlyshyn, Ivan Pećin, Mangesh S Pednekar, João M Pedro, Nasheeta Peer, Sergio Viana Peixoto, Markku Peltonen, Alexandre C Pereira, Karen Gda Peres, Marco A Peres, Annette Peters, Janina Petkeviciene, Niloofar Peykari, Son Thai Pham, Rafael N Pichardo, Iris Pigeot, Hynek Pikhart, Aida Pilav, Lorenza Pilotto, Freda Pitakaka, Aleksandra Piwonska, Andreia N Pizarro, Pedro Plans-Rubió, Ozren Polašek, Miquel Porta, Anil Poudyal, Farhad Pourfarzi, Akram Pourshams, Hossein Poustchi, Rajendra Pradeepa, Alison J Price, Jacqueline F Price, Rui Providencia, Soile E Puhakka, Maria Puiu, Margus Punab, Radwan F Qasrawi, Mostafa Qorbani, Daniel Queiroz, Tran Quoc Bao, Ivana Radić, Ricardas Radisauskas, Salar Rahimikazerooni, Mahfuzar Rahman, Olli Raitakari, Manu Raj, Ellina M Rakhimova, Sudha Ramachandra Rao, Ambady Ramachandran, Elisabete Ramos, Lekhraj Rampal, Sanjay Rampal, Daniel A Rangel Reina, Vayia Rarra, Cassiano Ricardo Rech, Josep Redon, Paul Ferdinand M Reganit, Valéria Regecová, Luis Revilla, Abbas Rezaianzadeh, Robespierre Ribeiro, Elio Riboli, Adrian Richter, Fernando Rigo, Tobias F Rinke de Wit, Raphael M Ritti-Dias, Cynthia Robitaille, Fernando Rodríguez-Artalejo, María Del Cristo Rodriguez-Perez, Laura A Rodríguez-Villamizar, Ulla Roggenbuck, Rosalba Rojas-Martinez, Dora Romaguera, Elisabetta L Romeo, Annika Rosengren, Joel Gr Roy, Adolfo Rubinstein, Jean-Bernard Ruidavets, Blanca Sandra Ruiz-Betancourt, Maria Ruiz-Castell, Iuliia A Rusakova, Paola Russo, Marcin Rutkowski, Charumathi Sabanayagam, Hamideh Sabbaghi, Harshpal S Sachdev, Alireza Sadjadi, Ali Reza Safarpour, Sare Safi, Saeid Safiri, Olfa Saidi, Sibel Sakarya, Nader Saki, Benoit Salanave, Eduardo Salazar Martinez, Diego Salmerón, Veikko Salomaa, Jukka T Salonen, Massimo Salvetti, Jose Sánchez-Abanto, Susana Sans, Diana A Santos, Ina S Santos, Lèlita C Santos, Maria Paula Santos, Rute Santos, Jouko L Saramies, Luis B Sardinha, Giselle Sarganas, Nizal Sarrafzadegan, Thirunavukkarasu Sathish, Kai-Uwe Saum, Savvas Savva, Norie Sawada, Mariana Sbaraini, Marcia Scazufca, Beatriz D Schaan, Herman Schargrodsky, Sabine Schipf, Carsten O Schmidt, Peter Schnohr, Ben Schöttker, Sara Schramm, Constance Schultsz, Aletta E Schutte, Sylvain Sebert, Aye Aye Sein, Abhijit Sen, Idowu O Senbanjo, Sadaf G Sepanlou, Jennifer Servais, Svetlana A Shalnova, Teresa Shamah-Levy, Morteza Shamshirgaran, Coimbatore Subramaniam Shanthirani, Maryam Sharafkhah, Sanjib K Sharma, Jonathan E Shaw, Amaneh Shayanrad, Ali Akbar Shayesteh, Zumin Shi, Kenji Shibuya, Hana Shimizu-Furusawa, Dong Wook Shin, Majid Shirani, Rahman Shiri, Namuna Shrestha, Khairil Si-Ramlee, Alfonso Siani, Rosalynn Siantar, Abla M Sibai, Caroline Ramos de Moura Silva, Diego Augusto Santos Silva, Mary Simon, Judith Simons, Leon A Simons, Michael Sjöström, Jolanta Slowikowska-Hilczer, Przemyslaw Slusarczyk, Liam Smeeth, Hung-Kwan So, Fernanda Cunha Soares, Eugène Sobngwi, Stefan Söderberg, Agustinus Soemantri, Reecha Sofat, Vincenzo Solfrizzi, Mohammad Hossein Somi, Emily Sonestedt, Yi Song, Thorkild Ia Sørensen, Elin P Sørgjerd, Maroje Sorić, Charles Sossa Jérome, Aïcha Soumaré, Bente Sparboe-Nilsen, Karen Sparrenberger, Jan A Staessen, Gregor Starc, Bill Stavreski, Jostein Steene-Johannessen, Peter Stehle, Aryeh D Stein, George S Stergiou, Jochanan Stessman, Jutta Stieber, Doris Stöckl, Tanja Stocks, Jakub Stokwiszewski, Karien Stronks, Maria Wany Strufaldi, Machi Suka, Chien-An Sun, Yn-Tz Sung, Paibul Suriyawongpaisal, Rody G Sy, Holly E Syddall, René Charles Sylva, Moyses Szklo, E Shyong Tai, Mari-Liis Tammesoo, Abdonas Tamosiunas, Eng Joo Tan, Xun Tang, Frank Tanser, Yong Tao, Mohammed Rasoul Tarawneh, Carolina B Tarqui-Mamani, Anne Taylor, Julie Taylor, William R Tebar, Grethe S Tell, Tania Tello, Yih Chung Tham, K R Thankappan, Holger Theobald, Xenophon Theodoridis, Lutgarde Thijs, Mikael Thinggaard, Nihal Thomas, Barbara Thorand, Betina H Thuesen, Erik J Timmermans, Dwi H Tjandrarini, Anne Tjonneland, Ulla Toft, Hanna K Tolonen, Janne S Tolstrup, Murat Topbas, Roman Topór-Madry, María José Tormo, Michael J Tornaritis, Maties Torrent, Laura Torres-Collado, Giota Touloumi, Pierre Traissac, Areti Triantafyllou, Dimitrios Trichopoulos, Antonia Trichopoulou, Oanh Th Trinh, Atul Trivedi, Lechaba Tshepo, Shoichiro Tsugane, Azaliia M Tuliakova, Marshall K Tulloch-Reid, Fikru Tullu, Tomi-Pekka Tuomainen, Jaakko Tuomilehto, Maria L Turley, Gilad Twig, Per Tynelius, Christophe Tzourio, Peter Ueda, Eunice Ugel, Hanno Ulmer, Hannu Mt Uusitalo, Gonzalo Valdivia, Damaskini Valvi, Rob M van Dam, Bert-Jan van den Born, Johan Van der Heyden, Yvonne T van der Schouw, Koen Van Herck, Hoang Van Minh, Natasja M Van Schoor, Irene Gm van Valkengoed, Elisabeth M van Zutphen, Dirk Vanderschueren, Diego Vanuzzo, Anette Varbo, Senthil K Vasan, Tomas Vega, Toomas Veidebaum, Gustavo Velasquez-Melendez, Giovanni Veronesi, Wm Monique Verschuren, Roosmarijn Verstraeten, Cesar G Victora, Lucie Viet, Salvador Villalpando, Paolo Vineis, Jesus Vioque, Jyrki K Virtanen, Sophie Visvikis-Siest, Bharathi Viswanathan, Tiina Vlasoff, Peter Vollenweider, Ari Voutilainen, Alisha N Wade, Janette Walton, Elvis Oa Wambiya, Wan Mohamad Wan Bebakar, Wan Nazaimoon Wan Mohamud, Rildo de Souza Wanderley Júnior, Ming-Dong Wang, Ningli Wang, Qian Wang, Xiangjun Wang, Ya Xing Wang, Ying-Wei Wang, S Goya Wannamethee, Nicholas Wareham, Wenbin Wei, Aneta Weres, Bo Werner, Peter H Whincup, Kurt Widhalm, Andrzej Wiecek, Rainford J Wilks, Johann Willeit, Peter Willeit, Emmanuel A Williams, Tom Wilsgaard, Bogdan Wojtyniak, Roy A Wong-McClure, Andrew Wong, Tien Yin Wong, Jean Woo, Frederick C Wu, Shouling Wu, Justyna Wyszynska, Haiquan Xu, Liang Xu, Nor Azwany Yaacob, Weili Yan, Ling Yang, Xiaoguang Yang, Yang Yang, Tabara Yasuharu, Xingwang Ye, Panayiotis K Yiallouros, Moein Yoosefi, Akihiro Yoshihara, San-Lin You, Novie O Younger-Coleman, Ahmad Faudzi Yusoff, Ahmad A Zainuddin, Seyed Rasoul Zakavi, Farhad Zamani, Sabina Zambon, Antonis Zampelas, Maria Elisa Zapata, Ko Ko Zaw, Kristyna Zejglicova, Tajana Zeljkovic Vrkic, Yi Zeng, Luxia Zhang, Zhen-Yu Zhang, Dong Zhao, Ming-Hui Zhao, Shiqi Zhen, Yingfeng Zheng, Bekbolat Zholdin, Dan Zhu, Marie Zins, Emanuel Zitt, Yanina Zocalo, Nada Zoghlami, Julio Zuñiga Cisneros, Majid Ezzati, Sakarya, Sibel (ORCID 0000-0002-9959-6240 & YÖK ID 172028), Zhou, Bin, Carrillo-Larco, Rodrigo M., Danaei, Goodarz, Riley, Leanne M., Paciorek, Christopher J., Stevens, Gretchen A., Gregg, Edward W., Bennett, James E., Solomon, Bethlehem, Singleton, Rosie K., Sophiea, Marisa K., Iurilli, Maria L. C., Lhoste, Victor P. F., Cowan, Melanie J., Savin, Stefan, Woodward, Mark, Balanova, Yulia, Cifkova, Renata, Damasceno, Albertino, Elliott, Paul, Farzadfar, Farshad, He, Jiang, Ikeda, Nayu, Kengne, Andre P., Khang, Young-Ho, Kim, Hyeon Chang, Laxmaiah, Avula, Lin, Hsien-Ho, Margozzini Maira, Paula, Miranda, J. Jaime, Neuhauser, Hannelore, Sundstrom, Johan, Varghese, Cherian, Widyahening, Indah S., Zdrojewski, Tomasz, Ezzati, Majid, Abarca-Gomez, Leandra, Abdeen, Ziad A., Rahim, Hanan F. Abdul, Abu-Rmeileh, Niveen M., Acosta-Cazares, Benjamin, Adams, Robert J., Aekplakorn, Wichai, Afsana, Kaosar, Afzal, Shoaib, Agdeppa, Imelda A., Aghazadeh-Attari, Javad, Aguilar-Salinas, Carlos A., Agyemang, Charles, Ahmad, Noor Ani, Ahmadi, Ali, Ahmadi, Naser, Ahmadi, Nastaran, Ahmadizar, Fariba, Ahmed, Soheir H., Ahrens, Wolfgang, Ajlouni, Kamel, Al-Raddadi, Rajaa, Alarouj, Monira, AlBuhairan, Fadia, AlDhukair, Shahla, Ali, Mohamed M., Alkandari, Abdullah, Alkerwi, Ala'a, Allin, Kristine, Aly, Eman, Amarapurkar, Deepak N., Amougou, Norbert, Amouyel, Philippe, Andersen, Lars Bo, Anderssen, Sigmund A., Anjana, Ranjit Mohan, Ansari-Moghaddam, Alireza, Ansong, Daniel, Aounallah-Skhiri, Hajer, Araujo, Joana, Ariansen, Inger, Aris, Tahir, Arku, Raphael E., Arlappa, Nimmathota, Aryal, Krishna K., Aspelund, Thor, Assah, Felix K., Assuncao, Maria Cecilia F., Auvinen, Juha, Avdicova, Maria, Azevedo, Ana, Azimi-Nezhad, Mohsen, Azizi, Fereidoun, Azmin, Mehrdad, Babu, Bontha V., Bahijri, Suhad, Balakrishna, Nagalla, Bamoshmoosh, Mohamed, Banach, Maciej, Banadinovic, Maja, Bandosz, Piotr, Banegas, Jose R., Baran, Joanna, Barbagallo, Carlo M., Barcelo, Alberto, Barkat, Amina, Barreto, Marta, Barros, Aluisio J. D., Gomes Barros, Mauro Virgilio, Bartosiewicz, Anna, Basit, Abdul, Bastos, Joao Luiz D., Bata, Iqbal, Batieha, Anwar M., Batyrbek, Assembekov, Baur, Louise A., Beaglehole, Robert, Belavendra, Antonisamy, Ben Romdhane, Habiba, Benet, Mikhail, Benson, Lowell S., Berkinbayev, Salim, Bernabe-Ortiz, Antonio, Bettiol, Heloisa, Bezerra, Jorge, Bhagyalaxmi, Aroor, Bhargava, Santosh K., Bia, Daniel, Biasch, Katia, Lele, Elysee Claude Bika, Bikbov, Mukharram M., Bista, Bihungum, Bjerregaard, Peter, Bjertness, Espen, Bjertness, Marius B., Bjorkelund, Cecilia, Bloch, Katia V., Blokstra, Anneke, Bo, Simona, Bobak, Martin, Boeing, Heiner, Boggia, Jose G., Boissonnet, Carlos P., Bojesen, Stig E., Bongard, Vanina, Bonilla-Vargas, Alice, Bopp, Matthias, Bovet, Pascal, Boyer, Christopher B., Braeckman, Lutgart, Brajkovich, Imperia, Branca, Francesco, Breckenkamp, Juergen, Brenner, Hermann, Brewster, Lizzy M., Briceno, Yajaira, Brito, Miguel, Bruno, Graziella, Bueno-de-Mesquita, H. Bas, Bueno, Gloria, Bugge, Anna, Burns, Con, Bursztyn, Michael, Cabrera de Leon, Antonio, Cacciottolo, Joseph, Cameron, Christine, Can, Gunay, Candido, Ana Paula C., Capanzana, Mario V., Capkova, Nadezda, Capuano, Eduardo, Capuano, Vincenzo, Cardoso, Viviane C., Carlsson, Axel C., Carvalho, Joana, Casanueva, Felipe F., Censi, Laura, Cervantes-Loaiza, Marvin, Chadjigeorgiou, Charalambos A., Chamukuttan, Snehalatha, Chan, Angelique W., Chan, Queenie, Chaturvedi, Himanshu K., Chaturvedi, Nish, Chee, Miao Li, Chen, Chien-Jen, Chen, Fangfang, Chen, Huashuai, Chen, Shuohua, Chen, Zhengming, Cheng, Ching-Yu, Cheraghian, Bahman, Dekkaki, Imane Cherkaoui, Chetrit, Angela, Chien, Kuo-Liong, Chiolero, Arnaud, Chiou, Shu-Ti, Chirita-Emandi, Adela, Chirlaque, Maria-Dolores, Cho, Belong, Christensen, Kaare, Christofaro, Diego G., Chudek, Jerzy, Cinteza, Eliza, Clarke, Janine, Clays, Els, Cohen, Emmanuel, Concin, Hans, Cooper, Cyrus, Coppinger, Tara C., Costanzo, Simona, Cottel, Dominique, Cowell, Chris, Craig, Cora L., Crampin, Amelia C., Crujeiras, Ana B., Cruz, Juan J., Csilla, Semanova, Cui, Liufu, Cureau, Felipe V., Cuschieri, Sarah, D'Arrigo, Graziella, d'Orsi, Eleonora, Dallongeville, Jean, Dankner, Rachel, Dantoft, Thomas M., Dauchet, Luc, Davletov, Kairat, De Backer, Guy, De Bacquer, Dirk, De Curtis, Amalia, de Gaetano, Giovanni, De Henauw, Stefaan, de Oliveira, Paula Duarte, De Ridder, David, De Smedt, Delphine, Deepa, Mohan, Deev, Alexander D., DeGennaro, Vincent Jr, Delisle, Helene, Demarest, Stefaan, Dennison, Elaine, Deschamps, Valerie, Dhimal, Meghnath, Di Castelnuovo, Augusto F., Dias-da-Costa, Juvenal Soares, Diaz, Alejandro, Dickerson, Ty T., Dika, Zivka, Djalalinia, Shirin, Do, Ha T. P., Dobson, Annette J., Donfrancesco, Chiara, Donoso, Silvana P., Doering, Angela, Dorobantu, Maria, Doerr, Marcus, Doua, Kouamelan, Dragano, Nico, Drygas, Wojciech, Duante, Charmaine A., Duboz, Priscilla, Duda, Rosemary B., Dulskiene, Virginija, Dushpanova, Anar, Dzakula, Aleksandar, Dzerve, Vilnis, Dziankowska-Zaborszczyk, Elzbieta, Eddie, Ricky, Eftekhar, Ebrahim, Eggertsen, Robert, Eghtesad, Sareh, Eiben, Gabriele, Ekelund, Ulf, El-Khateeb, Mohammad, El Ati, Jalila, Eldemire-Shearer, Denise, Eliasen, Marie, Elosua, Roberto, Erasmus, Rajiv T., Erbel, Raimund, Erem, Cihangir, Eriksen, Louise, Eriksson, Johan G., Escobedo-de la Pena, Jorge, Eslami, Saeid, Esmaeili, Ali, Evans, Alun, Faeh, David, Fakhretdinova, Albina A., Fall, Caroline H., Faramarzi, Elnaz, Farjam, Mojtaba, Fattahi, Mohammad Reza, Fawwad, Asher, Felix-Redondo, Francisco J., Felix, Stephan B., Ferguson, Trevor S., Fernandes, Romulo A., Fernandez-Berges, Daniel, Ferrante, Daniel, Ferrao, Thomas, Ferrari, Marika, Ferrario, Marco M., Ferreccio, Catterina, Ferreira, Haroldo S., Ferrer, Eldridge, Ferrieres, Jean, Figueiro, Thamara Hubler, Fink, Gunther, Fischer, Krista, Foo, Leng Huat, Forsner, Maria, Fouad, Heba M., Francis, Damian K., Franco, Maria do Carmo, Frikke-Schmidt, Ruth, Frontera, Guillermo, Fuchs, Flavio D., Fuchs, Sandra C., Fujita, Yuki, Fumihiko, Matsuda, Furdela, Viktoriya, Furer, Ariel, Furusawa, Takuro, Gaciong, Zbigniew, Galbarczyk, Andrzej, Galenkamp, Henrike, Galvano, Fabio, Gao, Jingli, Gao, Pei, Garcia-de-la-Hera, Manoli, Garcia, Pablo, Gareta, Dickman, Garnett, Sarah P., Gaspoz, Jean-Michel, Gasull, Magda, Gazzinelli, Andrea, Gehring, Ulrike, Geleijnse, Johanna M., George, Ronnie, Ghanbari, Ali, Ghasemi, Erfan, Gheorghe-Fronea, Oana-Florentina, Ghimire, Anup, Gialluisi, Alessandro, Giampaoli, Simona, Gieger, Christian, Gill, Tiffany K., Giovannelli, Jonathan, Gironella, Glen, Giwercman, Aleksander, Gkiouras, Konstantinos, Goldberg, Marcel, Goldsmith, Rebecca A., Gomez, Luis F., Gomula, Aleksandra, Cordeiro da Silva, Bruna Goncalves, Goncalves, Helen, Goncalves, Mauer, Gonzalez-Chica, David A., Gonzalez-Gross, Marcela, Gonzalez-Rivas, Juan P., Gonzalez-Villalpando, Clicerio, Gonzalez-Villalpando, Maria-Elena, Gonzalez, Angel R., Bonet Gorbea, Mariano, Gottrand, Frederic, Graff-Iversen, Sidsel, Grafnetter, Dusan, Grajda, Aneta, Grammatikopoulou, Maria G., Gregor, Ronald D., Grodzicki, Tomasz, Grosso, Giuseppe, Gruden, Gabriella, Gu, Dongfeng, Guan, Ong Peng, Gudmundsson, Elias F., Gudnason, Vilmundur, Guerrero, Ramiro, Guessous, Idris, Guimaraes, Andre L., Gulliford, Martin C., Gunnlaugsdottir, Johanna, Gunter, Marc J., Gupta, Prakash C., Gupta, Rajeev, Gureje, Oye, Gurzkowska, Beata, Gutierrez, Laura, Gutzwiller, Felix, Ha, Seongjun, Hadaegh, Farzad, Haghshenas, Rosa, Hakimi, Hamid, Halkjaer, Jytte, Hambleton, Ian R., Hamzeh, Behrooz, Hange, Dominique, Hanif, Abu A. M., Hantunen, Sari, Hao, Jie, Hardman, Carla Meneses, Kumar, Rachakulla Hari, Hashemi-Shahri, Seyed Mohammad, Hata, Jun, Haugsgjerd, Teresa, Hayes, Alison J., He, Yuna, Heier, Margit, Hendriks, Marleen Elisabeth, Henrique, Rafael dos Santos, Henriques, Ana, Cadena, Leticia Hernandez, Herrala, Sauli, Heshmat, Ramin, Hill, Allan G., Ho, Sai Yin, Ho, Suzanne C., Hobbs, Michael, Holdsworth, Michelle, Homayounfar, Reza, Dinc, Gonul Horasan, Horimoto, Andrea R. V. R., Hormiga, Claudia M., Horta, Bernardo L., Houti, Leila, Howitt, Christina, Htay, Thein Thein, Htet, Aung Soe, Htike, Maung Maung Than, Hu, Yonghua, Huerta, Jose Maria, Huhtaniemi, Ilpo Tapani, Huiart, Laetitia, Huisman, Martijn, Husseini, Abdullatif S., Huybrechts, Inge, Hwalla, Nahla, Iacoviello, Licia, Iannone, Anna G., Ibrahim, Mohsen M., Wong, Norazizah Ibrahim, Ikram, M. Arfan, Iotova, Violeta, Irazola, Vilma E., Ishida, Takafumi, Isiguzo, Godsent C., Islam, Muhammad, Islam, Sheikh Mohammed Shariful, Iwasaki, Masanori, Jackson, Rod T., Jacobs, Jeremy M., Jaddou, Hashem Y., Jafar, Tazeen, James, Kenneth, Jamrozik, Konrad, Janszky, Imre, Janus, Edward, Jarvelin, Marjo-Riitta, Jasienska, Grazyna, Jelakovic, Ana, Jelakovic, Bojan, Jennings, Garry, Jha, Anjani Kumar, Jiang, Chao Qiang, Jimenez, Ramon O., Joeckel, Karl-Heinz, Joffres, Michel, Johansson, Mattias, Jokelainen, Jari J., Jonas, Jost B., Jorgensen, Torben, Joshi, Pradeep, Joukar, Farahnaz, Jozwiak, Jacek, Juolevi, Anne, Jurak, Gregor, Juresa, Vesna, Kaaks, Rudolf, Kafatos, Anthony, Kajantie, Eero O., Kalmatayeva, Zhanna, Kalpourtzi, Natasa, Kalter-Leibovici, Ofra, Kampmann, Freja B., Kannan, Srinivasan, Karaglani, Eva, Karhus, Line L., Karki, Khem B., Katibeh, Marzieh, Katz, Joanne, Kauhanen, Jussi, Kaur, Prabhdeep, Kavousi, Maryam, Kazakbaeva, Gyulli M., Keil, Ulrich, Boker, Lital Keinan, Keinanen-Kiukaanniemi, Sirkka, Kelishadi, Roya, Kemper, Han C. G., Keramati, Maryam, Kerimkulova, Alina, Kersting, Mathilde, Key, Timothy, Khader, Yousef Saleh, Khalili, Davood, Khaw, Kay-Tee, Kheiri, Bahareh, Kheradmand, Motahareh, Khosravi, Alireza, Kiechl-Kohlendorfer, Ursula, Kiechl, Stefan, Killewo, Japhet, Kim, Dong Wook, Kim, Jeongseon, Klakk, Heidi, Klimek, Magdalena, Klumbiene, Jurate, Knoflach, Michael, Kolle, Elin, Kolsteren, Patrick, Kontto, Jukka P., Korpelainen, Raija, Korrovits, Paul, Kos, Jelena, Koskinen, Seppo, Kouda, Katsuyasu, Kowlessur, Sudhir, Koziel, Slawomir, Kratenova, Jana, Kriaucioniene, Vilma, Kristensen, Peter Lund, Krokstad, Steiner, Kromhout, Daan, Kruger, Herculina S., Kubinova, Ruzena, Kuciene, Renata, Kujala, Urho M., Kulaga, Zbigniew, Kumar, R. Krishna, Kurjata, Pawel, Kusuma, Yadlapalli S., Kutsenko, Vladimir, Kuulasmaa, Kari, Kyobutungi, Catherine, Laatikainen, Tiina, Lachat, Carl, Laid, Youcef, Lam, Tai Hing, Landrove, Orlando, Lanska, Vera, Lappas, Georg, Larijani, Bagher, Latt, Tint Swe, Le Coroller, Gwenaelle, Khanh Le Nguyen Bao, Le, Tuyen D., Lee, Jeannette, Lee, Jeonghee, Lehmann, Nils, Lehtimaki, Terho, Lemogoum, Daniel, Levitt, Naomi S., Li, Yanping, Lilly, Christa L., Lim, Wei-Yen, Lima-Costa, M. Fernanda, Lin, Xu, Lin, Yi-Ting, Lind, Lars, Lingam, Vijaya, Linneberg, Allan, Lissner, Lauren, Litwin, Mieczyslaw, Lo, Wei-Cheng, Loit, Helle-Mai, Lopez-Garcia, Esther, Lopez, Tania, Lotufo, Paulo A., Lozano, Jose Eugenio, Lovrencic, Iva Lukacevic, Lukrafka, Janice L., Luksiene, Dalia, Lundqvist, Annamari, Lundqvist, Robert, Lunet, Nuno, Lustigova, Michala, Luszczki, Edyta, Ma, Guansheng, Ma, Jun, Machado-Coelho, George L. L., Machado-Rodrigues, Aristides M., Macia, Enguerran, Macieira, Luisa M., Madar, Ahmed A., Maggi, Stefania, Magliano, Dianna J., Magriplis, Emmanuella, Mahasampath, Gowri, Maire, Bernard, Majer, Marjeta, Makdisse, Marcia, Malekzadeh, Fatemeh, Malekzadeh, Reza, Malhotra, Rahul, Mallikharjuna, Kodavanti, Malyutina, Sofia K., Maniego, Lynell V., Manios, Yannis, Mann, Jim I., Mansour-Ghanaei, Fariborz, Manzato, Enzo, Marcil, Anie, Margozzini, Paula, Marild, Staffan B., Glavic, Mihalea Marinovic, Marques-Vidal, Pedro, Marques, Larissa Pruner, Marrugat, Jaume, Martorell, Reynaldo, Mascarenhas, Luis P., Matasin, Marija, Mathiesen, Ellisiv B., Mathur, Prashant, Matijasevich, Alicia, Matlosz, Piotr, Matsha, Tandi E., Mavrogianni, Christina, Mbanya, Jean Claude N., Mc Donald Posso, Anselmo J., McFarlane, Shelly R., McGarvey, Stephen T., McLachlan, Stela, McLean, Rachael M., McLean, Scott B., McNulty, Breige A., Benchekor, Sounnia Mediene, Medzioniene, Jurate, Mehdipour, Parinaz, Mehlig, Kirsten, Mehrparvar, Amir Houshang, Meirhaeghe, Aline, Meisinger, Christa, Mendoza Montano, Carlos, Menezes, Ana Maria B., Menon, Geetha R., Mereke, Alibek, Meshram, Indrapal I., Metspalu, Andres, Meyer, Haakon E., Mi, Jie, Michels, Nathalie, Mikkel, Kairit, Milkowska, Karolina, Miller, Jody C., Minderico, Claudia S., Mini, G. K., Mirjalili, Mohammad Reza, Mirrakhimov, Erkin, Misigoj-Durakovic, Marjeta, Modesti, Pietro A., Moghaddam, Sahar Saeedi, Mohajer, Bahram, Mohamed, Mostafa K., Mohamed, Shukri F., Mohammad, Kazem, Mohammadi, Mohammad Reza, Mohammadi, Zahra, Mohammadifard, Noushin, Mohammadpourhodki, Reza, Mohan, Viswanathan, Mohanna, Salim, Yusoff, Muhammad Fadhli Mohd, Mohebbi, Iraj, Mohebi, Farnam, Moitry, Marie, Mollehave, Line T., Molnar, Denes, Momenan, Amirabbas, Mondo, Charles K., Monterrubio-Flores, Eric, Monyeki, Kotsedi Daniel K., Moon, Jin Soo, Moosazadeh, Mahmood, Moreira, Leila B., Morejon, Alain, Moreno, Luis A., Morgan, Karen, Moschonis, George, Mossakowska, Malgorzata, Mostafa, Aya, Mostafavi, Seyed-Ali, Mota, Jorge, Motlagh, Mohammad Esmaeel, Motta, Jorge, Andre Moura-dos-Santos, Marcos, Mridha, Malay K., Msyamboza, Kelias P., Mu, Thet Thet, Muhihi, Alfa J., Muiesan, Maria L., Muller-Nurasyid, Martina, Murphy, Neil, Mursu, Jaakko, Musa, Kamarul Imran, Milanovic, Sanja Music, Musil, Vera, Mustafa, Norlaila, Nabipour, Iraj, Naderimagham, Shohreh, Nagel, Gabriele, Naidu, Balkish M., Najafi, Farid, Nakamura, Harunobu, Namesna, Jana, Nang, Ei Ei K., Nangia, Vinay B., Narake, Sameer, Ndiaye, Ndeye Coumba, Neal, William A., Nejatizadeh, Azim, Nenko, Ilona, Neovius, Martin, Neuhauser, Hannelore K., Nguyen, Chung T., Nguyen, Nguyen D., Nguyen, Quang V., Quang Ngoc Nguyen, Nieto-Martinez, Ramfis E., Niiranen, Teemu J., Nikitin, Yury P., Ninomiya, Toshiharu, Nishtar, Sania, Njelekela, Marina A., Noale, Marianna, Noboa, Oscar A., Noorbala, Ahmad Ali, Norat, Teresa, Nordendahl, Maria, Nordestgaard, Borge G., Noto, Davide, Nowak-Szczepanska, Natalia, Al Nsour, Mohannad, Nunes, Baltazar, O'Neill, Terence W., O'Reilly, Dermot, Ochimana, Caleb, Oda, Eiji, Odili, Augustine N., Oh, Kyungwon, Ohara, Kumiko, Ohtsuka, Ryutaro, Olie, Valerie, Olinto, Maria Teresa A., Oliveira, Isabel O., Omar, Mohd Azahadi, Onat, Altan, Ong, Sok King, Ono, Lariane M., Ordunez, Pedro, Ornelas, Rui, Ortiz, Pedro J., Osmond, Clive, Ostojic, Sergej M., Ostovar, Afshin, Otero, Johanna A., Overvad, Kim, Owusu-Dabo, Ellis, Paccaud, Fred Michel, Padez, Cristina, Pahomova, Elena, de Paiva, Karina Mary, Pajak, Andrzej, Palli, Domenico, Palmieri, Luigi, Pan, Wen-Harn, Panda-Jonas, Songhomitra, Panza, Francesco, Paoli, Mariela, Papandreou, Dimitrios, Park, Soon-Woo, Park, Suyeon, Parnell, Winsome R., Parsaeian, Mahboubeh, Pasquet, Patrick, Patel, Nikhil D., Pavlyshyn, Halyna, Pecin, Ivan, Pednekar, Mangesh S., Pedro, Joao M., Peer, Nasheeta, Peixoto, Sergio Viana, Peltonen, Markku, Pereira, Alexandre C., Peres, Karen G. D. A., Peres, Marco A., Peters, Annette, Petkeviciene, Janina, Peykari, Niloofar, Son Thai Pham, Pichardo, Rafael N., Pigeot, Iris, Pikhart, Hynek, Pilav, Aida, Pilotto, Lorenza, Pitakaka, Freda, Piwonska, Aleksandra, Pizarro, Andreia N., Plans-Rubio, Pedro, Polasek, Ozren, Porta, Miquel, Poudyal, Anil, Pourfarzi, Farhad, Pourshams, Akram, Poustchi, Hossein, Pradeepa, Rajendra, Price, Alison J., Price, Jacqueline F., Providencia, Rui, Puhakka, Soile E., Puiu, Maria, Punab, Margus, Qasrawi, Radwan F., Qorbani, Mostafa, Queiroz, Daniel, Tran Quoc Bao, Radic, Ivana, Radisauskas, Ricardas, Rahimikazerooni, Salar, Rahman, Mahfuzar, Raitakari, Olli, Raj, Manu, Rakhimova, Ellina M., Rao, Sudha Ramachandra, Ramachandran, Ambady, Ramos, Elisabete, Rampal, Lekhraj, Rampal, Sanjay, Rangel Reina, Daniel A., Rarra, Vayia, Rech, Cassiano Ricardo, Redon, Josep, Reganit, Paul Ferdinand M., Regecova, Valeria, Revilla, Luis, Rezaianzadeh, Abbas, Ribeiro, Robespierre, Riboli, Elio, Richter, Adrian, Rigo, Fernando, de Wit, Tobias F. Rinke, Ritti-Dias, Raphael M., Robitaille, Cynthia, Rodriguez-Artalejo, Fernando, del Cristo Rodriguez-Perez, Maria, Rodriguez-Villamizar, Laura A., Roggenbuck, Ulla, Rojas-Martinez, Rosalba, Romaguera, Dora, Romeo, Elisabetta L., Rosengren, Annika, Roy, Joel G. R., Rubinstein, Adolfo, Ruidavets, Jean-Bernard, Sandra Ruiz-Betancourt, Blanca, Ruiz-Castell, Maria, Rusakova, Iuliia A., Russo, Paola, Rutkowski, Marcin, Sabanayagam, Charumathi, Sabbaghi, Hamideh, Sachdev, Harshpal S., Sadjadi, Alireza, Safarpour, Ali Reza, Safi, Sare, Safiri, Saeid, Saidi, Olfa, Saki, Nader, Salanave, Benoit, Salazar Martinez, Eduardo, Salmeron, Diego, Salomaa, Veikko, Salonen, Jukka T., Salvetti, Massimo, Sanchez-Abanto, Jose, Sans, Susana, Santos, Diana A., Santos, Ina S., Santos, Lelita C., Santos, Maria Paula, Santos, Rute, Saramies, Jouko L., Sardinha, Luis B., Sarganas, Giselle, Sarrafzadegan, Nizal, Sathish, Thirunavukkarasu, Saum, Kai-Uwe, Savva, Savvas, Sawada, Norie, Sbaraini, Mariana, Scazufca, Marcia, Schaan, Beatriz D., Schargrodsky, Herman, Schipf, Sabine, Schmidt, Carsten O., Schnohr, Peter, Schoettker, Ben, Schramm, Sara, Schultsz, Constance, Schutte, Aletta E., Sebert, Sylvain, Sein, Aye Aye, Sen, Abhijit, Senbanjo, Idowu O., Sepanlou, Sadaf G., Servais, Jennifer, Shalnova, Svetlana A., Shamah-Levy, Teresa, Shamshirgaran, Morteza, Shanthirani, Coimbatore Subramaniam, Sharafkhah, Maryam, Sharma, Sanjib K., Shaw, Jonathan E., Shayanrad, Amaneh, Shayesteh, Ali Akbar, Shi, Zumin, Shibuya, Kenji, Shimizu-Furusawa, Hana, Shin, Dong Wook, Shirani, Majid, Shiri, Rahman, Shrestha, Namuna, Si-Ramlee, Khairil, Siani, Alfonso, Siantar, Rosalynn, Sibai, Abla M., de Moura Silva, Caroline Ramos, Santos Silva, Diego Augusto, Simon, Mary, Simons, Judith, Simons, Leon A., Sjostrom, Michael, Slowikowska-Hilczer, Jolanta, Slusarczyk, Przemyslaw, Smeeth, Liam, So, Hung-Kwan, Soares, Fernanda Cunha, Sobngwi, Eugene, Soderberg, Stefan, Soemantri, Agustinus, Sofat, Reecha, Solfrizzi, Vincenzo, Somi, Mohammad Hossein, Sonestedt, Emily, Song, Yi, Sorensen, Thorkild I. A., Sorgjerd, Elin P., Soric, Maroje, Jerome, Charles Sossa, Soumare, Aicha, Sparboe-Nilsen, Bente, Sparrenberger, Karen, Staessen, Jan A., Starc, Gregor, Stavreski, Bill, Steene-Johannessen, Jostein, Stehle, Peter, Stein, Aryeh D., Stergiou, George S., Stessman, Jochanan, Stieber, Jutta, Stoeckl, Doris, Stocks, Tanja, Stokwiszewski, Jakub, Stronks, Karien, Strufaldi, Maria Wany, Suka, Machi, Sun, Chien-An, Sung, Yn-Tz, Suriyawongpaisal, Paibul, Sy, Rody G., Syddall, Holly E., Sylva, Rene Charles, Szklo, Moyses, Tai, E. Shyong, Tammesoo, Mari-Liis, Tamosiunas, Abdonas, Tan, Eng Joo, Tang, Xun, Tanser, Frank, Tao, Yong, Tarawneh, Mohammed Rasoul, Tarqui-Mamani, Carolina B., Taylor, Anne, Taylor, Julie, Tebar, William R., Tell, Grethe S., Tello, Tania, Tham, Yih Chung, Thankappan, K. R., Theobald, Holger, Theodoridis, Xenophon, Thinggaard, Mikael, Thomas, Nihal, Thorand, Barbara, Thuesen, Betina H., Timmermans, Erik J., Tjandrarini, Dwi H., Tjonneland, Anne, Toft, Ulla, Tolonen, Hanna K., Tolstrup, Janne S., Topbas, Murat, Topor-Madry, Roman, Jose Tormo, Maria, Tornaritis, Michael J., Torrent, Maties, Torres-Collado, Laura, Touloumi, Giota, Traissac, Pierre, Triantafyllou, Areti, Trichopoulos, Dimitrios, Trichopoulou, Antonia, Trinh, Oanh T. H., Trivedi, Atul, Tshepo, Lechaba, Tsugane, Shoichiro, Tuliakova, Azaliia M., Tulloch-Reid, Marshall K., Tullu, Fikru, Tuomainen, Tomi-Pekka, Tuomilehto, Jaakko, Turley, Maria L., Twig, Gilad, Tynelius, Per, Tzourio, Christophe, Ueda, Peter, Ugel, Eunice, Ulmer, Hanno, Uusitalo, Hannu M. T., Valdivia, Gonzalo, Valvi, Damaskini, van Dam, Rob M., van den Born, Bert-Jan, Van der Heyden, Johan, van der Schouw, Yvonne T., Van Herck, Koen, Hoang Van Minh, Van Schoor, Natasja M., van Valkengoed, Irene G. M., van Zutphen, Elisabeth M., Vanuzzo, Diego, Varbo, Anette, Vasan, Senthil K., Vega, Tomas, Veidebaum, Toomas, Velasquez-Melendez, Gustavo, Veronesi, Giovanni, Verschuren, W. M. Monique, Verstraeten, Roosmarijn, Victora, Cesar G., Viet, Lucie, Villalpando, Salvador, Vineis, Paolo, Vioque, Jesus, Virtanen, Jyrki K., Visvikis-Siest, Sophie, Viswanathan, Bharathi, Vlasoff, Tiina, Vollenweider, Peter, Voutilainen, Ari, Wade, Alisha N., Walton, Janette, Wambiya, Elvis O. A., Bebakar, Wan Mohamad Wan, Mohamud, Wan Nazaimoon Wan, Wanderley Junior, Rildo de Souza, Wang, Ming-Dong, Wang, Ningli, Wang, Qian, Wang, Xiangjun, Wang, Ya Xing, Wang, Ying-Wei, Wannamethee, S. Goya, Wareham, Nicholas, Wei, Wenbin, Weres, Aneta, Werner, Bo, Whincup, Peter H., Widhalm, Kurt, Wiecek, Andrzej, Wilks, Rainford J., Willeit, Johann, Willeit, Peter, Williams, Emmanuel A., Wilsgaard, Tom, Wojtyniak, Bogdan, Wong-McClure, Roy A., Wong, Andrew, Wong, Tien Yin, Woo, Jean, Wu, Frederick C., Wu, Shouling, Wyszynska, Justyna, Xu, Haiquan, Xu, Liang, Yaacob, Nor Azwany, Yan, Weili, Yang, Ling, Yang, Xiaoguang, Yang, Yang, Yasuharu, Tabara, Ye, Xingwang, Yiallouros, Panayiotis K., Yoosefi, Moein, Yoshihara, Akihiro, You, San-Lin, Younger-Coleman, Novie O., Yusoff, Ahmad Faudzi, Zainuddin, Ahmad A., Zakavi, Seyed Rasoul, Zamani, Farhad, Zambon, Sabina, Zampelas, Antonis, Elisa Zapata, Maria, Zaw, Ko Ko, Zejglicova, Kristyna, Vrkic, Tajana Zeljkovic, Zeng, Yi, Zhang, Luxia, Zhao, Dong, Zhao, Ming-Hui, Zhen, Shiqi, Zheng, Yingfeng, Zholdin, Bekbolat, Zhu, Dan, Zins, Marie, Zitt, Emanuel, Zocalo, Yanina, Zoghlami, Nada, Zuniga Cisneros, Julio., School of Medicine, ACS - Diabetes & metabolism, APH - Global Health, Pulmonology, Medical Informatics, Adult Psychiatry, Global Health, APH - Quality of Care, APH - Methodology, Vascular Medicine, ACS - Atherosclerosis & ischemic syndromes, Anesthesiology, Graduate School, and ACS - Heart failure & arrhythmias
Subjects: Male, Latin Americans, Nutrition and Disease, Epidemiology, [SDV]Life Sciences [q-bio], Medizin, BLOOD-PRESSURE, 030204 cardiovascular system & hematology, Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants, Hypertension, Prevalence, Control, Tretament, GUIDELINES, Global Health, Worldwide trends, 0302 clinical medicine, Hypertension prevalence, Voeding en Ziekte, Medicine and Health Sciences, kohonnut verenpaine, Medicine, 030212 general & internal medicine, Prevention and Control, 11 Medical and Health Sciences, ComputingMilieux_MISCELLANEOUS, education.field_of_study, food and beverages, Public Health, Global Health, Social Medicine and Epidemiology, General Medicine, Noncommunicable diseases, Period prevalence, Middle Aged, kansainvälinen vertailu, 3142 Public health care science, environmental and occupational health, 3. Good health, MIDDLE-INCOME, Pooled analysis, SYSTEMATIC ANALYSIS, INCOME COUNTRIES, ADULTS, PREVENTION, MANAGEMENT, ADHERENCE, DIAGNOSIS, Western europe, [SDE]Environmental Sciences, Hypertension/diagnosis, NCD Risk Factor Collaboration (NCD-RisC), Female, B990 Subjects Allied to Medicine not elsewhere classified, Life Sciences & Biomedicine, Adult, health-care, esiintyvyys, Central asia, Population, Nursing, 3121 Internal medicine, 03 medical and health sciences, Medicine, General & Internal, Drug Therapy, General & Internal Medicine, Life Science, Humans, ddc:610, education, Antihypertensive Agents, VLAG, Aged, Science & Technology, Antihypertensive Agents/therapeutic use, business.industry, Omvårdnad, fungi, General and internal medicine, Estados de Saúde e de Doença, Taking medication, Treatment, Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi, Blood pressure, Faculdade de Ciências Sociais, 3121 General medicine, internal medicine and other clinical medicine, lääkehoito, 1182 Biochemistry, cell and molecular biology, business, Demography
Abstract: Background: hypertension can be detected at the primary health-care level and low-cost treatments can effectively control hypertension. We aimed to measure the prevalence of hypertension and progress in its detection, treatment, and control from 1990 to 2019 for 200 countries and territories. Methods: we used data from 1990 to 2019 on people aged 30-79 years from population-representative studies with measurement of blood pressure and data on blood pressure treatment. We defined hypertension as having systolic blood pressure 140 mm Hg or greater, diastolic blood pressure 90 mm Hg or greater, or taking medication for hypertension. We applied a Bayesian hierarchical model to estimate the prevalence of hypertension and the proportion of people with hypertension who had a previous diagnosis (detection), who were taking medication for hypertension (treatment), and whose hypertension was controlled to below 140/90 mm Hg (control). The model allowed for trends over time to be non-linear and to vary by age. Findings: the number of people aged 30-79 years with hypertension doubled from 1990 to 2019, from 331 (95% credible interval 306-359) million women and 317 (292-344) million men in 1990 to 626 (584-668) million women and 652 (604-698) million men in 2019, despite stable global age-standardised prevalence. In 2019, age-standardised hypertension prevalence was lowest in Canada and Peru for both men and women; in Taiwan, South Korea, Japan, and some countries in western Europe including Switzerland, Spain, and the UK for women; and in several low-income and middle-income countries such as Eritrea, Bangladesh, Ethiopia, and Solomon Islands for men. Hypertension prevalence surpassed 50% for women in two countries and men in nine countries, in central and eastern Europe, central Asia, Oceania, and Latin America. Globally, 59% (55-62) of women and 49% (46-52) of men with hypertension reported a previous diagnosis of hypertension in 2019, and 47% (43-51) of women and 38% (35-41) of men were treated. Control rates among people with hypertension in 2019 were 23% (20-27) for women and 18% (16-21) for men. In 2019, treatment and control rates were highest in South Korea, Canada, and Iceland (treatment >70%; control >50%), followed by the USA, Costa Rica, Germany, Portugal, and Taiwan. Treatment rates were less than 25% for women and less than 20% for men in Nepal, Indonesia, and some countries in sub-Saharan Africa and Oceania. Control rates were below 10% for women and men in these countries and for men in some countries in north Africa, central and south Asia, and eastern Europe. Treatment and control rates have improved in most countries since 1990, but we found little change in most countries in sub-Saharan Africa and Oceania. Improvements were largest in high-income countries, central Europe, and some upper-middle-income and recently high-income countries including Costa Rica, Taiwan, Kazakhstan, South Africa, Brazil, Chile, Turkey, and Iran. Interpretation Improvements in the detection, treatment, and control of hypertension have varied substantially across countries, with some middle-income countries now outperforming most high-income nations. The dual approach of reducing hypertension prevalence through primary prevention and enhancing its treatment and control is achievable not only in high-income countries but also in low-income and middle-income settings., British Heart Foundation Centre of Research Excellence Grant; World Health Organization (WHO); Abdul Latif Jameel Institute for Disease and Emergency Analytics Fellowship
Published: 2021
Full Text: View/download PDF

36. Towards a shared understanding of Arctic climate change and urgency in Alaska

Author: Tero Mustonen and Brie Van Dam
Subjects: Geography, business.industry, Geography, Planning and Development, Environmental resource management, Arctic climate, business, Earth-Surface Processes
Published: 2021
Full Text: View/download PDF

37. The Behavioral and Psychological Symptoms of Dementia in Down Syndrome Scale (BPSD-DS II): Optimization and Further Validation1

Author: Gonny Beugelsdijk, Hepie Henstra, Aurora M Ulgiati, Anne-Sophie Rebillat, Roelie Fopma, Graziano Onder, Silvia Sacco, Marloes Hermelink, Anneke Loonstra-de Jong, Alain D. Dekker, Mieke Schippers, Liesbeth Willems, Lisa de Ruiter, Debby Van Dam, Marjo Oosterik, Ségolène Falquero, Antonella Di Paola, Martine Scholten-Kuiper, Antonia M. W. Coppus, Henk Groen, Juan Fortea, Marleen Tollenaere, Sílvia Valldeneu, Bessy Benejam, Peter Paul De Deyn, Judith Willink-Vos, Angelo Carfì, Vincent A. Boxelaar, Value, Affordability and Sustainability (VALUE), Reproductive Origins of Adult Health and Disease (ROAHD), and Molecular Neuroscience and Ageing Research (MOLAR)
Subjects: Male, 030506 rehabilitation, Trisomy 21, Down syndrome, Disease, Anxiety, Intellectual disabilities, Behavioral traits, 0302 clinical medicine, Medicine, Questionable dementia, General Neuroscience, General Medicine, Middle Aged, Alzheimer's disease, Irritable Mood, Neuropsychiatric symptoms, trisomy 21, Psychiatry and Mental health, Clinical Psychology, Scale (social sciences), Population study, Female, Behavioral and psychological symptoms of dementia, intellectual disabilities, Symptom Assessment, Erratum, 0305 other medical science, Alzheimer’s disease, Research Article, Clinical psychology, Adult, Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18], 03 medical and health sciences, Humans, Dementia, Aged, Behavior, behavior, business.industry, Reproducibility of Results, behavioral and psychological symptoms of dementia, medicine.disease, neuropsychiatric symptoms, Human medicine, Down Syndrome, Geriatrics and Gerontology, business, 030217 neurology & neurosurgery
Abstract: Altres ajuts: Research School Behavioral and Cognitive Neurosciences (RUG/UMCG); Gratama Stichting/Stichting Groninger Universiteitsfonds (2015-04); Research Foundation Flanders (G053218N); Fondo Europeo de Desarrollo Regional (FEDER); National Institutes of Health (NIA grants 1R01AG056850-01A1, R21AG056974, R01AG061566); Fundació La Marató de TV3 (20141210); Fundació Catalana Síndrome de Down; Fundació Víctor Grífols i Lucas; Generalitat de Catalunya (SLT006/17/00119). Background: People with Down syndrome (DS) are at high risk to develop Alzheimer's disease dementia (AD). Behavioral and psychological symptoms of dementia (BPSD) are common and may also serve as early signals for dementia. However, comprehensive evaluation scales for BPSD, adapted to DS, are lacking. Therefore, we previously developed the BPSD-DS scale to identify behavioral changes between the last six months and pre-existing life-long characteristic behavior. Objective: To optimize and further study the scale (discriminative ability and reliability) in a large representative DS study population. Methods: Optimization was based on item irrelevance and clinical experiences obtained in the initial study. Using the shortened and refined BPSD-DS II, informant interviews were conducted to evaluate 524 individuals with DS grouped according to dementia status: no dementia (DS, N = 292), questionable dementia (DS + Q, N = 119), and clinically diagnosed dementia (DS + AD, N = 113). Results: Comparing item change scores between groups revealed prominent changes in frequency and severity for anxious, sleep-related, irritable, restless/stereotypic, apathetic, depressive, and eating/drinking behavior. For most items, the proportion of individuals displaying an increased frequency was highest in DS + AD, intermediate in DS + Q, and lowest in DS. For various items within sections about anxious, sleep-related, irritable, apathetic, and depressive behaviors, the proportion of individuals showing an increased frequency was already substantial in DS + Q, suggesting that these changes may serve as early signals of AD in DS. Reliability data were promising. Conclusion: The optimized scale yields largely similar results as obtained with the initial version. Systematically evaluating BPSD in DS may increase understanding of changes among caregivers and (timely) adaptation of care/treatment.
Published: 2021
Full Text: View/download PDF

38. Added Value of Radiotherapy Following Neoadjuvant FOLFIRINOX for Resectable and Borderline Resectable Pancreatic Cancer: A Systematic Review and Meta-Analysis

Author: Hjalmar J. van Santvoort, Joost J. Nuyttens, Quisette P. Janssen, Hongchao Qi, Johanna W. Wilmink, Roeland F. de Wilde, Casper H.J. van Eijck, Geertjan van Tienhoven, Alice C. Wei, Bas Groot Koerkamp, Marc G. Besselink, Marjolein Y.V. Homs, Isabelle G. Kivits, Jacob L van Dam, Surgery, CCA - Cancer Treatment and Quality of Life, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, Oncology, CCA - Cancer biology and immunology, Radiotherapy, Internal medicine, VU University medical center, Radiation Oncology, Medical Oncology, and Epidemiology
Subjects: medicine.medical_specialty, FOLFIRINOX, medicine.medical_treatment, Perineural invasion, Leucovorin, Irinotecan, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, SDG 3 - Good Health and Well-being, law, Surgical oncology, Pancreatic cancer, Antineoplastic Combined Chemotherapy Protocols, Clinical endpoint, Medicine, Humans, 030212 general & internal medicine, Prospective Studies, business.industry, Pancreatic Tumors, medicine.disease, Neoadjuvant Therapy, Radiation therapy, Oxaliplatin, Pancreatic Neoplasms, Oncology, 030220 oncology & carcinogenesis, Meta-analysis, Surgery, Radiology, Fluorouracil, business
Abstract: Background The added value of radiotherapy following neoadjuvant FOLFIRINOX chemotherapy in patients with resectable or borderline resectable pancreatic cancer ((B)RPC) is unclear. The objective of this meta-analysis was to compare outcomes of patients who received neoadjuvant FOLFIRINOX alone or combined with radiotherapy. Methods A systematic literature search was performed in Embase, Medline (ovidSP), Web of Science, Scopus, Cochrane, and Google Scholar. The primary endpoint was pooled median overall survival (OS). Secondary endpoints included resection rate, R0 resection rate, and other pathologic outcomes. Results We included 512 patients with (B)RPC from 15 studies, of which 7 were prospective nonrandomized studies. In total, 351 patients (68.6%) were treated with FOLFIRINOX alone (8 studies) and 161 patients (31.4%) were treated with FOLFIRINOX and radiotherapy (7 studies). The pooled estimated median OS was 21.6 months (range 18.4–34.0 months) for FOLFIRINOX alone and 22.4 months (range 11.0–37.7 months) for FOLFIRINOX with radiotherapy. The pooled resection rate was similar (71.9% vs. 63.1%, p = 0.43) and the pooled R0 resection rate was higher for FOLFIRINOX with radiotherapy (88.0% vs. 97.6%, p = 0.045). Other pathological outcomes (ypN0, pathologic complete response, perineural invasion) were comparable. Conclusions In this meta-analysis, radiotherapy following neoadjuvant FOLFIRINOX was associated with an improved R0 resection rate as compared with neoadjuvant FOLFIRINOX alone, but a difference in survival could not be demonstrated. Randomized trials are needed to determine the added value of radiotherapy following neoadjuvant FOLFIRINOX in patients with (B)PRC.
Published: 2021
Full Text: View/download PDF

39. External validation of blue light imaging (BLI) criteria for the optical characterization of colorectal polyps by endoscopy experts

Author: Kevin F. Kennedy, Alessandro Repici, Irving Waxman, John R. Saltzman, Prateek Sharma, Hiroyuki Aihara, Jacques Van Dam, Heiko Pohl, Gregory B. Haber, Douglas K. Rex, Amrita Sethi, Madhav Desai, Seth A. Gross, Kenneth K. Wang, and Michael B. Wallace
Subjects: Adenoma, Light, Colonic Polyps, Color, Sensitivity and Specificity, Adenomatous Polyps, 03 medical and health sciences, 0302 clinical medicine, medicine, Humans, Blue light, Observer Variation, Hepatology, medicine.diagnostic_test, business.industry, Optical Imaging, Gastroenterology, External validation, Colonoscopy, medicine.disease, Predictive value, United States, Endoscopy, Colon polyps, Homogeneous, 030220 oncology & carcinogenesis, 030211 gastroenterology & hepatology, Colorectal Neoplasms, business, Nuclear medicine, Precancerous Conditions, Kappa
Abstract: BACKGROUND AND AIM Recently, the BLI Adenoma Serrated International Classification (BASIC) system was developed by European experts to differentiate colorectal polyps. Our aim was to validate the BASIC classification system among the US-based endoscopy experts. METHODS Participants utilized a web-based interactive learning system where the group was asked to characterize polyps using the BASIC criteria: polyp surface (presence of mucus, regular/irregular and [pseudo]depressed), pit appearance (featureless, round/non-round with/without dark spots; homogeneous/heterogeneous distribution with/without focal loss), and vessels (present/absent, lacy, peri-cryptal, irregular). The final testing consisted of reviewing BLI images/videos to determine whether the criteria accurately predicted the histology results. Confidence in adenoma identification (rated "1" to "5") and agreement in polyp (adenoma vs non-adenoma) identification and characterization per BASIC criteria were derived. Strength of interobserver agreement with kappa (k) value was reported for adenoma identification. RESULTS Ten endoscopy experts from the United States identified conventional adenoma (vs non-adenoma) with 94.4% accuracy, 95.0% sensitivity, 93.8% specificity, 93.8% positive predictive value, and 94.9% negative predictive value using BASIC criteria. Overall strength of interobserver agreement was high: kappa 0.89 (0.82-0.96). Agreement for the individual criteria was as follows: surface mucus (93.8%), regularity (65.6%), type of pit (40.6%), pit visibility (66.9%), pit distribution (57%), vessel visibility (73%), and being lacy (46%) and peri-cryptal (61%). The confidence in diagnosis was rated at high ≥4 in 67% of the cases. CONCLUSIONS A group of US-based endoscopy experts have validated a simple and easily reproducible BLI classification system to characterize colorectal polyps with >90% accuracy and a high level of interobserver agreement.
Published: 2021
Full Text: View/download PDF

40. Immunoglobin G/total antibody testing for SARS-CoV-2: A prospective cohort study of ambulatory patients and health care workers in two Belgian oncology units comparing three commercial tests

Author: Fien H. R. De Winter, Pieter Moons, Ella Roelant, Annelies Janssens, Lieselot Croes, Peter van Dam, Evelien Smits, Hans Prenen, Marc Peeters, An Hotterbeekx, Zwi N. Berneman, Manon T. Huizing, Zainab Amajoud, Wim Vanden Berghe, Leander Meuris, Christof Vulsteke, and Samir Kumar-Singh
Subjects: Male, 0301 basic medicine, Oncology, Cancer Research, Antibodies, Viral, Cohort Studies, immunoglobulin G, 0302 clinical medicine, Belgium, Seroepidemiologic Studies, Neoplasms, Oncology Service, Hospital, Ambulatory Care, Prospective Studies, Child, Prospective cohort study, Original Research, education.field_of_study, Middle Aged, Exact test, COVID-19 Nucleic Acid Testing, Child, Preschool, 030220 oncology & carcinogenesis, Population study, Female, medicine.medical_specialty, Adolescent, Health Personnel, Population, health care workers, COVID-19 Serological Testing, 03 medical and health sciences, McNemar's test, Internal medicine, medicine, Humans, cancer, Seroprevalence, Seroconversion, education, seroconversion, Aged, SARS-CoV-2, business.industry, Reproducibility of Results, COVID-19, Cancer, medicine.disease, 030104 developmental biology, Case-Control Studies, Reagent Kits, Diagnostic, Human medicine, business
Abstract: Background: Coronavirus disease (COVID-19) is interfering heavily with the screening, diagnosis and treatment of cancer patients. Better knowledge of the seroprevalence and immune response after Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection in this population is important to manage them safely during the pandemic. Methods: 922 cancer patients, 100 non-cancer patients and 94 health care workers (HCW) attending the Multidisciplinary Oncology Unit of Antwerp University Hospital from 24th of March 2020 till 31st of May 2020, and the Oncology Unit of AZ Maria Middelares Hospital, Ghent, from 13th of April 2020 till 31st of May 2020 participated in the study. The Alinity (A; Abbott) and Liaison (D; DiaSorin) commercially available assays were used to measure SARS-CoV-2 IgG, while total SARS-CoV-2 Ig was measured by Elecsys (R; Roche). Results: In the overall study population IgG/total SARS-CoV-2 antibodies were found in respectively 32/998 (3.2%), 68/1020 (6.7%), 37/1010 (3.7%) and of individuals using the A, D or R test. Forty-six out of 618 (7.4%) persons had a positive SARS-CoV-2 polymerase chain reaction (RT-PCR) test. Seroprevalence in cancer patients (A:2.2%, D:6.2%, R:3.0%), did not significantly differ from that in non-cancer patients (A:1.1%, D:5.6%, R:0.0%), but was lower than the HCW (A:13%, D:12%, R:12%; respectively Fisher’s exact test p Z 0.00001, p Z 0.046, p Z 0.0004). A positive SARS-CoV-2 RT-PCR was found in 6.8% of the cancer patients, 2.3% of the non-cancer patients and 28.1% of the HCW (Fisher’s exact test p Z 0.0004). Correlation between absolute values of the different Ig tests was poor in the cancer population. Dichotomising a positive versus negative test result, the A and R test correlated well (kappa 0.82 p McNemar test Z 0.344), while A and D and R and D did not (respectively kappa 0.49 and 0.57; result significantly different p McNemar test Z 75%) and median absolute antibody levels (A: 7.0 versus 4.7; D 74.0 versus 26.6, R: 16.34 versus 7.32; all >P Mann Whitney U test Z 0.28) in cancer patients and HCW with a positive RT-PCR at least 7 days earlier did not show any differences. However, none (N Z 0/4) of the patients with hematological tumours had seroconversion and absolute antibody levels remained much lower compared to patients with solid tumours (R: 0.1 versus 37.6, p 0.003; D 4.1 versus 158, p 0.008) or HCW (all p < 0.0001). Conclusion: HCW were at high risk of being infected by SARS-CoV-2 during the first wave of the pandemic. Seroprevalence in cancer patients was low in the study period. Although Ig immune response in cancer patients with solid tumours does not differ from healthy volunteers, patients with hematological tumours have a very poor humoral immune response. This has to be taken into account in future vaccination programmes in this population. SARS-CoV-2 antibody tests have divergent results and seem to have little added value in the management of cancer patients.
Published: 2021
Full Text: View/download PDF

41. International multicenter propensity score matched study on laparoscopic versus open left lateral sectionectomy

Author: Thomas M. van Gulik, Ronald M. van Dam, Mathieu D'Hondt, Marcel J. van der Poel, Cornelis Verhoef, Marieke T. de Boer, R. Fichtinger, Pieter J. Tanis, Mohammed Abu Hilal, Marc G. Besselink, Türkan Terkivatan, Burak Görgec, Olivier R. Busch, Arab Rawashdeh, RS: NUTRIM - R2 - Liver and digestive health, Surgery, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, MUMC+: MA Heelkunde (9), Graduate School, Radiology and Nuclear Medicine, CCA - Cancer Treatment and Quality of Life, and Amsterdam Gastroenterology Endocrinology Metabolism
Subjects: Liver surgery, medicine.medical_specialty, RESECTION, Operative Time, LEFT-SIDED HEPATECTOMY, 03 medical and health sciences, Postoperative Complications, 0302 clinical medicine, Blood loss, REGRESSION, medicine, Hepatectomy, Humans, HEPATIC SECTIONECTOMY, Propensity Score, Retrospective Studies, LIVER SURGERY, Hepatology, HEPATOLITHIASIS, business.industry, Gastroenterology, Retrospective cohort study, Guideline, Length of Stay, Surgery, Treatment Outcome, 030220 oncology & carcinogenesis, Baseline characteristics, Propensity score matching, Operative time, Laparoscopy, 030211 gastroenterology & hepatology, business, Hospital stay, SYSTEM
Abstract: Background: Despite a lack of high-level evidence, current guidelines recommend laparoscopic left lateral sectionectomy (LLLS) as the routine approach over open LLS (OLLS). Randomized studies and propensity score matched studies on LLLS vs OLLS for all indications, including malignancy, are lacking.Methods: This international multicenter propensity score matched retrospective cohort study included consecutive patients undergoing LLLS or OLLS in six centers from three European countries (January 2000-December 2016). Propensity scores were calculated based on nine preoperative variables and LLLS and OLLS were matched in a 1:1 ratio. Short-term operative outcomes were compared using paired tests.Results: A total of 560 patients were included. Out of 200 LLLS, 139 could be matched to 139 OLLS. After matching, baseline characteristics were well balanced. LLLS was associated with shorter operative time (144 (110-200) vs 199 (138-283) minutes, P < 0.001), less blood loss (100 (50-300) vs 350 (100-750) mL, P = 0.005) and a 3-day shorter postoperative hospital stay (4 (3-7) vs 7 (5-9) days, P < 0.001).Conclusion: This international multicenter propensity score matched study confirms the superiority of LLLS over OLLS based on shorter postoperative hospital stay, operative time, and less blood loss thus validating current guideline advice.
Published: 2021

42. High prevalence and resistance rates of Mycoplasma genitalium among patients visiting two sexually transmitted infection clinics in the Netherlands

Author: Alje P. van Dam, David J. Hetem, Roel H. T. Nijhuis, Joyce F. Braam, Martijn S. van Rooijen, Jean-Marie Brand, Sophie Kuizenga Wessel, Clarissa E. Vergunst, Mary Berns, Sylvia M. Bruisten, Dermatology, Graduate School, Medical Microbiology and Infection Prevention, AII - Infectious diseases, and Finance
Subjects: medicine.medical_specialty, macrolide resistance, Prevalence, Cervicitis, Mycoplasma genitalium, Dermatology, urologic and male genital diseases, medicine.disease_cause, Azithromycin, Men who have sex with men, 03 medical and health sciences, 0302 clinical medicine, SDG 3 - Good Health and Well-being, Internal medicine, Pelvic inflammatory disease, medicine, Pharmacology (medical), Urethritis, 030212 general & internal medicine, sexual transmitted diseases, azithromycin, 0303 health sciences, biology, 030306 microbiology, business.industry, Public Health, Environmental and Occupational Health, bacterial infections and mycoses, medicine.disease, biology.organism_classification, female genital diseases and pregnancy complications, Infectious Diseases, Neisseria gonorrhoeae, business, medicine.drug
Abstract: Mycoplasma genitalium is a well-known cause of urethritis in men and has been associated with cervicitis, pelvic inflammatory disease, and adverse obstetric outcomes in women. In this cross-sectional study, we determined the current prevalence of M. genitalium infection and the rate of macrolide resistance in M. genitalium isolates, in patients visiting two large Dutch sexually transmitted infection (STI) clinics, to evaluate whether the recommendations in Dutch guidelines should be revised. In addition, risk factors for M. genitalium were identified. In total, 3225 patients were included. M. genitalium prevalence rates were 13.8% for all patients; 20.1% for men who have sex with men, 8.2% for men who have sex with women, and 12.6% for women. Macrolide resistance-associated mutations were detected in 66% of the patients infected with M. genitalium. Age, educational level, country of origin, number of sexual partners, HIV-positivity, infection with Neisseria gonorrhoeae, and urethral symptoms in men were independently associated with M. genitalium infection. In conclusion, we found very high prevalence rates and macrolide resistance rates of M. genitalium in patients visiting STI clinics.
Published: 2021
Full Text: View/download PDF

43. Sugar-sweetened beverage consumption, weight gain, and risk of type 2 diabetes and cardiovascular diseases in Asia: a systematic review

Author: Rob M. van Dam, Guo-Chong Chen, Su Hyun Park, and Nithya Neelakantan
Subjects: Sugar-Sweetened Beverages, Nutrition and Dietetics, business.industry, Weight change, Medicine (miscellaneous), Context (language use), Type 2 diabetes, Weight Gain, medicine.disease, Obesity, Beverages, Diabetes Mellitus, Type 2, Cardiovascular Diseases, Environmental health, Relative risk, Humans, Medicine, medicine.symptom, business, Weight gain, Body mass index, Abdominal obesity
Abstract: Context The prevalence of type 2 diabetes mellitus (T2DM) and cardiovascular diseases (CVDs) is increasing in Asia and several countries are adopting preventive policies to reduce consumption of sugar-sweetened beverages (SSBs). However, evidence on the relation between SSB consumption and cardiometabolic health in Asian populations has not been summarized. Objective In this systematic review, the associations between consumption of SSBs and cardiometabolic outcomes, including obesity, T2DM, and CVD, are examined in Asian populations. Data sources The PubMed, Scopus, and Web of Science databases, and gray literature were searched up to October, 2020 to identify relevant articles. Data extraction Two investigators independently extracted data from included studies. Data analysis When sufficient studies were available, a random-effects meta-analysis was used to calculate the pooled estimates (expressed as risk ratio [RR] and 95% confidence interval [CI]). Heterogeneity was tested and quantified using the Cochrane Q test and I2 statistic, respectively. Results Of the 17 studies included, 8 provided results about measures of adiposity (3 on weight change, 4 on body mass index (BMI), 2 on percent body fat, and 1 on abdominal obesity), 6 reported results about T2DM, and 3 reported on different CVD outcomes. High SSB consumption was significantly associated with greater weight gain and with a higher risk of selected CVD outcomes as compared with low consumption. In the meta-analysis, high SSB consumption was associated with greater T2DM risk before (RR, 1.51; 95%CI, 1.15–1.98 for highest vs lowest category; I2 = 76%) and after (RR, 1.38; 95%CI, 1.09–1.73; I2 = 56%) adjustment for BMI. Conclusions These findings suggest that high SSB consumption is directly associated with weight gain, risk of T2DM, and, possibly, selected CVD outcomes in Asian populations. Public health strategies to reduce SSB consumption in Asian countries are warranted. Systematic Review Registration PROSPERO registration no. CRD42019129456.Keywords: adiposity. cardiovascular disease, Asia, sugar-sweetened beverages, type 2 diabetes.
Published: 2021
Full Text: View/download PDF

44. Specificity of the Point-of-Care Urine Strip Test for Schistosoma Circulating Cathodic Antigen (POC-CCA) Tested in Non-Endemic Pregnant Women and Young Children

Author: Meta Roestenberg, Paul L. A. M. Corstjens, Miriam Casacuberta-Partal, Cornelis H. Hokke, Pytsje T. Hoekstra, Govert J. van Dam, Dieuwke Kornelis, Claudia J. de Dood, Margreet M T Beenakker, Lisa Kroon, and Lisette van Lieshout
Subjects: Adult, Male, Point-of-Care Systems, 030231 tropical medicine, Population, Physiology, Urine, Sensitivity and Specificity, Feces, South Africa, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Antigen, Pregnancy, Virology, parasitic diseases, Animals, Humans, Medicine, Non endemic, education, Point of care, Schistosoma, education.field_of_study, Strip test, biology, business.industry, Infant, Newborn, Infant, Articles, Schistosoma mansoni, Middle Aged, biology.organism_classification, Schistosomiasis mansoni, Infectious Diseases, Antigens, Helminth, Child, Preschool, Female, Parasitology, Pregnant Women, Reagent Kits, Diagnostic, business
Abstract: The point-of-care urine based strip test for the detection of circulating cathodic antigen (POC-CCA) in schistosome infections is a frequently used tool for diagnosis and mapping of Schistosoma mansoni in school-aged children. Because of its ease of use, the test is increasingly applied to adults and preschool-aged children (PSAC), but its performance has not been specifically evaluated in these target groups. Recent observations have raised concerns about possible reduced specificity, in particular in pregnant women (PW) and PSAC. We thus explored specificity of the POC-CCA urine strip test (Rapid Medical Diagnostics, Pretoria, South Africa) in a non-endemic, nonexposed population of 47 healthy nonpregnant adults (NPAs), 52 PW, and 58 PSAC. A total of 157 urines were tested with POC-CCA, of which five (10.6%) NPAs, 17 (32.7%) PW, and 27 (46.5%) PSAC were positive. The highest scores were found in the youngest babies, with an infant of 9 months being the oldest positive case. On measuring pH, it appeared that all POC-CCA strongly positive urines were acidic (pH range 5–5.5), whereas addition of pH-neutral buffer to a subsample reversed the false positivity. We conclude that the POC-CCA test has reduced specificity in PW and infants younger than 9 months, but that the false positivity might be eliminated by modifications in the buffers used in the test.
Published: 2021
Full Text: View/download PDF

45. Youth Initiated Mentoring in Social Work: Sustainable Solution for Youth with Complex Needs?

Author: Levi van Dam, Lotte Heijmans, Geert J. Stams, and Forensic Child and Youth Care (RICDE, FMG)
Subjects: Medical education, Social network, Social work, business.industry, 05 social sciences, 050301 education, General Social Sciences, 0501 psychology and cognitive sciences, Confidentiality, business, Psychology, 0503 education, Social Sciences (miscellaneous), Young person, 050104 developmental & child psychology, Complex needs
Abstract: Youth Initiated Mentoring (YIM) is a new approach in child and family services, in which collaboration with natural mentors from within the social network of the young person is central. Young people themselves choose a mentor from within their environment. This mentor is their confidential advisor and he or she stands up for the interests of the young person. In addition, the YIM is a cooperation partner for parents and social workers. Research into the long-term effects is lacking, therefore, in the current study, a total of 24 (former) YIMs were interviewed (14 women, 10 men). The ages of the YIMs range from 23 to 78 years (M = 50, SD = 13.7). On average, the YIMs know the young people for a periode of 9 years and 6 months (SD = 5.1), family members not included. The YIM program were closed 6 months to 4 years ago (M = 2.3, SD = 1.12). The majority of YIMs keep in touch with the young person (75%) and currently most young persons lives at home or in within their community (79%). The YIM approach is a resilient and promising approach in social work, prerequisite that it is valued by parties involved.
Published: 2021
Full Text: View/download PDF

46. Trends in the incidence of diagnosed diabetes: a multicountry analysis of aggregate data from 22 million diagnoses in high-income and middle-income settings

Author: Paz Lopez-Doriga Ruiz, Lei Chen, Jonathan E. Shaw, Marta Baviera, Didac Mauricio, Yi Xian Chua, Naama Yekutiel, Linda J. Andes, Thomas R. Hird, Mykola Khalangot, Romualdas Gurevicius, Rakibul M. Islam, Gillian L. Booth, Maria Carla Roncaglioni, Gregory A. Nichols, Mark M. Nielen, Deanette Pang, Sarah H. Wild, György Jermendy, Elise Boersma-van Dam, Chun Yi Lin, Sonsoles Fuentes, Bendix Carstensen, Kyoung Hwa Ha, Marina Vladimirovna Shestakova, Santa Pildava, Hanne Løvdal Gulseth, Stephanie H. Read, Juliana C.N. Chan, Dianna J. Magliano, Meda E. Pavkov, Zoltán Kiss, Avi Porath, Kang Ling Wang, Ran D. Balicer, Dae Jung Kim, Andrea O.Y. Luk, Olga K. Vikulova, Catherine Pelletier, Sanjoy K. Paul, Edward W. Gregg, Victor Kravchenko, Sandrine Fosse-Edorh, Manel Mata-Cases, and Maya Leventer-Roberts
Subjects: education.field_of_study, business.industry, Endocrinology, Diabetes and Metabolism, Incidence (epidemiology), Population, 030209 endocrinology & metabolism, Type 2 diabetes, medicine.disease, 03 medical and health sciences, symbols.namesake, 0302 clinical medicine, Endocrinology, Diabetes mellitus, Data quality, Internal Medicine, medicine, symbols, Aggregate data, 030212 general & internal medicine, Poisson regression, Population Risk, business, education, Demography
Abstract: Summary Background Diabetes prevalence is increasing in most places in the world, but prevalence is affected by both risk of developing diabetes and survival of those with diabetes. Diabetes incidence is a better metric to understand the trends in population risk of diabetes. Using a multicountry analysis, we aimed to ascertain whether the incidence of clinically diagnosed diabetes has changed over time. Methods In this multicountry data analysis, we assembled aggregated data describing trends in diagnosed total or type 2 diabetes incidence from 24 population-based data sources in 21 countries or jurisdictions. Data were from administrative sources, health insurance records, registries, and a health survey. We modelled incidence rates with Poisson regression, using age and calendar time (1995–2018) as variables, describing the effects with restricted cubic splines with six knots for age and calendar time. Findings Our data included about 22 million diabetes diagnoses from 5 billion person-years of follow-up. Data were from 19 high-income and two middle-income countries or jurisdictions. 23 data sources had data from 2010 onwards, among which 19 had a downward or stable trend, with an annual estimated change in incidence ranging from −1·1% to −10·8%. Among the four data sources with an increasing trend from 2010 onwards, the annual estimated change ranged from 0·9% to 5·6%. The findings were robust to sensitivity analyses excluding data sources in which the data quality was lower and were consistent in analyses stratified by different diabetes definitions. Interpretation The incidence of diagnosed diabetes is stabilising or declining in many high-income countries. The reasons for the declines in the incidence of diagnosed diabetes warrant further investigation with appropriate data sources. Funding US Centers for Disease Control and Prevention, Diabetes Australia Research Program, and Victoria State Government Operational Infrastructure Support Program.
Published: 2021
Full Text: View/download PDF

47. Development of imaging-based risk scores for prediction of intracranial haemorrhage and ischaemic stroke in patients taking antithrombotic therapy after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies

Author: Henry Ma, Eleni Sakka, Hugues Chabriat, Duncan Wilson, Appu Suman, Peter J. Kelly, SL Ho, Charlotte Zerna, Eric Jouvent, Lawrence K.S. Wong, Anthea Parry, Frances Harrington, Jan Stam, Christopher Patterson, Rustam Al-Shahi Salman, Shigeru Inamura, Krishna A Dani, Henry Houlden, Sebastian Thilemann, Kotaro Iida, Chao Xu, Eunbin Ko, Daniel Guisado-Alonso, Urs Fischer, Caroline E. Lovelock, Man Yu Tse, Wing Chi Fong, Azlisham Mohd Nor, Clare Shakeshaft, Philippe Maeder, Henrik Gensicke, Stefan T. Engelter, James Okwera, Christopher Chen, Dulka Manawadu, John F. Corrigan, Efrat Kliper, Shelagh B. Coutts, Alexander P. Leff, Kam Tat Leung, Chathuri Yatawara, Leopold Hertzberger, M. Eline Kooi, Kazuhisa Yoshifuji, Hing Lung Ip, Keon-Joo Lee, Sanjeevikumar Meenakishundaram, Hiroyuki Irie, Marc Randall, Hatice Ozkan, Hideo Hara, Jill Abrigo, Raquel Delgado-Mederos, Shaloo Singhal, Enrico Flossmann, Beatriz Gómez-Ansón, Paul O'Mahony, Carmen Barbato, Ahamad Hassan, Francesca M Chappell, Harald Proschel, Vincent Mok, Masashi Nishihara, Lakshmanan Sekaran, Derya Selcuk Demirelli, Chu Peng Hoi, Hakan Ay, Joan Martí-Fàbregas, Rebeca Marín, Anne Cristine Guevarra, Martin Cooper, Einor Ben Assayag, Anne-Marie Mendyk, Christine Roffe, Myung Suk Jang, Maarten van Gemert, Hannah Cohen, Jae-Sung Lim, YK Wong, Bonnie Y.K. Lam, Janet Putterill, Wouter Schoonewille, Nick S. Ward, Nikola Sprigg, Kui Kai Lau, Bernard Esisi, Peter M. Rothwell, Henk Verbiest, Kirsty Harkness, Elisa Merino, Gareth Ambler, Arumug Nallasivam, Nigel Smyth, Paul A. Armitage, Heinrich Mattle, Pol Camps-Renom, Martin M. Brown, David Cohen, Min Lou, Pankaj Sharma, Sarah Gunkel, Elles Douven, Andreas Charidimou, Djamil Vahidassr, Cathy Soufan, Alexandros A Polymeris, Michael G. Hennerici, Chris Moran, Rachel Marsh, Mahmud Sajid, Kyohei Fujita, David J. Werring, Joanna M. Wardlaw, Derek Hayden, Joseph Kwan, Timothy J. England, Jaap van der Sande, Luis Prats-Sánchez, Paul Guyler, Ryan Hoi Kit Cheung, Koon-Ho Chan, Frank-Erik de Leeuw, Simone Browning, Jon Scott, Adrian Barry, Alejandro Martínez-Domeño, Luc Bracoub, Dinesh Chadha, Ijaz Anwar, Deborah Kelly, Moon-Ku Han, Anil M. Tuladhar, Thomas Gattringer, Fiona Carty, Abduelbaset Elmarim, Syed Mansoor, Enrico Flossman, Dilek Necioglu Orken, Jane Sword, Velandai Srikanth, Ping Wing Ng, Thomas W. Leung, Richard Shek-kwan Chang, Hans Rolf Jäger, Marwan El-Koussy, Jeroen Hendrikse, Khaled Darawil, Kazunori Toyoda, Mathuri Prabhakaran, Karim Mahawish, Ethem Murat Arsava, Jihoon Kang, Kwok Kui Wong, Michael Power, Felix Fluri, Enas Lawrence, Maam Mamun, Sissi Ispoglou, Mathew Burn, Siu Hung Li, Henry K.F. Mak, Kaori Miwa, Els De Schryver, Franz Fazekas, Jonathan G. Best, Louise Shaw, Hen Hallevi, Keith W. Muir, Ilse Burger, Adrian Wong, Nils Peters, Susana Muñoz-Maniega, Yusuke Yakushiji, David Calvet, Mark White, Michael McCormick, Vinodh Krishnamurthy, David Hargroves, Jan C. Purrucker, Tae Jin Song, Masayuki Shiozawa, Noortje A.M. Maaijwee, Prasanna Aghoram, Nicolas Christ, Lino Ramos, Yannie Soo, Thanh G. Phan, Parashkev Nachev, David J. Seiffge, Kim Wiegertjes, Leo H. Bonati, Chahin Pachai, Oi Ling Chan, Yvo B.W.E.M. Roos, Santiago Medrano-Martorell, Natan M. Bornstein, Elizabeth A. Warburton, Richard Li, Prabel Datta, Pascal P. Gratz, Edmund Ka Ming Wong, Hedley C. A. Emsley, Marie-Yvonne Douste-Blazy, Gunaratam Gunathilagan, Nagaendran Kandiah, Masatoshi Koga, Roland Veltkamp, Lee-Anne Slater, Suk Fung Tsang, Beom Joon Kim, Simon Jung, Zeynep Tanriverdi, Sarah Caine, Peter J. Koudstaal, Laurence Legrand, Kari Saastamoinen, Ale Algra, Jean-Louis Mas, Christine Delmaire, Fidel Nuñez, Robert J. van Oostenbrugge, Sebastian Eppinger, Lillian Choy, Robert Luder, Vincent I.H. Kwa, Aad van der Lugt, Marie Dominique Fratacci, Stephen Makin, Layan Akijian, Régis Bordet, Mi Hwa Yang, Ying Zhou, Elio Giallombardo, Adrian R Parry-Jones, John S. Thornton, Amos D. Korczyn, Narayanaswamy Venketasubramanian, David J. Williams, Aravindakshan Manoj, Julie Staals, Solveig Horstmann, Dianne H.K. van Dam-Nolen, Claire Cullen, Benjamin Wagner, Jun Tanaka, Martin Dennis, Stef Bakker, Gregory Y.H. Lip, L. Jaap Kappelle, Robin Lemmens, Achim Gass, David Mangion, Matthew Smith, Toshio Imaizumi, Wenyan Liu, Jeremy Molad, Christopher Price, Paul J. Nederkoorn, P. J. A. M. Brouwers, Vincent Thijs, Sze Ho Ma, Mark Schembri, Peter Wilkinson, Janice E. O’Connell, Karen Ma, John Ly, Leonidas Panos, Chung Yan Chan, Toshihiro Ide, Christopher Traenka, Joost Jöbsis, Gargi Banerjee, Paul Berntsen, Michael J. Thrippleton, Raymond T.F. Cheung, Christopher Karayiannis, Werner H. Mess, Robert Simister, Jayesh Modi Medanta, Syuhei Ikeda, John Mitchell, Linxin Li, Mauro S.B. Silva, Eric Vicaut, John Coyle, Shoichiro Sato, Michelle Davis, Jonathan Birns, Richard J. Perry, Sean M. Murphy, KC Teo, Maria del C. Valdés Hernández, Bibek Gyanwali, Tarek A. Yousry, Kath Pasco, Sebastian Köhler, Joachim Fladt, Edward S. Hui, Philippe Lyrer, Young Dae Kim, Anna K. Heye, Eric E. Smith, Saima Hilal, Ender Uysal, Ji Hoe Heo, Ysoline Beigneux, Cisca Linn, Hee-Joon Bae, Simon Leach, Winnie C.W. Chu, Ronil V. Chandra, Neurology, ACS - Atherosclerosis & ischemic syndromes, ANS - Neurovascular Disorders, MUMC+: HZC Med Staf Spec Klinische Neurofys (9), RS: Carim - B06 Imaging, MUMC+: HZC Klinische Neurofysiologie (5), Klinische Neurowetenschappen, Psychiatrie & Neuropsychologie, RS: MHeNs - R1 - Cognitive Neuropsychiatry and Clinical Neuroscience, MUMC+: MA Neurologie (3), RS: Carim - B05 Cerebral small vessel disease, MUMC+: Hersen en Zenuw Centrum (3), MUMC+: MA Med Staf Spec Neurologie (9), RS: NUTRIM - R1 - Obesity, diabetes and cardiovascular health, Beeldvorming, and MUMC+: DA BV Klinisch Fysicus (9)
Subjects: Adult, Male, Risk, EXTERNAL VALIDATION, medicine.medical_specialty, Neurology, MODELS, Clinical Neurology, 030204 cardiovascular system & hematology, 03 medical and health sciences, 0302 clinical medicine, Fibrinolytic Agents, Recurrence, Internal medicine, Antithrombotic, Humans, Medicine, Prospective cohort study, 610 Medicine & health, Stroke, METAANALYSIS, Aged, Ischemic Stroke, Science & Technology, medicine.diagnostic_test, business.industry, Proportional hazards model, Magnetic resonance imaging, Middle Aged, Disorders of movement Donders Center for Medical Neuroscience [Radboudumc 3], medicine.disease, Magnetic Resonance Imaging, Ischemic Attack, Transient, ATRIAL-FIBRILLATION, Cardiology, Female, Neurology (clinical), Neurosciences & Neurology, business, Intracranial Hemorrhages, Life Sciences & Biomedicine, 030217 neurology & neurosurgery, Fibrinolytic agent, Cohort study
Abstract: Contains fulltext : 235277.pdf (Publisher’s version ) (Closed access) BACKGROUND: Balancing the risks of recurrent ischaemic stroke and intracranial haemorrhage is important for patients treated with antithrombotic therapy after ischaemic stroke or transient ischaemic attack. However, existing predictive models offer insufficient performance, particularly for assessing the risk of intracranial haemorrhage. We aimed to develop new risk scores incorporating clinical variables and cerebral microbleeds, an MRI biomarker of intracranial haemorrhage and ischaemic stroke risk. METHODS: We did a pooled analysis of individual-patient data from the Microbleeds International Collaborative Network (MICON), which includes 38 hospital-based prospective cohort studies from 18 countries. All studies recruited participants with previous ischaemic stroke or transient ischaemic attack, acquired baseline MRI allowing quantification of cerebral microbleeds, and followed-up participants for ischaemic stroke and intracranial haemorrhage. Participants not taking antithrombotic drugs were excluded. We developed Cox regression models to predict the 5-year risks of intracranial haemorrhage and ischaemic stroke, selecting candidate predictors on biological relevance and simplifying models using backward elimination. We derived integer risk scores for clinical use. We assessed model performance in internal validation, adjusted for optimism using bootstrapping. The study is registered on PROSPERO, CRD42016036602. FINDINGS: The included studies recruited participants between Aug 28, 2001, and Feb 4, 2018. 15 766 participants had follow-up for intracranial haemorrhage, and 15 784 for ischaemic stroke. Over a median follow-up of 2 years, 184 intracranial haemorrhages and 1048 ischaemic strokes were reported. The risk models we developed included cerebral microbleed burden and simple clinical variables. Optimism-adjusted c indices were 0·73 (95% CI 0·69-0·77) with a calibration slope of 0·94 (0·81-1·06) for the intracranial haemorrhage model and 0·63 (0·62-0·65) with a calibration slope of 0·97 (0·87-1·07) for the ischaemic stroke model. There was good agreement between predicted and observed risk for both models. INTERPRETATION: The MICON risk scores, incorporating clinical variables and cerebral microbleeds, offer predictive value for the long-term risks of intracranial haemorrhage and ischaemic stroke in patients prescribed antithrombotic therapy for secondary stroke prevention; external validation is warranted. FUNDING: British Heart Foundation and Stroke Association.
Published: 2021
Full Text: View/download PDF

48. Laparoscopic versus open extended radical left pancreatectomy for pancreatic ductal adenocarcinoma: an international propensity-score matched study

Author: D. Gomez, Safi Dokmak, Frederik Berrevoet, Andrea Pietrabissa, Riccardo Casadei, Maarten Korrel, Adnan Alseidi, C. Krautz, Tobias Keck, O.R.C. Busch, A. Sa Cunha, Antonello Forgione, J. van Hilst, Bergthor Björnsson, Thilo Hackert, Ugo Boggi, A. Balduzzi, Brice Gayet, Jean-Michel Fabre, B. Groot Koerkamp, P.B. van den Boezem, Massimo Falconi, Ignasi Poves, Santiago Sánchez-Cabús, Giovanni Butturini, Ravi Marudanayagam, Zahir Soonawalla, Roberto Salvia, R. Van Dam, Mushegh A. Sahakyan, Bilal Al-Sarireh, Bjørn Edwin, S. Lof, Giorgio Ercolani, Marc G. Besselink, M. Abu Hilal, Igor Khatkov, K. Menon, Graduate School, CCA - Cancer Treatment and Quality of Life, Amsterdam Gastroenterology Endocrinology Metabolism, Surgery, Balduzzi A., van Hilst J., Korrel M., Lof S., Al-Sarireh B., Alseidi A., Berrevoet F., Bjornsson B., van den Boezem P., Boggi U., Busch O.R., Butturini G., Casadei R., van Dam R., Dokmak S., Edwin B., Sahakyan M.A., Ercolani G., Fabre J.M., Falconi M., Forgione A., Gayet B., Gomez D., Koerkamp B.G., Hackert T., Keck T., Khatkov I., Krautz C., Marudanayagam R., Menon K., Pietrabissa A., Poves I., Cunha A.S., Salvia R., Sanchez-Cabus S., Soonawalla Z., Hilal M.A., Besselink M.G., RS: NUTRIM - R2 - Liver and digestive health, and MUMC+: MA Heelkunde (9)
Subjects: medicine.medical_specialty, Left pancreatectomy, ERLP, 030230 surgery, SURGICAL COMPLICATIONS, PANCREATOSPLENECTOMY, CLASSIFICATION, 03 medical and health sciences, 0302 clinical medicine, Pancreatectomy, Retrospective Studie, Internal medicine, medicine, Humans, Lymph node, Retrospective Studies, Gastric emptying, business.industry, Cancer, PDAC, cohort, Hepatology, medicine.disease, CANCER, DISTAL PANCREATECTOMY, Surgery, Reconstructive and regenerative medicine Radboud Institute for Health Sciences [Radboudumc 10], Pancreatic Neoplasms, DEFINITION, medicine.anatomical_structure, Treatment Outcome, Propensity score matching, Cohort, 030211 gastroenterology & hepatology, Laparoscopy, business, Abdominal surgery, Human, Carcinoma, Pancreatic Ductal, Extended resection
Abstract: Item does not contain fulltext BACKGROUND: A radical left pancreatectomy in patients with pancreatic ductal adenocarcinoma (PDAC) may require extended, multivisceral resections. The role of a laparoscopic approach in extended radical left pancreatectomy (ERLP) is unclear since comparative studies are lacking. The aim of this study was to compare outcomes after laparoscopic vs open ERLP in patients with PDAC. METHODS: An international multicenter propensity-score matched study including patients who underwent either laparoscopic or open ERLP (L-ERLP; O-ERLP) for PDAC was performed (2007-2015). The ISGPS definition for extended resection was used. Primary outcomes were overall survival, margin negative rate (R0), and lymph node retrieval. RESULTS: Between 2007 and 2015, 320 patients underwent ERLP in 34 centers from 12 countries (65 L-ERLP vs. 255 O-ERLP). After propensity-score matching, 44 L-ERLP could be matched to 44 O-ERLP. In the matched cohort, the conversion rate in L-ERLP group was 35%. The L-ERLP R0 resection rate (matched cohort) was comparable to O-ERLP (67% vs 48%; P = 0.063) but the lymph node yield was lower for L-ERLP than O-ERLP (median 11 vs 19, P = 0.023). L-ERLP was associated with less delayed gastric emptying (0% vs 16%, P = 0.006) and shorter hospital stay (median 9 vs 13 days, P = 0.005), as compared to O-ERLP. Outcomes were comparable for additional organ resections, vascular resections (besides splenic vessels), Clavien-Dindo grade ≥ III complications, or 90-day mortality (2% vs 2%, P = 0.973). The median overall survival was comparable between both groups (19 vs 20 months, P = 0.571). Conversion did not worsen outcomes in L-ERLP. CONCLUSION: The laparoscopic approach may be used safely in selected patients requiring ERLP for PDAC, since morbidity, mortality, and overall survival seem comparable, as compared to O-ERLP. L-ERLP is associated with a high conversion rate and reduced lymph node yield but also with less delayed gastric emptying and a shorter hospital stay, as compared to O-ERLP.
Published: 2021

49. Herpes zoster after COVID vaccination

Author: C.S. van Dam, R. Rösken, I. Lede, M. Smits, J. Schaar, M. Al-Dulaimy, Internal medicine, and ACS - Diabetes & metabolism
Subjects: Microbiology (medical), Skin manifestations, Coronavirus disease 2019 (COVID-19), business.industry, viruses, Pulmonary disease, COVID-19, Context (language use), Case Report, General Medicine, Disease, Infectious and parasitic diseases, RC109-216, medicine.disease, Herpes Zoster, Virus, Vaccination, Infectious Diseases, vaccine, Immunology, Medicine, Lymphocytopenia, business
Abstract: COVID-19 presents in various ways, but mainly as a pulmonary disease (Marzano, 2020). Skin manifestations have been reported, including reactivation of the varicella-zoster virus (Marzano, 2020). Our case report describes two adults developing herpes zoster after vaccination with tozinameran (the Pfizer-BioNTech COVID-19 mRNA vaccine). A possible cause for this reaction is a transient lymphocytopenia that occurs after the vaccination — similar to that in COVID-19 disease (Mulligan, 2020; Wang, 2020; Qin, 2020; Brabilla, 2020; Wang, 2020; Wei, 2017). In the context of vaccinating older and/or immunocompromised adults, our observations can be the starting point for further evaluation of a possible relationship between COVID-19, COVID vaccines, and herpes zoster.
Published: 2021
Full Text: View/download PDF

50. A standard operating procedure for developing and hosting a webinar for healthcare professionals new to online teaching

Author: Marije P. Hennus and Marjel van Dam
Subjects: Medical education, business.industry, Distancing, Health Personnel, media_common.quotation_subject, Distance education, General Medicine, 030204 cardiovascular system & hematology, Education, Distance, Dilemma, 03 medical and health sciences, Face-to-face, Presentation, 0302 clinical medicine, Humans, Medicine, The Internet, 030212 general & internal medicine, business, Delivery of Health Care, Parallels, Standard operating procedure, media_common
Abstract: In the previous decades, distance learning in (medical) education, has taken flight worldwide. Many medical educational institutions have successfully embraced online distance learning (ODL), with online courses now being delivered by a great number of organisations, ranging from community colleges to renowned universities all around the globe.1–4 The current era of physical distancing in light of the COVID-19 pandemic has further underscored the need for online learning programmes for healthcare professionals. Although some medical educators with a degree in teaching may have abundant experience in developing and hosting online training programmes (eg, ODL postgraduate programmes), many clinical teachers, for example, physicians, nurses and other allied healthcare professionals, may feel quite hesitant and out of their depth when faced with the request to provide their lectures or trainings online instead of face to face. Without previous training and/or specific expertise, developing and presenting an engaging e-learning can be quite a challenge. To help overcome this practical dilemma, we have developed a robust standard operating procedure (SOP) for clinical teachers with limited experience in online teaching on how to develop and host an engaging webinar. A webinar, an aggregation of the words ‘web-based’ and ‘seminar’ can be defined as a presentation, lecture or workshop which is transmitted real time through the internet with the option to interact with the presenter and/or other participants.5 Alternatively, a recording of the webinar can often be viewed at a later moment but does not offer the option of live interaction. Webinar history parallels that of the internet with the appearance of predecessors like real-time text messaging apps emerging at the end of 1980s, followed by web chats and instant messaging apps in the mid 1990s, to the registration of the trademark ‘webinar’ in 1998.6 With today’s available software, it is no longer deemed …
Published: 2021
Full Text: View/download PDF

Catalog

Books, media, physical & digital resources

See catalog results

Searchworks

Select search scope, currently: Articles Catalog books, media & more in Jio Institute collections Articles journal articles & other e-resources

Search

Search Constraints

Refine your results

Search Limiters

Topic

Publication Year Range

Language

Publication Type

Journal

Region

Database

Publisher

3,239 results on '"Van, Dam"'

Search Results

Catalog

Select search scope, currently: Articles

Catalog

books, media & more in Jio Institute collections

Articles

journal articles & other e-resources